Amgen Inc. v. Amneal Pharmaceuticals et al
Plaintiff: Amgen Inc.
Defendant: Aurobindo Pharma Ltd, Cadila Healthcare Ltd. doing business as Zydus Cadila, Hetero USA Inc., Mylan Pharmaceuticals Inc., Cipla Limited, Cipla USA Inc., Strides Pharma Inc., Zydus Pharmaceuticals (USA) Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Micro Labs USA, Inc., Aurobindo Pharma USA Inc., Hetero Labs Ltd., Dr. Reddys Laboratories, Inc., Ajanta Pharma USA Inc., Aurobindo Pharma Ltd., Micro Labs Limited, Slate Run Pharmaceuticals, LLC, Actavis Pharma, Inc., Watson Laboratories, Inc., Amneal Pharmaceuticals of New York LLC, Hetero Labs Ltd. Unit V, Apotex Inc., Apotex Corp., Mylan Inc., Cipla Ltd., Breckenridge Pharmaceutical Inc., Sun Pharmaceutical Industries, Inc., Ajanta Pharma Limited, Strides Pharma Global PTE Limited, Piramal Healthcare Limited, Dr. Reddys Laboratories, Ltd., Sun Pharma Global FZE, Cipla USA, Inc. and Sun Pharmaceutical Industries Ltd.,
3Rd Party Defendant: Alkem Laboratories Ltd. and Ascend Laboratories, LLC
Counter Claimant: Cadila Healthcare Ltd.
Case Number: 1:2016cv00853
Filed: September 22, 2016
Court: U.S. District Court for the District of Delaware
Office: Wilmington Office
County: New Castle
Presiding Judge: Mitchell S Goldberg
Nature of Suit: Patent
Cause of Action: 35 U.S.C. § 271
Jury Demanded By: None
RSS RSS Track this Docket
Docket Report

This docket was last retrieved on October 19, 2021. A more recent docket listing may be available from PACER.

Date Filed Document Text
June 7, 2021 Opinion or Order Filing 683 REDACTED VERSION of #679 Response to Motion by Amgen Inc.. (Blumenfeld, Jack)
June 4, 2021 Opinion or Order Filing 682 [SEALED] REPLY BRIEF re #676 MOTION to Redact #665 Transcript, #667 Transcript filed by Slate Run Pharmaceuticals, LLC. (Phillips, John)
May 28, 2021 Opinion or Order Filing 681 MOTION to Seal Trial Exhibit PSR-075 - filed by Amgen Inc.. (Attachments: #1 Exs. 1-3)(Blumenfeld, Jack)
May 28, 2021 Opinion or Order Filing 680 MOTION to Seal Trial Exhibits (Unopposed) - filed by Cipla Limited, Cipla USA Inc.. (Attachments: #1 Text of Proposed Order)(Brauerman, Stephen)
May 28, 2021 Opinion or Order Filing 679 [SEALED] RESPONSE to Motion re #676 MOTION to Redact #665 Transcript, #667 Transcript - filed by Amgen Inc.. (Blumenfeld, Jack)
May 28, 2021 Opinion or Order Filing 678 MOTION to Seal Trial Exhibits - filed by Actavis Pharma, Inc., Watson Laboratories, Inc., Teva Pharmaceuticals USA, Inc.. (Attachments: #1 Text of Proposed Order)(Hoeschen, Nathan)
May 28, 2021 Opinion or Order Filing 677 MOTION for Extension of Time to File Motions to Seal Trial Exhibits [UNOPPOSED] - filed by Piramal Healthcare Limited, Slate Run Pharmaceuticals, LLC. (Attachments: #1 Text of Proposed Order)(Bilson, David)
May 14, 2021 Opinion or Order Filing 676 [SEALED] MOTION to Redact #665 Transcript, #667 Transcript - filed by Slate Run Pharmaceuticals, LLC. (Attachments: #1 Text of Proposed Order, #2 Exhibit A - D)(Bilson, David)
May 7, 2021 Opinion or Order Filing 675 Letter to The Honorable Mitchell S. Goldberg from Jack B. Blumenfeld regarding Copies of Post-Trial and Trial Documents. (Blumenfeld, Jack)
May 6, 2021 Opinion or Order Filing 674 Letter to The Honorable Mitchell S. Goldberg from David A. Bilson regarding courtesy copies. (Bilson, David)
April 28, 2021 Opinion or Order Filing 673 ORDER, Motions to seal portions of the transcript from the March 24-25, 2021 bench trial shall be filed by May 14, 2021. Motions to seal any trial exhibits shall be filed by May 28, 2021. The parties shall not file trial exhibits that are cumulative, repetitive, and/or not germane to the issues before the Court, or not referenced at trial. (**See Order for further details). Signed by Judge Mitchell S. Goldberg on 4/28/2021. (nmg)
April 27, 2021 Opinion or Order Filing 672 REDACTED VERSION of #669 POST Trial Brief by Amgen Inc.. (Blumenfeld, Jack)
April 27, 2021 Opinion or Order Filing 671 REDACTED VERSION of #668 POST Trial Brief by Piramal Healthcare Limited, Slate Run Pharmaceuticals, LLC. (Bilson, David)
April 26, 2021 Opinion or Order Filing 670 Letter to The Honorable Mitchell S. Goldberg from Jack B. Blumenfeld regarding request for oral argument - re #669 POST Trial Brief, #668 POST Trial Brief. (Blumenfeld, Jack)
April 20, 2021 Opinion or Order Filing 669 [SEALED] POST TRIAL BRIEF by Amgen Inc.. (Blumenfeld, Jack)
April 20, 2021 Opinion or Order Filing 668 [SEALED] POST TRIAL BRIEF for Recovery of Damages from the Injunction Bond by Piramal Healthcare Limited, Slate Run Pharmaceuticals, LLC. (Phillips, John)
April 19, 2021 Opinion or Order CORRECTING ENTRY: Docket entry previously marked as 664 deleted as it was a duplicate entry of entry 663. (amf)
April 17, 2021 Opinion or Order Filing 667 [SEALED] Transcript of Official Transcript of Bench Trial - Volume B held on March 25, 2021 before Judge Mitchell S. Goldberg. (bpg)
April 17, 2021 Opinion or Order Filing 666 Official Transcript of Bench Trial - Volume B held on March 25, 2021 before Judge Mitchell S. Goldberg. Court Reporter Brian Gaffigan, email: [email protected]. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/10/2021. Redacted Transcript Deadline set for 5/18/2021. Release of Transcript Restriction set for 7/16/2021.(bpg)
April 17, 2021 Opinion or Order Filing 665 [SEALED] Transcript of Official Transcript of Bench Trial - Volume A held on March 24, 2021 before Judge Mitchell S. Goldberg. (bpg)
April 17, 2021 Opinion or Order Filing 663 Official Transcript of Bench Trial - Volume A held on March 24, 2021 before Judge Mitchell S. Goldberg. Court Reporter Brian Gaffigan, email: [email protected]. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/10/2021. Redacted Transcript Deadline set for 5/18/2021. Release of Transcript Restriction set for 7/16/2021. (bpg)
March 31, 2021 Opinion or Order Filing 662 STIPULATION AND ORDER - Post-trial briefs shall be served and filed by April 20, 2021 and each side's post-trial brief shall be limited to 45 pages. Signed by Judge Mitchell S. Goldberg on 3/31/2021. (amf)
March 30, 2021 Opinion or Order Filing 661 REDACTED VERSION of #651 Letter [No Redactions] by Piramal Healthcare Limited, Slate Run Pharmaceuticals, LLC. (Bilson, David)
March 30, 2021 Opinion or Order Filing 660 [SEALED] DEPOSITION DESIGNATIONS filed by Amgen Inc.. (Attachments: #1 Exhibits A-B)(Blumenfeld, Jack)
March 30, 2021 Opinion or Order Filing 659 REDACTED VERSION of #648 Declaration by Piramal Healthcare Limited, Slate Run Pharmaceuticals, LLC. (Phillips, John)
March 30, 2021 Opinion or Order Filing 658 REDACTED VERSION of #647 Answering Brief in Opposition, by Piramal Healthcare Limited, Slate Run Pharmaceuticals, LLC. (Phillips, John)
March 29, 2021 Opinion or Order Filing 657 STIPULATION regarding post-trial briefs by Amgen Inc.. (Blumenfeld, Jack)
March 29, 2021 Opinion or Order Filing 656 REDACTED VERSION of #650 MOTION to Redact #629 Transcript,, [and Motion to Seal Transcript] by Slate Run Pharmaceuticals, LLC. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Proposed Order)(Phillips, John)
March 26, 2021 Opinion or Order Filing 655 REDACTED VERSION of #645 Declaration by Piramal Healthcare Limited, Slate Run Pharmaceuticals, LLC. (Attachments: #1 Exhibits A-D)(Phillips, John)
March 26, 2021 Opinion or Order Filing 654 REDACTED VERSION of #644 Reply Brief by Piramal Healthcare Limited, Slate Run Pharmaceuticals, LLC. (Phillips, John)
March 26, 2021 Opinion or Order Filing 653 Official Transcript of Telephonic Status Conference held on 2/11/2021 before Judge Judge Mitchell S. Goldberg. Court Reporter Suzanne R. White, (215) 299-7252. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER Redaction Request due 4/16/2021. Redacted Transcript Deadline set for 4/26/2021. Release of Transcript Restriction set for 6/24/2021. (nmg)
March 26, 2021 Opinion or Order Filing 652 Official Transcript of Status Conference held via Teleconference held on March 22,2021 before Judge Mitchell S. Goldberg. Court Reporter/Transcriber Suzzane R. White. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER Redaction Request due 4/16/2021. Redacted Transcript Deadline set for 4/26/2021. Release of Transcript Restriction set for 6/24/2021. (myr)
March 25, 2021 Opinion or Order Minute Entry for proceedings held before Judge Mitchell S. Goldberg - Bench Trial Day 2 completed on 3/25/2021. (Court Reporter Brian Gaffigan and Valerie Gunning.) (amf)
March 24, 2021 Opinion or Order Minute Entry for proceedings held before Judge Mitchell S. Goldberg - Bench Trial Day 1 held on 3/24/2021. (Court Reporter Brian Gaffigan and Valerie Gunning.) (amf)
March 23, 2021 Opinion or Order Filing 651 [SEALED] Letter to The Honorable Mitchell S. Goldberg from John C. Phillips, Jr. regarding Follow-up to March 22, 2021 Teleconference with the Court. (Phillips, John)
March 23, 2021 Opinion or Order CORRECTING ENTRY: D.I. #650 is filed by Slate Run Pharmaceuticals, LLC only; this document is not filed on behalf of Piramal Healthcare Limited. (kmd)
March 22, 2021 Opinion or Order Filing 650 [SEALED] MOTION to Redact #629 Transcript,, [and Motion to Seal Transcript] - filed by Slate Run Pharmaceuticals, LLC. (Attachments: #1 Text of Proposed Order, #2 Exhibit A, #3 Exhibit B)(Phillips, John) Modified on 3/23/2021 (kmd).
March 22, 2021 Opinion or Order Filing 649 NOTICE OF SERVICE of Piramal and Slate Run's List of Deposition Designations for the Deposition of Craig P. Cowman filed by Piramal Healthcare Limited, Slate Run Pharmaceuticals, LLC.(Bilson, David)
March 22, 2021 Opinion or Order Filing 648 [SEALED] DECLARATION re #647 Answering Brief in Opposition, of Ben J. Mahon by Piramal Healthcare Limited, Slate Run Pharmaceuticals, LLC. (Attachments: #1 Exhibits 1-11)(Phillips, John)
March 22, 2021 Opinion or Order Filing 647 [SEALED] ANSWERING BRIEF in Opposition re #646 MOTION to Exclude Piramal and Slate Run's Reliance on Opinion of Counsel re #630 Opening Brief in Support filed by Piramal Healthcare Limited, Slate Run Pharmaceuticals, LLC.Reply Brief due date per Local Rules is 3/29/2021. (Phillips, John)
March 22, 2021 Opinion or Order Minute Entry for proceedings held before Judge Mitchell S. Goldberg: Telephone Conference held on 3/22/2021. (nmg)
March 22, 2021 Opinion or Order Remark: The public dial-in information for the trial beginning on 3/24/2021 is as follows - PUBLIC access dial in phone number: 703-552-8058. Conference number: 163265. (amf)
March 19, 2021 Opinion or Order Filing 646 [SEALED] MOTION to Exclude Piramal and Slate Run's Reliance on Opinion of Counsel re #630 Opening Brief in Support - filed by Amgen Inc.. (Attachments: #1 Exhibits A-C)(Blumenfeld, Jack)
March 19, 2021 Opinion or Order Filing 645 [SEALED] Supplemental DECLARATION re #644 Reply Brief by Piramal Healthcare Limited, Slate Run Pharmaceuticals, LLC. (Attachments: #1 Exhibit A - D)(Phillips, John)
March 19, 2021 Opinion or Order Filing 644 [SEALED] REPLY BRIEF [Piramal and Slate Run's Reply Brief for Recovery of Damages From the Injunction Bond] filed by Piramal Healthcare Limited, Slate Run Pharmaceuticals, LLC. (Phillips, John)
March 19, 2021 Opinion or Order Filing 643 REDACTED VERSION of #636 Declaration by Amgen Inc.. (Blumenfeld, Jack)
March 19, 2021 Opinion or Order Filing 642 REDACTED VERSION of #635 Answering Brief in Opposition by Amgen Inc.. (Blumenfeld, Jack)
March 17, 2021 Opinion or Order Filing 641 ORDER granting #639 Motion to Appear Pro Hac Vice of Attorney Ashley Ratycz. Signed by Judge Mitchell S. Goldberg on 3/17/2021. (kmd)
March 17, 2021 Opinion or Order Pro Hac Vice Attorney Ashley M. Ratycz for Piramal Healthcare Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
March 16, 2021 Opinion or Order Filing 640 Letter to The Honorable Mitchell S. Goldberg from Jack B. Blumenfeld regarding March 24 hearing. (Blumenfeld, Jack)
March 16, 2021 Opinion or Order Filing 639 MOTION for Pro Hac Vice Appearance of Attorney Ashley Ratycz - filed by Piramal Healthcare Limited. (Attachments: #1 Ratycz Pro Hac Certification)(Bilson, David)
March 15, 2021 Opinion or Order Filing 638 REDACTED VERSION of #631 Declaration by Piramal Healthcare Limited, Slate Run Pharmaceuticals, LLC. (Phillips, John)
March 15, 2021 Opinion or Order Filing 637 REDACTED VERSION of #630 Opening Brief in Support by Piramal Healthcare Limited, Slate Run Pharmaceuticals, LLC. (Phillips, John)
March 12, 2021 Opinion or Order Filing 636 [SEALED] DECLARATION re #635 Answering Brief in Opposition -- Declaration of Robert S. Pickens -- by Amgen Inc.. (Attachments: #1 Exs. 1-26)(Blumenfeld, Jack)
March 12, 2021 Opinion or Order Filing 635 [SEALED] ANSWERING BRIEF in Opposition #630 OPENING BRIEF in Support for Recovery of Damages from the Injunction Bond - filed by Amgen Inc..Reply Brief due date per Local Rules is 3/19/2021. (Blumenfeld, Jack)
March 8, 2021 Opinion or Order Filing 634 NOTICE of Intent to Request Redaction by John C. Phillips, Jr re #629 Transcript,, (Phillips, John)
March 8, 2021 Opinion or Order Filing 633 Letter to The Honorable Mitchell S. Goldberg from Jack B. Blumenfeld regarding representation for the March 24, 2021 hearing - re #632 Order,, Set Hearings,. (Blumenfeld, Jack)
March 8, 2021 Opinion or Order Filing 632 ORDER, a hearing is scheduled to take place in person in the United States District Court for the District of Delaware, Courtroom 4A on March 24, 2021 at 10:00 a.m. before Judge Mitchell S. Goldberg and may continue into March 25, 2021 starting at 10:00 a.m., if needed. Signed by Judge Mitchell S. Goldberg on 3/8/2021. (nmg)
March 5, 2021 Opinion or Order Filing 631 [SEALED] DECLARATION re #630 Opening Brief in Support For Recovery of Damages from the Injunction Bond by Piramal Healthcare Limited, Slate Run Pharmaceuticals, LLC. (Attachments: #1 Exhibit 1-16)(Phillips, John)
March 5, 2021 Opinion or Order Filing 630 [SEALED] OPENING BRIEF in Support For Recovery of Damages from the Injunction Bond filed by Piramal Healthcare Limited, Slate Run Pharmaceuticals, LLC.Answering Brief/Response due date per Local Rules is 3/19/2021. (Phillips, John)
March 1, 2021 Opinion or Order Filing 629 Official Transcript of Telephone Conference held on 2/24/2021 before Judge Mitchell S. Goldberg. Court Reporter/Transcriber Michael T. Keating. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER Redaction Request due 3/22/2021. Redacted Transcript Deadline set for 4/1/2021. Release of Transcript Restriction set for 6/1/2021. (myr)
February 25, 2021 Opinion or Order Filing 628 STIPULATION AND ORDER re #627 STIPULATION and [Proposed] Order Amending Scheduling Order. Signed by Judge Mitchell S. Goldberg on 2/25/2021. (nmg)
February 24, 2021 Opinion or Order Filing 627 STIPULATION and [Proposed] Order Amending Scheduling Order by Piramal Healthcare Limited, Slate Run Pharmaceuticals, LLC. (Bilson, David)
February 24, 2021 Opinion or Order Minute Entry for proceedings held before Judge Mitchell S. Goldberg - Telephone Conference held on 2/24/2021. (50 Minutes) (myr)
February 22, 2021 Opinion or Order Filing 626 Joint Letter to The Honorable Mitchell S. Goldberg from John C. Phillips, Jr. regarding parties' views on logistics for the March 24 hearing - re #613 Order,,,, Set Hearings,,,, Set Scheduling Order Deadlines,,,. (Phillips, John)
February 22, 2021 Opinion or Order Filing 625 NOTICE OF SERVICE of [HIGHLY CONFIDENTIAL] Supplemental Reply Expert Report of Ivan T. Hofmann filed by Piramal Healthcare Limited, Slate Run Pharmaceuticals, LLC.(Bilson, David)
February 19, 2021 Opinion or Order Filing 624 ORDER re #623 REPORT AND RECOMMENDATIONS of Special Master: I have reviewed the Report and agree with the analysis and recommendations contained therein. I will provide the parties an opportunity to serve and file specific written objections by February 24, 2020. Objections shall be limited to three (3) pages per party. Signed by Judge Mitchell S. Goldberg on 2/19/2021. (kmd)
February 17, 2021 Opinion or Order Filing 623 [SEALED] REPORT AND RECOMMENDATIONS of Special Master re #593 MOTION to Compel Discovery. Objections to R&R due by 2/24/2021. Signed by Special Master Lawrence F. Stengel on 2/17/2021. This order has been emailed to local counsel. (amf)
February 11, 2021 Opinion or Order Filing 622 NOTICE OF SERVICE of Expert Report of Michael E. Tate filed by Amgen Inc..(Blumenfeld, Jack)
February 11, 2021 Opinion or Order Minute Entry for proceedings held before Judge Mitchell S. Goldberg - Telephone Conference held on 2/11/2021. (nmg)
February 3, 2021 Opinion or Order Filing 621 ORDER Setting Telephone Conference for 2/11/2021 at 01:30 PM before Judge Mitchell S. Goldberg. The conference will be held on the record. Counsel are directed to dial in to 571-353-2300, passcode 427102124#. Signed by Judge Mitchell S. Goldberg on 2/3/2021. (myr)
January 25, 2021 Opinion or Order Filing 620 ORDER: The Hon. Lawrence F. Stengel, be and is hereby appointed Special Master for Discovery re #593 MOTION to Compel, as per Order #613 . See Order for further details. Signed by Judge Mitchell S. Goldberg on 1/25/2020. (kmd)
January 22, 2021 Opinion or Order Filing 619 Pro Hac Vice Fee - Check received for the Bankruptcy Court for Dina Yunker. ( Payment of $ 25.00, receipt number # DEX034993) (amf)
January 22, 2021 Opinion or Order Filing 618 [SEALED] Transcript of Discovery Dispute Hearing held on 1/14/2021 before Judge Mitchell S. Goldberg. (amf)
January 20, 2021 Opinion or Order Filing 617 REDACTED VERSION of #611 Reply Brief by Amgen Inc.. (Blumenfeld, Jack)
January 19, 2021 Opinion or Order Filing 616 REDACTED VERSION of #606 MOTION to Amend/Correct the Protective Order by Amgen Inc.. (Fahnestock, Derek)
January 19, 2021 Opinion or Order Filing 615 REDACTED VERSION of #605 MOTION to Amend the Scheduling Order by Amgen Inc.. (Fahnestock, Derek)
January 19, 2021 Opinion or Order Filing 614 REDACTED VERSION of #607 Memorandum in Opposition, by Piramal Healthcare Limited, Slate Run Pharmaceuticals, LLC. (Attachments: #1 Exhibit A-B)(Bilson, David)
January 19, 2021 Opinion or Order Filing 613 ORDER - Plaintiff Amgen Inc.'s Motion to Amend the Scheduling Order (D.I. #605 ) is GRANTED in part and DENIED in part. The Scheduling Order will be amended, but not as to the dates proposed by Plaintiff. Plaintiff Amgen Inc.'s Motion to Compel Discovery from Slate Run (D.I. #593 ) is REFERRED to a Special Master, with costs to be split 50/50 between Amgen and Piramal/Slate Run. Unless the parties file an objection by January 19, 2021, the Court will appoint the Honorable Lawrence F. Stengel (retired) to serve as Special Master. Plaintiff Amgen Inc.'s Motion to Amend the Protective Order (D.I. #606 ) is DENIED for the reasons stated on the record at the January 14, 2021 teleconference. Please see attached Order for further details. Signed by Judge Mitchell S. Goldberg on 1/19/2021. (amf)
January 15, 2021 Opinion or Order Filing 612 [SEALED] ORDER to seal transcript of the telephone hearing held in the above-captioned case on January 14, 2021. Signed by Judge Mitchell S. Goldberg on 1/15/2021.This order has been emailed to local counsel. (amf) (Main Document 612 replaced on 1/15/2021) (amf).
January 15, 2021 Opinion or Order Minute Entry for proceedings held before Judge Mitchell S. Goldberg - Telephone Hearing held on 1/14/2021. (amf)
January 13, 2021 Opinion or Order Filing 611 [SEALED] REPLY BRIEF re #605 MOTION to Amend the Scheduling Order filed by Amgen Inc.. (Attachments: #1 Exhibits 1-6)(Blumenfeld, Jack)
January 13, 2021 Opinion or Order Filing 610 REDACTED VERSION of #602 Reply Brief by Amgen Inc.. (Attachments: #1 Exhibit 1)(Blumenfeld, Jack)
January 12, 2021 Opinion or Order Filing 609 ORDER - a TELEPHONE CONFERENCE on Plaintiff's Motion to Compel (D.I. #593 ) is scheduled for Thursday, January 14, 2021 at 2:00 p.m. The conference will be held on the record. Counsel are directed to dial in to 571-353-2300, passcode 427102124#. Signed by Judge Mitchell S. Goldberg on 1/12/2021. (amf)
January 11, 2021 Opinion or Order Filing 608 Letter to The Honorable Mitchell S. Goldberg from John C. Phillips, Jr. regarding Request for Expedited Treatment of Plaintiff's Motion to Amend Scheduling Order - re #607 Memorandum in Opposition,. (Phillips, John)
January 11, 2021 Opinion or Order Filing 607 [SEALED] MEMORANDUM in Opposition re #605 MOTION to Amend the Scheduling Order filed by Piramal Healthcare Limited, Slate Run Pharmaceuticals, LLC.Reply Brief due date per Local Rules is 1/19/2021. (Attachments: #1 Exhibit A-B)(Phillips, John)
January 11, 2021 Opinion or Order Filing 606 [SEALED] MOTION to Amend/Correct the Protective Order - filed by Amgen Inc.. (Attachments: #1 [Proposed] Order, #2 Exs. 1-5)(Blumenfeld, Jack)
January 8, 2021 Opinion or Order Filing 605 [SEALED] MOTION to Amend the Scheduling Order - filed by Amgen Inc.. (Attachments: #1 Exhibit 1-6, #2 Text of Proposed Order)(Fahnestock, Derek)
January 7, 2021 Opinion or Order Filing 604 REDACTED VERSION of #594 Opening Brief in Support by Amgen Inc.. (Attachments: #1 Exhibit A, #2 Exhibits 1-16)(Blumenfeld, Jack)
January 7, 2021 Opinion or Order Filing 603 REDACTED VERSION of #593 MOTION to Compel by Amgen Inc.. (Blumenfeld, Jack)
January 6, 2021 Opinion or Order Filing 602 [SEALED] REPLY BRIEF re #593 MOTION to Compel filed by Amgen Inc.. (Attachments: #1 Exhibit 1)(Blumenfeld, Jack)
December 29, 2020 Opinion or Order Filing 601 REDACTED VERSION of #598 Answering Brief in Opposition, by Slate Run Pharmaceuticals, LLC. (Attachments: #1 Exhibits 1-3)(Phillips, John)
December 29, 2020 Opinion or Order Filing 600 STIPULATION AND ORDER re #599 STIPULATION TO EXTEND TIME for plaintiff to file its reply brief to January 6, 2021. Signed by Judge Mitchell S. Goldberg on 12/29/2020. (nmg)
December 23, 2020 Opinion or Order Filing 599 STIPULATION TO EXTEND TIME for plaintiff to file its reply brief to January 6, 2021 - filed by Amgen Inc.. (Blumenfeld, Jack)
December 23, 2020 Opinion or Order CORRECTING ENTRY: Exhibit 1 to DI 598 replaced per counsel's request. (kmd)
December 22, 2020 Opinion or Order Filing 598 [SEALED] ANSWERING BRIEF in Opposition re #593 MOTION to Compel filed by Slate Run Pharmaceuticals, LLC.Reply Brief due date per Local Rules is 12/29/2020. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3)(Phillips, John) (Attachment 1 replaced on 12/23/2020) (kmd).
December 16, 2020 Opinion or Order Filing 597 REDACTED VERSION of #588 MOTION to Seal and Redact Transcript MOTION to Seal Document: #568 Transcript,, [UNOPPOSED] by Slate Run Pharmaceuticals, LLC. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Proposed Order)(Phillips, John)
December 14, 2020 Opinion or Order Filing 596 [SEALED] ORDER granting #588 [SEALED] MOTION to Seal and Redact Transcript, MOTION to Seal Document: 568 Transcript, [UNOPPOSED]. Signed by Judge Mitchell S. Goldberg on 12/14/2020. This order has been emailed to local counsel. (nmg)
December 10, 2020 Opinion or Order Filing 595 REDACTED VERSION of #585 Answer to Intervenor Complaint by Amgen Inc.. (Blumenfeld, Jack)
December 9, 2020 Opinion or Order Pro Hac Vice Attorney J. Drew Diamond for Amgen Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
December 8, 2020 Opinion or Order Filing 594 [SEALED] OPENING BRIEF in Support re #593 MOTION to Compel filed by Amgen Inc..Answering Brief/Response due date per Local Rules is 12/22/2020. (Attachments: #1 Exhibit A, #2 Exhibits 1-16)(Blumenfeld, Jack)
December 8, 2020 Opinion or Order Filing 593 [SEALED] MOTION to Compel - filed by Amgen Inc.. (Blumenfeld, Jack)
December 7, 2020 Opinion or Order Filing 592 STIPULATION AND ORDER to Amend Scheduling Order as to Piramal's damages case re D.I. #499 . (Joint Letter to the Court due by 1/12/2021; Piramal's Reply Expert Reports due by 12/11/2020; Deadline to Complete Expert Depositions set for 1/8/2021; Piramal's Opening Brief due by 1/15/2021; Amgen's Responsive Brief due by 2/12/2021; Piramal's Reply Brief due by 2/26/2021; Pre-hearing Telephone Conference is set for 3/10/2021 at 02:00 PM before Judge Mitchell S. Goldberg; Hearing is set for March 24, 2021 before Judge Mitchell S. Goldberg.) (See Order for further detail.) Signed by Judge Mitchell S. Goldberg on 12/7/2020. (kmd)
December 7, 2020 Opinion or Order Filing 591 STIPULATION AND ORDER to Extend Time. The deadline to submit requests to redact the transcript of the telephonic hearing held on November 10, 2020 (D.I. #568 ) shall be extended from December 3, 2020 to December 4, 2020. Signed by Judge Mitchell S. Goldberg on 12/7/2020. (kmd)
December 7, 2020 Opinion or Order Filing 590 ORDER granting #584 Motion to Appear Pro Hac Vice. Signed by Judge Mitchell S. Goldberg on 12/7/2020. (kmd)
December 4, 2020 Opinion or Order Filing 589 NOTICE OF SERVICE of Supplemental Objections and Responses to Defendant Piramal's Interrogatory Number 13 filed by Amgen Inc..(Blumenfeld, Jack)
December 4, 2020 Opinion or Order Filing 588 [SEALED] MOTION to Seal and Redact Transcript, MOTION to Seal Document: #568 Transcript,, [UNOPPOSED] - filed by Slate Run Pharmaceuticals, LLC. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Text of Proposed Order)(Phillips, John)
December 4, 2020 Opinion or Order Filing 587 STIPULATION and [Proposed] Order to Amend Scheduling Order re #499 Order by Amgen Inc.. (Blumenfeld, Jack)
December 3, 2020 Opinion or Order Filing 586 STIPULATION TO EXTEND TIME to submit requests to redact the transcript of the telephonic hearing held on November 10, 2020 to December 4, 2020 - filed by Piramal Healthcare Limited, Slate Run Pharmaceuticals, LLC. (Phillips, John)
December 3, 2020 Opinion or Order Filing 585 [SEALED] ANSWER to #556 Intervenor Complaint by Amgen Inc..(Blumenfeld, Jack)
December 1, 2020 Opinion or Order Filing 584 MOTION for Pro Hac Vice Appearance of Attorney J. Drew Diamond - filed by Amgen Inc.. (Blumenfeld, Jack)
November 24, 2020 Opinion or Order Filing 583 STIPULATION AND ORDER re #580 STIPULATION TO EXTEND TIME for Piramal and Slate Run to serve their Reply Expert Report(s) to December 9, 2020. Signed by Judge Mitchell S. Goldberg on 11/24/2020. (nmg)
November 24, 2020 Opinion or Order Filing 582 STIPULATION AND ORDER re #579 STIPULATION TO EXTEND TIME for plaintiff to respond to Slate Run's Complaint in Intervention (D.I. 556) to December 3, 2020. Signed by Judge Mitchell S. Goldberg on 11/24/2020. (nmg)
November 23, 2020 Opinion or Order Filing 581 NOTICE OF SERVICE of Expert Report of Jerry A. Hausman filed by Amgen Inc..(Blumenfeld, Jack)
November 23, 2020 Opinion or Order Filing 580 STIPULATION TO EXTEND TIME for Piramal and Slate Run to serve their Reply Expert Report(s) to December 9, 2020 - filed by Piramal Healthcare Limited, Slate Run Pharmaceuticals, LLC. (Phillips, John)
November 23, 2020 Opinion or Order Filing 579 STIPULATION TO EXTEND TIME for plaintiff to respond to Slate Run's Complaint in Intervention (D.I. 556) to December 3, 2020 - filed by Amgen Inc.. (Blumenfeld, Jack)
November 23, 2020 Opinion or Order Filing 578 REDACTED VERSION of #570 Letter by Amgen Inc.. (Blumenfeld, Jack)
November 18, 2020 Opinion or Order Filing 577 REDACTED VERSION of #567 Letter by Slate Run Pharmaceuticals, LLC. (Phillips, John)
November 17, 2020 Opinion or Order Filing 576 REDACTED VERSION of #566 Letter by Slate Run Pharmaceuticals, LLC. (Phillips, John)
November 17, 2020 Opinion or Order Filing 575 REDACTED VERSION of #565 Letter, by Piramal Healthcare Limited. (Phillips, John)
November 17, 2020 Opinion or Order Filing 574 ORDER - Amgen's request to extend its deadline to file a Responsive Expert Report (D.I. #559 ; D.I. #562 ) is GRANTED. Amgen shall file a Responsive Expert Report by November 23, 2020 regardless of whether it has obtained the additional discovery it seeks. (*See Order for additional details.) Signed by Judge Mitchell S. Goldberg on 11/17/2020. (amf)
November 16, 2020 Opinion or Order Filing 573 REDACTED VERSION of #562 Letter, by Amgen Inc.. (Blumenfeld, Jack)
November 16, 2020 Opinion or Order Filing 572 REDACTED VERSION of #559 Letter by Amgen Inc.. (Blumenfeld, Jack)
November 13, 2020 Opinion or Order Filing 571 REDACTED VERSION of #561 Letter by Piramal Healthcare Limited, Slate Run Pharmaceuticals, LLC. (Bilson, David)
November 13, 2020 Opinion or Order Filing 570 [SEALED] Letter to Honorable Mitchell S. Goldberg from Jack B. Blumenfeld regarding response to Slate Runs letter - re #567 Letter. (Attachments: #1 Exhibit A)(Blumenfeld, Jack)
November 12, 2020 Opinion or Order Filing 569 NOTICE of Intent to Request Redaction by David A. Bilson re #568 Transcript,, (Bilson, David)
November 12, 2020 Opinion or Order Filing 568 Official Transcript of Teleconference held on 11/10/2020 before Judge Mitchell S. Goldberg. Court Reporter/Transcriber: TK Transcribers. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 12/3/2020. Redacted Transcript Deadline set for 12/14/2020. Release of Transcript Restriction set for 2/10/2021. (amf)
November 12, 2020 Opinion or Order Minute Entry for proceedings held before Judge Mitchell S. Goldberg - Telephone Conference held on 11/10/2020. (nmg)
November 12, 2020 Opinion or Order Pro Hac Vice Attorney Christopher J. Dutton for Slate Run Pharmaceuticals, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
November 11, 2020 Opinion or Order Filing 567 [SEALED] Letter to The Honorable Mitchell S. Goldberg from John C. Phillips, Jr. regarding follow up to November 10, 2020 teleconference with the Court. (Phillips, John)
November 10, 2020 Opinion or Order Filing 566 [SEALED] Letter to The Honorable Mitchell S. Goldberg from John C. Phillips, Jr. regarding Slate Run's Response to Amgen's November 9, 2020 Letter - re #562 Letter,. (Phillips, John)
November 10, 2020 Opinion or Order Filing 565 [SEALED] Letter to The Honorable Mitchell S. Goldberg from John C. Phillips, Jr. regarding response to Amgen's letters dates November 4 and 9, 2020 and in support of Slate Run's letter dated November 6, 2020 - re #562 Letter, #561 Letter, #559 Letter. (Attachments: #1 Exhibit A)(Phillips, John)
November 10, 2020 Opinion or Order Pro Hac Vice Attorney Wendy A. Whiteford for Amgen Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
November 9, 2020 Opinion or Order Filing 564 ORDER Setting Teleconference: A Telephone Conference is set for 11/10/2020 at 01:00 PM before Judge Mitchell S. Goldberg. Counsel are directed to dial in to 571-353-2300, passcode 427102124#. All deadlines are STAYED until the November 10, 2020 telephone conference. Signed by Judge Mitchell S. Goldberg on 11/9/2020. (nmg)
November 9, 2020 Opinion or Order Filing 563 ORDER granting #558 MOTION for Pro Hac Vice Appearance of Attorney Holly D. Kozlowski and Christopher J. Dutton. Signed by Judge Mitchell S. Goldberg on 11/9/2020. (nmg)
November 9, 2020 Opinion or Order Filing 562 [SEALED] Letter to Honorable Mitchell S. Goldberg from Jack B. Blumenfeld regarding request to extend the November 10, 2020 date to serve an expert report and in response to Intervenor Slate Runs letter - re #561 Letter. (Attachments: #1 Exhibits 1-7)(Blumenfeld, Jack)
November 9, 2020 Opinion or Order Pro Hac Vice Attorney Lois M. Kwasigroch for Amgen Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
November 9, 2020 Opinion or Order Pro Hac Vice Attorney Holly D. Kozlowski for Slate Run Pharmaceuticals, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
November 6, 2020 Opinion or Order Filing 561 [SEALED] Letter to The Honorable Mitchell S. Goldberg from John C. Phillips, Jr. regarding response to Amgen's letter requesting extension to serve expert report - re #559 Letter. (Phillips, John)
November 4, 2020 Opinion or Order Filing 560 Letter to The Honorable Mitchell S. Goldberg from Jack B. Blumenfeld regarding request for expedited decision on extension request - re #559 Letter. (Blumenfeld, Jack)
November 4, 2020 Opinion or Order Filing 559 [SEALED] Letter to The Honorable Mitchell S. Goldberg from Jack B. Blumenfeld regarding request for extension to serve expert report. (Attachments: #1 Exhibits 1-9)(Blumenfeld, Jack)
November 2, 2020 Opinion or Order Filing 558 MOTION for Pro Hac Vice Appearance of Attorney Holly D. Kozlowski and Christopher J. Dutton - filed by Slate Run Pharmaceuticals, LLC. (Attachments: #1 Certification of Holly D. Kozlowski, #2 Certification of Christopher J. Dutton)(Bilson, David)
November 2, 2020 Opinion or Order Filing 557 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Slate Run Pharmaceuticals, LLC. (Phillips, John)
November 2, 2020 Opinion or Order Filing 556 Intervenor COMPLAINT - filed by Slate Run Pharmaceuticals, LLC.(Phillips, John)
October 14, 2020 Opinion or Order Filing 555 ORDER GRANTING #523 MOTION to Intervene filed by Slate Run Pharmaceuticals, LLC. Signed by Judge Mitchell S. Goldberg on 10/14/2020. (nmg)
October 14, 2020 Opinion or Order Filing 554 MEMORANDUM OPINION. Signed by Judge Mitchell S. Goldberg on 10/14/2020. (nmg)
October 14, 2020 Opinion or Order Filing 553 NOTICE OF SERVICE of (1) [HIGHLY CONFIDENTIAL] Expert Report of Ivan T. Hofmann; (2) [HIGHLY CONFIDENTIAL] Declaration of Michael Plessinger; and (3) [HIGHLY CONFIDENTIAL] Declaration of Christopher Leahy filed by Piramal Healthcare Limited.(Bilson, David)
October 9, 2020 Opinion or Order Filing 552 STIPULATION AND ORDER re #551 STIPULATION TO EXTEND TIME to submit a Joint Letter to November 19, 2020. Signed by Judge Mitchell S. Goldberg on 10/9/2020. (nmg)
October 9, 2020 Opinion or Order Filing 551 STIPULATION TO EXTEND TIME to submit a Joint Letter to November 19, 2020 - filed by Piramal Healthcare Limited. (Phillips, John)
October 5, 2020 Opinion or Order Filing 550 NOTICE to Take Deposition of Kate Tansey Chevlen on October 6, 2020 filed by Piramal Healthcare Limited.(Bilson, David)
September 30, 2020 Opinion or Order Filing 549 NOTICE OF SERVICE of (1) Piramal's [HIGHLY CONFIDENTIAL] Supplemental Damages Contentions; (2) Defendant Piramal's [HIGHLY CONFIDENTIAL] First Amended Responses to Plaintiff's Third Set of Interrogatories; and (3) Piramal's [HIGHLY CONFIDENTIAL] First Amended Responses to Plaintiff's Fourth Set of Interrogatories filed by Piramal Healthcare Limited.(Bilson, David)
September 30, 2020 Opinion or Order Filing 548 NOTICE OF SERVICE of (1) First Supplemental Objections and Responses to Defendant Piramal's First Set of Interrogatories to Amgen; and (2) First Supplemental Objections and Responses to Defendant Piramal's Second Set of Interrogatories to Amgen filed by Amgen Inc..(Blumenfeld, Jack)
September 23, 2020 Opinion or Order Filing 547 NOTICE to Take Deposition of Christopher Leahy on a date and at a time agreed upon by the parties or ordered by the Court filed by Amgen Inc..(Blumenfeld, Jack)
September 17, 2020 Opinion or Order Filing 546 NOTICE of Subpoena by Amgen Inc. (Blumenfeld, Jack)
September 16, 2020 Opinion or Order Filing 545 ORDER - #544 STIPULATION TO EXTEND TIME to Amend Scheduling Order Dates (SEE ORDER FOR DETAILS). SO ORDERED by Judge Mitchell S. Goldberg on 9/16/2020. (amf)
September 16, 2020 Opinion or Order Filing 544 STIPULATION TO EXTEND TIME to Amend Scheduling Order Dates to See Stipulation - filed by Piramal Healthcare Limited. (Phillips, John)
September 11, 2020 Opinion or Order Filing 543 REDACTED VERSION of #537 Declaration by Slate Run Pharmaceuticals, LLC. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Bilson, David)
September 11, 2020 Opinion or Order Filing 542 REDACTED VERSION of #536 Reply Brief by Slate Run Pharmaceuticals, LLC. (Bilson, David)
September 11, 2020 Opinion or Order Filing 541 REDACTED VERSION of #524 Opening Brief in Support by Slate Run Pharmaceuticals, LLC. (Attachments: #1 Exhibit A [Public Version Without Any Redactions])(Bilson, David)
September 10, 2020 Opinion or Order Filing 540 Letter to The Honorable Mitchell S. Goldberg from Jack B. Blumenfeld regarding request for oral argument - re #523 MOTION to Intervene . (Blumenfeld, Jack)
September 8, 2020 Opinion or Order Filing 539 NOTICE of Subpoenas by Amgen Inc. (Blumenfeld, Jack)
September 8, 2020 Opinion or Order Filing 538 CONSENT JUDGMENT. Signed by Judge Mitchell S. Goldberg on 9/8/2020. Associated Cases: 1:16-cv-00925-MSG, 1:16-cv-00853-MSG(nmg)
September 4, 2020 Opinion or Order Filing 537 [SEALED] DECLARATION re #523 MOTION to Intervene by Slate Run Pharmaceuticals, LLC. (Attachments: #1 Exhibit 1, #2 Exhibit 2)(Phillips, John)
September 4, 2020 Opinion or Order Filing 536 [SEALED] REPLY BRIEF re #523 MOTION to Intervene filed by Slate Run Pharmaceuticals, LLC. (Phillips, John)
September 1, 2020 Opinion or Order Filing 535 PROPOSED CONSENT JUDGMENT (Amneal Defendants) by Amgen Inc.. (Blumenfeld, Jack)
August 31, 2020 Opinion or Order Filing 534 NOTICE OF SERVICE of (1) Response to Defendant's Supplemental Notice of Deposition of Plaintiff Amgen Inc. Pursuant to Fed. R. Civ. P. 30(b)(6); (2) Objections and Responses to Defendant Piramal's Second Set of Interrogatories to Amgen; and (3) Responses to Defendant Piramal Healthcare UK Limited's Third Set of Request for Production of Documents and Things filed by Amgen Inc..(Blumenfeld, Jack)
August 31, 2020 Opinion or Order Filing 533 NOTICE OF SERVICE of Piramal's [HIGHLY CONFIDENTIAL] Responses to Plaintiff's Fourth Set of Interrogatories and Piramal's [HIGHLY CONFIDENTIAL] Responses to Plaintiff's Sixth Set of Requests for the Production of Documents and Things filed by Piramal Healthcare Limited.(Bilson, David)
August 28, 2020 Opinion or Order Filing 532 [SEALED] ANSWERING BRIEF in Opposition re #523 MOTION to Intervene filed by Amgen Inc..Reply Brief due date per Local Rules is 9/4/2020. (Attachments: #1 Exhibits 1-5)(Blumenfeld, Jack)
August 27, 2020 Opinion or Order Filing 531 NOTICE OF SERVICE of (1) Actavis Pharma Inc., Barr Laboratories, Inc., Teva Pharmaceuticals USA, Inc., and Watson Laboratories, LLC's, Responses and Objections to Amgen Inc.'s Subpoena to Testify at a Deposition in a Civil Action and Amgen Inc.'s Document Requests filed by Actavis Pharma, Inc., Watson Laboratories, Inc..(Keller, Karen)
August 26, 2020 Opinion or Order Filing 530 NOTICE OF SERVICE of Alkem and Ascend's responses to subpoenas filed by Ascend Laboratories, LLC, Alkem Laboratories Ltd..(Dorsney, Kenneth)
August 25, 2020 Opinion or Order Filing 529 ORDER granting D.I. #528 Motion to Appear Pro Hac Vice. Signed by Judge Mitchell S. Goldberg on 8/25/2020. (amf)
August 25, 2020 Opinion or Order Pro Hac Vice Attorney Brian Kao for Amgen Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
August 24, 2020 Opinion or Order Filing 528 MOTION for Pro Hac Vice Appearance of Attorney Brian Kao - filed by Amgen Inc.. (Blumenfeld, Jack)
August 21, 2020 Opinion or Order Filing 527 ORDER granting #526 MOTION for Pro Hac Vice Appearance of Attorney Katherine Y. Kim and Zachary L. Garrett. Signed by Judge Mitchell S. Goldberg on 8/19/2020. (nmg)
August 19, 2020 Opinion or Order Filing 526 MOTION for Pro Hac Vice Appearance of Attorney Katherine Y. Kim and Zachary L. Garrett of VENABLE LLP - filed by Amgen Inc.. (Blumenfeld, Jack)
August 17, 2020 Opinion or Order Filing 525 NOTICE of Subpoena by Amgen Inc. (Blumenfeld, Jack)
August 14, 2020 Opinion or Order Filing 524 [SEALED] OPENING BRIEF in Support re #523 MOTION to Intervene filed by Slate Run Pharmaceuticals, LLC.Answering Brief/Response due date per Local Rules is 8/28/2020. (Attachments: #1 Exhibit A)(Phillips, John)
August 14, 2020 Opinion or Order Filing 523 MOTION to Intervene - filed by Slate Run Pharmaceuticals, LLC. (Attachments: #1 Proposed Order)(Phillips, John)
August 14, 2020 Opinion or Order Filing 522 NOTICE of Subpoena by Amgen Inc. (Blumenfeld, Jack)
August 13, 2020 Opinion or Order Filing 521 NOTICE of Subpoenas by Amgen Inc. (Blumenfeld, Jack)
August 12, 2020 Opinion or Order Filing 520 NOTICE to Take Deposition of John Fowler on August 28, 2020 filed by Amgen Inc..(Blumenfeld, Jack)
August 11, 2020 Opinion or Order Filing 519 NOTICE of Subpoenas by Amgen Inc. (Blumenfeld, Jack)
August 10, 2020 Opinion or Order Filing 518 NOTICE OF SERVICE of (1) Defendant Piramal's [HIGHLY CONFIDENTIAL] Responses to Plaintiff's Third Set of Interrogatories; and (2) Defendant Piramal's Responses to Plaintiff's Fifth Set of Requests to Piramal for the Production of Documents and Things filed by Piramal Healthcare Limited.(Bilson, David)
August 6, 2020 Opinion or Order Filing 517 NOTICE OF SERVICE of (1) Objections and Responses to Defendant Piramal's First Set of Interrogatories to Amgen; (2) Responses to Defendant Piramal Healthcare UK Limited's Second Set of Requests for Production of Documents and Things; and (3) Response to Defendant's Notice of Deposition of Plaintiff Amgen Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Amgen Inc..(Blumenfeld, Jack)
July 31, 2020 Opinion or Order Filing 516 NOTICE to Take Deposition of [Supplemental Notice] Amgen Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) on TBD filed by Piramal Healthcare Limited.(Bilson, David)
July 31, 2020 Opinion or Order Filing 515 NOTICE OF SERVICE of (1) Defendant Piramal's Second Set of Interrogatories (Nos. 14-16); (2) Defendant Piramal's Third Set of Requests for Produciton of Documents and Things (Nos. 32-28); and (3) Defendant Piramal's Responses to Plaintiff's Fourth Set of Requests to Piramal for the Production of Documents and Things filed by Piramal Healthcare Limited.(Bilson, David)
July 31, 2020 Opinion or Order Filing 514 NOTICE to Take Deposition of Defendant Piramal Healthcare UK, Limited Pursuant to Fed. R. Civ. P. 30(b)(6) on a date and at a time to be determined filed by Amgen Inc..(Blumenfeld, Jack)
July 31, 2020 Opinion or Order Filing 513 NOTICE OF SERVICE of (1) Plaintiff Amgen Inc.'s Responses to Defendant Piramal Healthcare UK Limited's First Set of Requests for Production of Documents and Things; (2) Plaintiff's Fourth Set of Interrogatories to Piramal; and (3) Plaintiff's Fifth Set of Requests to Piramal for the Production of Documents and Things filed by Amgen Inc..(Blumenfeld, Jack)
July 30, 2020 Opinion or Order Filing 512 NOTICE of Subpoena by Amgen Inc. (Blumenfeld, Jack)
July 27, 2020 Opinion or Order Filing 511 SO ORDERED - re #510 Stipulation filed by Amgen Inc. Signed by Judge Mitchell S. Goldberg on 7/27/2020. (amf)
July 23, 2020 Opinion or Order Filing 510 STIPULATION to Amend Scheduling Order re #499 Order by Amgen Inc.. (Blumenfeld, Jack)
July 20, 2020 Opinion or Order Filing 509 ORDER - D.I. #507 counsel's motion for admission pro hac vice is GRANTED. Signed by Judge Mitchell S. Goldberg on 7-20-2020. (amf)
July 15, 2020 Opinion or Order Filing 508 NOTICE OF SERVICE of Piramal's [HIGHLY CONFIDENTIAL] Initial Damages Contentions filed by Piramal Healthcare Limited.(Bilson, David)
July 14, 2020 Opinion or Order Filing 507 MOTION for Pro Hac Vice Appearance of Attorney Ben J. Mahon - filed by Piramal Healthcare Limited. (Attachments: #1 Mahon Pro Hac Certification)(Bilson, David)
July 10, 2020 Opinion or Order Filing 506 NOTICE OF SERVICE of (1) Plaintiff's Third Set of Interrogatories to Piramal; and (2) Plaintiff's Fifth Set of Requests to Piramal for the Production of Documents and Things filed by Amgen Inc..(Blumenfeld, Jack)
July 10, 2020 Opinion or Order Filing 505 NOTICE to Take Deposition of Piramal Healthcare UK, Limited Pursuant to Fed. R. Civ. P. 30(b)(6) on a date and at a time to be determined filed by Amgen Inc..(Blumenfeld, Jack)
July 9, 2020 Opinion or Order Filing 504 USCA Order (Federal Circuit) Terminating Appeals 2019-1650 and 2019-1770. USCA Decision: motion to voluntarily dismiss the above-captioned appeals pursuant to Fed. R. App. P. 42(b), with each side bearing its own fees and costs is GRANTED. Order issued as a mandate on 7/9/2020. (amf)
July 7, 2020 Opinion or Order Filing 503 NOTICE OF SERVICE of Defendant Piramal's First Set of Interrogatories (Nos. 1-13) and Second Set of Requests for Production of Documents and Things (Nos. 2-31) filed by Piramal Healthcare Limited.(Bilson, David)
July 7, 2020 Opinion or Order Filing 502 NOTICE to Take Deposition of Amgen Inc. Pursuant to Fed. R. Civ. P. 30(b)(6) on TBD filed by Piramal Healthcare Limited.(Bilson, David)
July 1, 2020 Opinion or Order Filing 501 NOTICE OF SERVICE of Defendant Piramal's First Set of Remand Requests for Documents and Things to Plaintiff filed by Piramal Healthcare Limited.(Bilson, David)
July 1, 2020 Opinion or Order Filing 500 NOTICE OF SERVICE of Plaintiff's Fourth Set of Requests to Piramal for the Production of Documents and Things filed by Amgen Inc..(Blumenfeld, Jack)
June 30, 2020 Opinion or Order Filing 499 ORDER SETTING SCHEDULE - as to Piramal's damages case and Amneal's infringement and invalidity case. See attached Order for details. Signed by Judge Mitchell S. Goldberg on 6/30/2020. (amf)
June 25, 2020 Opinion or Order Filing 498 Joint STATUS REPORT by Amgen Inc.. (Attachments: #1 Letter to The Honorable Mitchell S. Goldberg)(Blumenfeld, Jack)
June 15, 2020 Opinion or Order Filing 497 Official Transcript of Telephone Conference held on 6/11/2020 before Judge Mitchell S. Goldberg. Court Reporter/Transcriber Suzanne R. White, Phone number: (215) 299-7252. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER Redaction Request due 7/6/2020. Redacted Transcript Deadline set for 7/16/2020. Release of Transcript Restriction set for 9/14/2020. (lak)
June 11, 2020 Opinion or Order Filing 496 Letter to Honorable Mitchell S. Goldberg from Jack B. Blumenfeld regarding deconsolidation - re #495 Letter. (Blumenfeld, Jack)
June 9, 2020 Opinion or Order Filing 495 Letter to The Honorable Mitchell S. Goldberg from John C. Phillips, Jr. regarding Request for Deconsolidation. (Phillips, John)
May 14, 2020 Opinion or Order Filing 494 ORDER, Setting Scheduling Order Deadlines ( A Status Conference is set for 6/11/2020 at 02:00 PM before Judge Mitchell S. Goldberg) (See Order for details). Signed by Judge Mitchell S. Goldberg on 5/14/2020. (myr)
May 6, 2020 Opinion or Order Filing 493 [SEALED] DECLARATION re (492 in 1:16-cv-00853-MSG) Bill of Costs by Amgen Inc.. (Attachments: #1 Exhibits A-F)(Blumenfeld, Jack)
May 6, 2020 Opinion or Order Filing 492 BILL OF COSTS by Amgen Inc.. (Blumenfeld, Jack)
April 22, 2020 Opinion or Order Filing 491 MANDATE of USCA as to #397 Notice of Appeal (Federal Circuit), #406 Notice of Appeal (Federal Circuit). USCA Decision: Affirmed-in-Part, Reversed-in-Part, Vacated-in-Part, and Remanded. (Attachments: #1 Opinion, #2 Judgment)(kmd)
April 15, 2020 Opinion or Order Filing 490 ORDER of USCA. Decision of USCA: petitions for panel rehearing are denied; petition for rehearing en banc is denied; mandate of the court will issue on April 22, 2020. (kmd)
September 24, 2019 Opinion or Order Filing 489 SO ORDERED - re (D.I. #488 in 1:16-cv-00853-MSG) Stipulation - filed by Sun Pharmaceutical Industries, Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., and Sun Pharmaceutical Industries Ltd. Signed by Judge Mitchell S. Goldberg on 9/24/2019. Associated Cases: 1:16-cv-00853-MSG, 1:16-cv-00882-GMS(amf)
September 23, 2019 Opinion or Order Filing 488 STIPULATION and [Proposed] Order that Sealed Documents shall be Unsealed re #465 Reply Brief, #437 Opening Brief in Support, #455 Answering Brief in Opposition, by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd.,, Sun Pharmaceutical Industries, Inc.. (Gattuso, Dominick)
September 19, 2019 Opinion or Order Filing 487 ORDER - Counsel shall advise the Court, on or before September 25, 2019, why the sealed versions of the parties' briefs (D.I. #437 , #455 , #465 ) should not be unsealed. Signed by Judge Mitchell S. Goldberg on 9/19/2019. (nmg)
September 19, 2019 Opinion or Order Filing 486 ORDER, the Motion to Enforce the Parties' Settlement Agreement ( #436 ) and Sun's request for discovery are DENIED. Signed by Judge Mitchell S. Goldberg on 9/18/2019. (lak)
September 19, 2019 Opinion or Order Filing 485 MEMORANDUM OPINION. Signed by Judge Mitchell S. Goldberg on 9/18/2019. (lak)
July 9, 2019 Opinion or Order Filing 484 REDACTED VERSION of #481 Transcript from June 13, 2019 Hearing by Sun Pharmaceutical Industries Ltd.,, Sun Pharmaceutical Industries, Inc.. (Gattuso, Dominick)
June 25, 2019 Opinion or Order Filing 483 ORDER, Follow up telephone conference to the hearing on the Motion to Enforce the Litigation Settlement is scheduled for Thursday, June 27, 2019 at 10:00 a.m. Counsel are to phone in at (877) 336-1828; access code 4305075. Signed by Judge Mitchell S. Goldberg on 6/25/2019. (lak)
June 18, 2019 Opinion or Order Filing 482 ORDER, the Court will seal from the public the courtroom and transcript for the June 13, 2019 hearing on Suns Motion to Enforce the Settlement Agreement; and that any person or entity, who believes that Sun did not satisfy the standard set forth in In re Avandia, may move this Court to unseal the transcript. Signed by Judge Mitchell S. Goldberg on 6/18/2019. (lak)
June 17, 2019 Opinion or Order Filing 480 ORDER, the Court will seal from the public the courtroom and transcript for the June 13, 2019 hearing on Suns Motion to Enforce the Settlement Agreement; and that any person or entity, who believes that Sun did not satisfy the standard set forth in In re Avandia, may move this Court to unseal the transcript. Signed by Judge Mitchell S. Goldberg on 6/17/2019. (nmg)
June 13, 2019 Opinion or Order Filing 481 [SEALED] Transcript of Oral Argument held on June 13, 2019 before Judge Mitchell S. Goldberg. Transcribed by: Michael T. Keating. TK Transcribers 609-440-2177. (lak)
June 13, 2019 Opinion or Order Minute Entry for proceedings held before Judge Mitchell S. Goldberg at the James A. Byrne U.S. Courthouse, 601 Market Street, Philadelphia, Pennsylvania - Oral Argument held on 6/13/2019 regarding D.I. #477 . (Court Reporter Stephen Sonnie.) (lak)
May 30, 2019 Opinion or Order Filing 479 REDACTED VERSION of #478 Sur-Reply Brief by Amgen Inc.. (Fahnestock, Derek)
May 30, 2019 Opinion or Order Filing 478 [SEALED] SUR-REPLY BRIEF re #436 MOTION to Enforce the Parties' Settlement Agreement filed by Amgen Inc.. (Fahnestock, Derek)
May 30, 2019 Opinion or Order Filing 477 ORDER: Amgen shall file their Surreply Brief on or before June 5, 2019. Sun's request for oral argument is GRANTED. Oral argument on the Motion to Enforce the Settlement Agreement (D.I. #436 ) will be held on Thursday, June 13, 2019 at 2:00 p.m. in Courtroom 4-B at the James A. Byrne U.S. Courthouse, 601 Market Street, Philadelphia, Pennsylvania. The parties shall be prepared to address their discovery dispute (D.I. #472 , D.I. #474 ) at oral argument on the Motion to Enforce the Settlement Agreement. Signed by Judge Mitchell S. Goldberg on 5/29/2019. (nmg)
May 22, 2019 Opinion or Order Filing 476 STATEMENT re #462 Order on Motion for Preliminary Injunction -- Injunction Bond -- by Amgen Inc.. (Attachments: #1 Attachment)(Blumenfeld, Jack)
May 7, 2019 Opinion or Order Filing 475 ORDER granting D.I. #470 SEALED UNOPPOSED MOTION for Leave to File a Surreply Brief In Opposition to Sun's Motion to Enforce the Parties' Settlement Agreement. Signed by Judge Mitchell S. Goldberg on 5/6/2019. (nmg)
May 6, 2019 Opinion or Order Filing 474 Letter to The Honorable Mitchell S. Goldberg from Jack B. Blumenfeld regarding response to Sun's letter of May 6, 2019 concerning an alleged "discovery dispute". (Attachments: #1 Attachment - Amgen's April 26, 2019 letter)(Blumenfeld, Jack)
May 6, 2019 Opinion or Order Filing 473 REDACTED VERSION of #470 MOTION for Leave to File a Surreply Brief In Opposition to Sun's Motion to Enforce the Parties' Settlement Agreement by Amgen Inc.. (Attachments: #1 Exhibit A)(Fahnestock, Derek)
May 6, 2019 Opinion or Order Filing 472 Letter to The Honorable Mitchell S. Goldberg from Dominick T. Gattuso, Esquire regarding Discovery dispute - re #437 Opening Brief in Support, #436 MOTION to Enforce the Parties' Settlement Agreement . (Gattuso, Dominick)
April 29, 2019 Opinion or Order Filing 471 ORDER of USCA as to #453 Notice of Appeal (Federal Circuit) filed by Amgen Inc. Decision of USCA: The stay of Appeal No. 2019-1650 is lifted, and it and Appeal No. 2019-1770 are consolidated. One set of briefs should be filed for the two appeals. Amgens opening brief is due no later than 60 days from the date of filing of this order. (nmg)
April 29, 2019 Opinion or Order Filing 470 [SEALED] UNOPPOSED MOTION for Leave to File a Surreply Brief In Opposition to Sun's Motion to Enforce the Parties' Settlement Agreement - filed by Amgen Inc.. (Attachments: #1 Exhibit A)(Fahnestock, Derek) Modified docket entry text on 4/30/2019 per counsel (ddp).
April 25, 2019 Opinion or Order Filing 469 REDACTED VERSION of #465 Reply Brief Sun's [Redacted] Reply in Support of Its Motion to Enforce The Settlement Agreement by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,, Sun Pharmaceutical Industries, Inc.. (Gattuso, Dominick)
April 18, 2019 Opinion or Order Filing 468 REDACTED VERSION of #455 Answering Brief in Opposition, by Amgen Inc.. (Attachments: #1 Exhibits A-K)(Fahnestock, Derek)
April 18, 2019 Opinion or Order Filing 467 REDACTED VERSION of #457 Proposed Order by Amgen Inc.. (Blumenfeld, Jack)
April 18, 2019 Opinion or Order Filing 466 REQUEST for Oral Argument by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,, Sun Pharmaceutical Industries, Inc. re #436 MOTION to Enforce the Parties' Settlement Agreement . (Gattuso, Dominick)
April 18, 2019 Opinion or Order Filing 465 [SEALED] REPLY BRIEF re #436 MOTION to Enforce the Parties' Settlement Agreement filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,, Sun Pharmaceutical Industries, Inc.. (Gattuso, Dominick)
April 17, 2019 Opinion or Order Filing 464 NOTICE of Sun's First Set of Requests for Production of Documents and Things to Plaintiff Amgen Inc. by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,, Sun Pharmaceutical Industries, Inc. (Gattuso, Dominick)
April 17, 2019 Opinion or Order Filing 463 NOTICE of Deposition of Plaintiff Amgen Inc. by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,, Sun Pharmaceutical Industries, Inc. (Gattuso, Dominick)
April 15, 2019 Opinion or Order Filing 462 ORDER granting D.I. #430 Motion for Preliminary Injunction. Signed by Judge Mitchell S. Goldberg on 4/15/2019. (nmg)
April 15, 2019 Opinion or Order Filing 461 NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re #453 Notice of Appeal (Federal Circuit) filed by Amgen Inc. USCA Case Number 19-1770 (ceg)
April 12, 2019 Opinion or Order Filing 460 REDACTED VERSION of #448 Declaration by Piramal Healthcare Limited. (Bilson, David)
April 12, 2019 Opinion or Order Filing 459 REDACTED VERSION of #447 Answering Brief in Opposition, by Piramal Healthcare Limited. (Attachments: #1 Text of Proposed Order)(Bilson, David)
April 12, 2019 Opinion or Order Filing 458 Letter to The Honorable Mitchell S. Goldberg from Jack B. Blumenfeld - re #457 Proposed Order. (Blumenfeld, Jack)
April 12, 2019 Opinion or Order Filing 457 [SEALED] PROPOSED ORDER -- [Proposed] Stipulated Order -- re #430 Emergency MOTION for Preliminary Injunction Pending Appeal by Amgen Inc.. (Blumenfeld, Jack)
April 12, 2019 Opinion or Order Filing 456 SO ORDERED, D.I. #452 Stipulation to Extend Time for Plaintiff to file its Reply Brief in Support of its Emergency Motion for an Injunction Pending Appeal (D.I. 430) to April 16, 2019 (*Reply Brief due 4/16/2019). Signed by Judge Mitchell S. Goldberg on 4/12/2019. (ceg)
April 11, 2019 Opinion or Order Filing 455 [SEALED] ANSWERING BRIEF in Opposition re #436 MOTION to Enforce the Parties' Settlement Agreement filed by Amgen Inc..Reply Brief due date per Local Rules is 4/18/2019. (Attachments: #1 Exhibits A-K)(Blumenfeld, Jack)
April 11, 2019 Opinion or Order Filing 454 ORDER: A Status Conference regarding the Motion for Preliminary Injunction shall take place on Monday, April 15, 2019 at 10:00 a.m. The conference will be held via telephone. Signed by Judge Mitchell S. Goldberg on 4/10/2019. (ceg)
April 10, 2019 Opinion or Order Filing 453 NOTICE OF APPEAL to the Federal Circuit of #439 Order on Motion for Miscellaneous Relief for an Indicative Ruling Pursuant to Federal Rule of Civil Procedure 62.1 (D.I. 412). Appeal filed by Amgen Inc.. (Blumenfeld, Jack)
April 10, 2019 Opinion or Order Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re #453 Notice of Appeal (Federal Circuit). (ddp)
April 10, 2019 Opinion or Order Notification regarding #453 Notice of Appeal (Federal Circuit) sent to Reporter Gunning (ddp)
April 10, 2019 Opinion or Order Notification regarding #453 Notice of Appeal (Federal Circuit) sent to Reporter Hawkins (ddp)
April 10, 2019 Opinion or Order APPEAL - Credit Card Payment of $505.00 received re #453 Notice of Appeal (Federal Circuit) filed by Amgen Inc.. ( Filing fee $505, receipt number 0311-2616045.) (Blumenfeld, Jack)
April 9, 2019 Opinion or Order Filing 452 STIPULATION TO EXTEND TIME for plaintiff to file its reply brief in support of its Emergency Motion for an Injunction Pending Appeal (D.I. 430) to April 16, 2019 - filed by Amgen Inc.. (Blumenfeld, Jack)
April 4, 2019 Opinion or Order Filing 451 SO ORDERED, granting re #449 STIPULATION TO EXTEND TIME for the plaintiff to submit its opposition to Sun's Motion to Enforce the Parties' Settlement Agreement (D.I. 436) to April 11, 2019 filed by Amgen Inc., Set Briefing Schedule: re #436 MOTION to Enforce the Parties' Settlement Agreement . (Answering Brief due 4/11/2019.). Signed by Judge Mitchell S. Goldberg on 4/4/19. (rwc)
April 4, 2019 Opinion or Order Filing 450 ORDER - granting #435 Motion for Leave to File Opening Brief Under Seal. Signed by Judge Mitchell S. Goldberg on 4/4/19. (rwc)
April 3, 2019 Opinion or Order Filing 449 STIPULATION TO EXTEND TIME for the plaintiff to submit its opposition to Sun's Motion to Enforce the Parties' Settlement Agreement (D.I. 436) to April 11, 2019 - filed by Amgen Inc.. (Blumenfeld, Jack)
April 2, 2019 Opinion or Order Filing 448 [SEALED] DECLARATION re #447 Answering Brief in Opposition, Declaration of John Fowler by Piramal Healthcare Limited. (Phillips, John) (Main Document 448 replaced on 4/3/2019) (nmg).
April 2, 2019 Opinion or Order Filing 447 [SEALED] ANSWERING BRIEF in Opposition re #430 Emergency MOTION for Preliminary Injunction Pending Appeal filed by Piramal Healthcare Limited.Reply Brief due date per Local Rules is 4/9/2019. (Attachments: #1 Text of Proposed Order)(Phillips, John) (Main Document 447 replaced on 4/3/2019) (nmg). (Attachment 1 replaced on 4/3/2019) (nmg).
April 2, 2019 Opinion or Order Pro Hac Vice Attorneys Kasey E. Koballa, Mitchell G. Stockwell, Courtney S. Dabbiere, and David Clay Holloway for Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., and Sun Pharmaceutical Industries, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp)
March 29, 2019 Opinion or Order Filing 446 REDACTED VERSION of #445 Letter Regarding Preliminary Injunction by Mylan Inc., Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios)
March 28, 2019 Opinion or Order Filing 445 [SEALED] Letter to the Honorable Mitchell S. Goldberg from Stamatios Stamoulis regarding Amgen's Motion for Preliminary Injunction - re #430 Emergency MOTION for Preliminary Injunction Pending Appeal. (Stamoulis, Stamatios)
March 28, 2019 Opinion or Order Filing 444 REDACTED VERSION of #437 Opening Brief in Support, of Motion to Enforce the Parties' Settlement Agreement by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,, Sun Pharmaceutical Industries, Inc.. (Attachments: #1 Exhibit A - H)(Gattuso, Dominick)
March 27, 2019 Opinion or Order Filing 443 ORDER granting D.I. #438 MOTION for Pro Hac Vice Appearance of Attorney D. Clay Holloway, Mitchell G. Stockwell, Courtney S. Dabbiere, and Kasey E. Koballa. Signed by Judge Mitchell S. Goldberg on 3/26/2019. (nmg)
March 26, 2019 Opinion or Order Filing 442 REDACTED VERSION of #433 Declaration of Christos Georghiou by Amgen Inc.. (Blumenfeld, Jack)
March 26, 2019 Opinion or Order Filing 441 REDACTED VERSION of #432 Declaration of Jerry A. Hausman by Amgen Inc.. (Blumenfeld, Jack)
March 26, 2019 Opinion or Order Filing 440 REDACTED VERSION of #431 Opening Brief in Support, of Emergency Motion for Preliminary Injunction Pending Appeal by Amgen Inc.. (Blumenfeld, Jack)
March 26, 2019 Opinion or Order Filing 439 ORDER denying #412 Joint MOTION for an Indicative Ruling Pursuant to Federal Rule of Civil Procedure 62.1 . Signed by Judge Mitchell S. Goldberg on 3/26/2019. (nmg)
March 25, 2019 Opinion or Order Filing 438 MOTION for Pro Hac Vice Appearance of Attorney D. Clay Holloway, Mitchell G. Stockwell, Courtney S. Dabbiere, and Kasey E. Koballa - filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,, Sun Pharmaceutical Industries, Inc.. (Gattuso, Dominick)
March 21, 2019 Opinion or Order Filing 437 [SEALED] OPENING BRIEF in Support re #435 MOTION to Seal Document: , #436 MOTION to Enforce the Parties' Settlement Agreement filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,, Sun Pharmaceutical Industries, Inc..Answering Brief/Response due date per Local Rules is 4/4/2019. (Attachments: #1 Exhibit A - H, #2 Certificate of Service)(Gattuso, Dominick)
March 21, 2019 Opinion or Order Filing 436 MOTION to Enforce the Parties' Settlement Agreement - filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,, Sun Pharmaceutical Industries, Inc.. (Attachments: #1 Text of Proposed Order)(Gattuso, Dominick)
March 21, 2019 Opinion or Order Filing 435 MOTION to Seal Document: - filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,, Sun Pharmaceutical Industries, Inc.. (Attachments: #1 Text of Proposed Order)(Gattuso, Dominick)
March 21, 2019 Opinion or Order Filing 434 NOTICE of Appearance by Dominick T. Gattuso on behalf of Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.,, Sun Pharmaceutical Industries, Inc. (Gattuso, Dominick)
March 19, 2019 Opinion or Order Filing 433 [SEALED] DECLARATION re #430 Emergency MOTION for Preliminary Injunction Pending Appeal -- Declaration of Christos Georghiou -- by Amgen Inc.. (Blumenfeld, Jack)
March 19, 2019 Opinion or Order Filing 432 [SEALED] DECLARATION re #430 Emergency MOTION for Preliminary Injunction Pending Appeal -- Declaration of Jerry A. Hausman -- by Amgen Inc.. (Attachments: #1 Exhibit A)(Blumenfeld, Jack)
March 19, 2019 Opinion or Order Filing 431 [SEALED] OPENING BRIEF in Support re #430 Emergency MOTION for Preliminary Injunction Pending Appeal filed by Amgen Inc..Answering Brief/Response due date per Local Rules is 4/2/2019. (Attachments: #1 Exhibit A)(Blumenfeld, Jack)
March 19, 2019 Opinion or Order Filing 430 Emergency MOTION for Preliminary Injunction Pending Appeal - filed by Amgen Inc.. (Blumenfeld, Jack)
February 12, 2019 Opinion or Order Filing 429 REDACTED VERSION of #427 Reply Brief in Support of Motion for an Indicative Ruling Pursuant to Federal Rule of Civil Procedure 62.1 by Amgen Inc.. (Blumenfeld, Jack)
February 8, 2019 Opinion or Order Filing 428 REDACTED VERSION of #418 Answering Brief in Opposition, by Cipla USA, Inc.. (Farnan, Brian)
February 5, 2019 Opinion or Order Filing 427 [SEALED] REPLY BRIEF re #412 Joint MOTION for an Indicative Ruling Pursuant to Federal Rule of Civil Procedure 62.1 filed by Amgen Inc.. (Fahnestock, Derek)
February 4, 2019 Opinion or Order Filing 426 SO ORDERED, D.I. #425 Stipulation to Extend Time for Amgen and Watson to reply to the oppositions of Cipla and Sun to February 5, 2019 (*Reply Brief due 2/5/2019). Signed by Judge Mitchell S. Goldberg on 2/4/2019. (ceg)
February 1, 2019 Opinion or Order Filing 425 STIPULATION TO EXTEND TIME for Amgen and Watson to reply to the oppositions of Cipla and Sun to February 5, 2019 - filed by Amgen Inc.. (Blumenfeld, Jack)
January 31, 2019 Opinion or Order Filing 424 SO ORDERED, D.I. #422 Stipulation to Extend Time for Defendants Cipla Ltd. and Cipla USA, Inc. to file a redacted version of their Opposition to Amgen's and Watson's Joint Motion for Indicative Ruling to February 8, 2019. Signed by Judge Mitchell S. Goldberg on 1/31/2019. (ceg)
January 30, 2019 Opinion or Order Filing 423 REDACTED VERSION of #419 Answering Brief in Opposition, by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.. (Phillips, John)
January 30, 2019 Opinion or Order Filing 422 STIPULATION TO EXTEND TIME for Defendants Cipla Ltd. and Cipla USA, Inc. to file a redacted version of their Opposition to Amgen's and Watson's Joint Motion for Indicative Ruling to 2/8/2019 - filed by Cipla Ltd., Cipla USA, Inc.. (Farnan, Michael)
January 25, 2019 Opinion or Order Filing 421 STIPULATION AND ORDER approving D.I. #420 STIPULATION TO EXTEND TIME for Amgen and Watson to reply to the oppositions of Cipla and Sun to February 1, 2019. Signed by Judge Mitchell S. Goldberg on 1/24/2019. (nmg)
January 25, 2019 Opinion or Order CORRECTING ENTRY: Answering Brief #419 replaced and attached exhibit removed per filing party's request. (ceg)
January 24, 2019 Opinion or Order Filing 420 STIPULATION TO EXTEND TIME for Amgen and Watson to reply to the oppositions of Cipla and Sun to February 1, 2019 - filed by Amgen Inc.. (Blumenfeld, Jack)
January 23, 2019 Opinion or Order Filing 419 [SEALED] ANSWERING BRIEF in Opposition re #412 Joint MOTION for an Indicative Ruling Pursuant to Federal Rule of Civil Procedure 62.1 filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..Reply Brief due date per Local Rules is 1/30/2019. (Attachments: # 1 Exhibit 1)(Phillips, John) (Attachment 1 replaced on 1/24/2019) (nmg). (Main Document 419 replaced on 1/25/2019) (ceg).
January 18, 2019 Opinion or Order Filing 418 [SEALED] ANSWERING BRIEF in Opposition re #412 Joint MOTION for an Indicative Ruling Pursuant to Federal Rule of Civil Procedure 62.1 filed by Cipla Ltd., Cipla USA, Inc..Reply Brief due date per Local Rules is 1/25/2019. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Farnan, Michael)
January 11, 2019 Opinion or Order Filing 417 ORDER of USCA; Upon consideration of the motion to stay the briefing schedule on the appeal, pending the district courts disposition of the movants request for an indicative ruling as it relates to a settlement agreement, IT IS ORDERED that the motion is granted to the extent that the briefing schedule is stayed. The movants are directed to inform this court within 14 days of the district court's action on the motion, or within 60 days of this order, whichever is sooner, concerning how these appeals should proceed. (bkb)
January 11, 2019 Opinion or Order Filing 416 NOTICE of Appearance by Brian E. Farnan on behalf of Cipla Ltd., Cipla USA, Inc. (Farnan, Brian)
January 11, 2019 Opinion or Order Filing 415 NOTICE of Appearance by Michael J. Farnan on behalf of Cipla Ltd., Cipla USA, Inc. (Farnan, Michael)
January 10, 2019 Opinion or Order Filing 414 Letter to The Honorable Mitchell S. Goldberg from Michael J. Farnan regarding Amgen's and Watson's Joint Motion for an Indicative Ruling Pursuant to Federal Rule of Civil Procedure 62.1 - re #412 Joint MOTION for an Indicative Ruling Pursuant to Federal Rule of Civil Procedure 62.1 . (Farnan, Michael)
January 9, 2019 Opinion or Order Filing 413 Joint OPENING BRIEF in Support re #412 Joint MOTION for an Indicative Ruling Pursuant to Federal Rule of Civil Procedure 62.1 filed by Amgen Inc..Answering Brief/Response due date per Local Rules is 1/23/2019. (Attachments: #1 Exhibits A-B)(Blumenfeld, Jack)
January 9, 2019 Opinion or Order Filing 412 Joint MOTION for an Indicative Ruling Pursuant to Federal Rule of Civil Procedure 62.1 - filed by Amgen Inc.. (Blumenfeld, Jack)
December 27, 2018 Opinion or Order Filing 411 ORDER of USCA - Federal Circuit: Amgen's unopposed motion re confidentiality is GRANTED. See order for details. (bkb)
November 19, 2018 Opinion or Order Filing 410 NOTICE of Change of Law Firm Name and Email Address of Pro Hac Vice Counsel by Amgen Inc. (Blumenfeld, Jack)
October 16, 2018 Opinion or Order Filing 409 NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re #406 Notice of Appeal (Federal Circuit) filed by Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Ltd. USCA Case Number 19-1086. Entry of Appearance due 10/30/2018. Certificate of Interest due 10/30/2018. Docketing Statement due 10/30/2018. Appellants' brief due 12/17/2018. (bkb)
October 16, 2018 Opinion or Order Filing 408 TRANSCRIPT REQUEST by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc. (Phillips, John)
October 15, 2018 Opinion or Order Filing 407 NOTICE of Withdrawal of Co-Counsel by Amgen Inc. (Blumenfeld, Jack)
October 11, 2018 Opinion or Order Filing 406 NOTICE OF APPEAL to the Federal Circuit of #405 Judgment,, . Appeal filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.. (Phillips, John)
October 11, 2018 Opinion or Order Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re #406 Notice of Appeal (Federal Circuit). (ceg)
October 11, 2018 Opinion or Order APPEAL - Credit Card Payment of $505.00 received re #406 Notice of Appeal (Federal Circuit) filed by Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Ltd.. ( Filing fee $505, receipt number 0311-2479026.) (Phillips, John)
October 9, 2018 Opinion or Order Filing 405 JUDGMENT in favor of Amgen Inc. against Cadila Healthcare Ltd., and Zydus Pharmaceuticals (USA) Inc. on Plaintiff's claim of infringement of claims 1-4, 6, 8-9, 15-17 and 19 of U.S. Patent No. 9,375,405 ("the '405 patent") by the cinacalcet HCl tablets, 30mg, 60g, and 90mg, that are the subject of Abbreviated New Drug Application ("ANDA") No. 208971. This Judgment as to infringement of the '405 patent is final and appealable. Signed by Judge Mitchell S. Goldberg on 10/9/2018. Associated Cases: 1:16-cv-00853-MSG, 1:17-cv-00183-MSG (nmg)
October 5, 2018 Opinion or Order Filing 404 Letter to The Honorable Mitchell S. Goldberg from John C. Phillips, Jr. regarding Proposed agreed-upon order of final judgment on the issue of infringement with respect to Zydus. (Attachments: #1 Proposed Order)(Phillips, John)
October 1, 2018 Opinion or Order Filing 403 ORDER withdrawing D.I. #337 Motion for Judgment on the Pleadings and withdrawing D.I. #379 Motion to Amend. Signed by Judge Mitchell S. Goldberg on 10/1/2018. (nmg)
September 28, 2018 Opinion or Order Filing 402 NOTICE of Withdrawal of Zydus' Pending Motion for Reconsideration and Motion for Judgment by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc. re #337 MOTION for Judgment on the Pleadings, #379 MOTION to Amend/Correct #376 Order,,, (Attachments: #1 Letter to The Honorable Mitchell S. Goldberg re: Withdrawal)(Phillips, John)
September 27, 2018 Opinion or Order Filing 401 ORDER Setting Telephone Conference for 9/28/2018 at 01:30 PM before Judge Mitchell S. Goldberg. Counsel for Plaintiff shall initiate the conference call with counsel and contact chambers at 267-299-7500 after all counsel are connected. Signed by Judge Mitchell S. Goldberg on 9/27/2018. (crb)
September 25, 2018 Opinion or Order Filing 400 NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re #397 Notice of Appeal (Federal Circuit) filed by Amgen Inc.. USCA Case Number 18-2414; Entry of Appearance due 10/09/2018. Certificate of Interest due 10/09/2018. Docketing Statement due 10/09/2018. Appellant's brief due 11/26/2018. (bkb)
September 24, 2018 Opinion or Order Filing 399 TRANSCRIPT REQUEST by Amgen Inc. (Blumenfeld, Jack)
September 24, 2018 Opinion or Order Filing 398 Joint Letter to The Honorable Mitchell S. Goldberg from John C. Phillips, Jr. regarding validity trial and request for teleconference - re #384 Order,,, #394 Letter. (Phillips, John)
September 21, 2018 Opinion or Order Notification regarding #397 Notice of Appeal (Federal Circuit) sent to Reporter Gunning (nmg)
September 21, 2018 Opinion or Order Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re #397 Notice of Appeal (Federal Circuit). (nmg)
September 20, 2018 Opinion or Order Filing 397 NOTICE OF APPEAL to the Federal Circuit of #386 Judgment,, . Appeal filed by Amgen Inc.. (Blumenfeld, Jack)
September 20, 2018 Opinion or Order APPEAL - Credit Card Payment of $505.00 received re #397 Notice of Appeal (Federal Circuit) filed by Amgen Inc.. ( Filing fee $505, receipt number 0311-2464363.) (Blumenfeld, Jack)
September 13, 2018 Opinion or Order Filing 396 ORDER granting #395 Motion for Pro Hac Vice Appearance of Attorney of Sona De of SIDLEY AUSTIN LLP. Signed by Judge Mitchell S. Goldberg on 9/13/2018. (crb)
September 12, 2018 Opinion or Order Filing 395 MOTION for Pro Hac Vice Appearance of Attorney of Sona De of SIDLEY AUSTIN LLP - filed by Amgen Inc.. (Blumenfeld, Jack)
September 6, 2018 Opinion or Order Filing 394 Letter to the Honorable Mitchell S. Goldberg from John C. Phillips, Jr. regarding Zydus' clarified position. (Phillips, John)
September 5, 2018 Opinion or Order Filing 393 REDACTED VERSION of #388 Reply Brief by Zydus Pharmaceuticals (USA) Inc.. (Phillips, John)
September 4, 2018 Opinion or Order Filing 392 ORDER granting #390 Motion for Pro Hac Vice Appearance of Attorney Ryan C. Morris. Signed by Judge Mitchell S. Goldberg on 9/4/2018. (ceg)
September 4, 2018 Opinion or Order Filing 391 ORDER granting #389 Motion for Pro Hac Vice Appearance of Attorney Bradford J. Badke, Caroline Bercier, Lauren C. Cranford and Anna M. Weinberg. Signed by Judge Mitchell S. Goldberg on 9/4/2018. (ceg)
August 31, 2018 Opinion or Order Filing 390 MOTION for Pro Hac Vice Appearance of Attorney Ryan C. Morris of SIDLEY AUSTIN LLP - filed by Amgen Inc.. (Blumenfeld, Jack)
August 31, 2018 Opinion or Order Filing 389 MOTION for Pro Hac Vice Appearance of Attorney Bradford J. Badke, Caroline Bercier, Lauren C. Cranford and Anna M. Weinberg of SIDLEY AUSTIN LLP - filed by Amgen Inc.. (Blumenfeld, Jack)
August 29, 2018 Opinion or Order Filing 388 [SEALED] REPLY BRIEF re #379 MOTION to Amend/Correct #376 Order,,, filed by Zydus Pharmaceuticals (USA) Inc.. (Phillips, John)
August 29, 2018 Opinion or Order Filing 387 REDACTED VERSION of #383 Answering Brief in Opposition to Motion to Amend by Amgen Inc.. (Blumenfeld, Jack)
August 27, 2018 Opinion or Order Filing 385 Official Transcript of status conference held on August 23, 2018 before Judge Goldberg. Court Reporter/Transcriber Valerie Gunning,Telephone number (302) 573-6194. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 9/17/2018. Redacted Transcript Deadline set for 9/27/2018. Release of Transcript Restriction set for 11/26/2018. (vjg)
August 24, 2018 Opinion or Order Filing 386 JUDGMENT, IT IS HEREBY ORDERED AND ADJUDGED that A judgment of NON-INFRINGEMENT of claims 1-4, 6, 8-12, and 14-18 of the '405 patent is hereby entered in favor of Amneal and against Amgen; A judgment of NON-INFRINGEMENT of claims 1-6 and 8-20 of the '405 patent is hereby entered in favor of Piramal and against Amgen; and A judgment of NON-INFRINGEMENT of claims 1-6 and 8-20 of the '405 patent is hereby entered in favor of Watson and against Amgen. Signed by Judge Mitchell S. Goldberg on 8/24/2018. (nmg)
August 24, 2018 Opinion or Order Filing 384 ORDER denying as moot #325 MOTION for Judgment on Partial Findings. The invalidity counterclaims of Amneal, Piramal, and Watson are DISMISSED without prejudice as moot. A judgment of NON-INFRINGEMENT of claims 1-4, 6, 8-12, and 14-18 of the '405 patent shall be entered in favor of Amneal and against Amgen. A judgment of NON-INFRINGEMENT of claims 1-6 and 8-20 of the '405 patent shall be entered in favor of Piramal and against Amgen. A judgment of NON-INFRINGEMENT of claims 1-6 and 8-20 of the '405 patent shall be entered in favor of Watson and against Amgen. Local counsel for Amgen and Zydus shall contact chambers to schedule a three-day trial on invalidity to commence in early January 2019. Local counsel for Amgen and Zydus shall contact chambers for Judge Thynge to schedule a mediation between them to occur before the trial on invalidity. Signed by Judge Mitchell S. Goldberg on 8/24/2018. (SEE ORDER FOR FURTHER DETAILS) (crb)
August 23, 2018 Opinion or Order Minute Entry for proceedings held before Judge Mitchell S. Goldberg - Status Conference held on 8/23/2018. (Court Reporter V. Gunning.) (crb)
August 22, 2018 Opinion or Order Filing 383 [SEALED] ANSWERING BRIEF in Opposition re #379 MOTION to Amend/Correct #376 Order,,, filed by Amgen Inc..Reply Brief due date per Local Rules is 8/29/2018. (Attachments: #1 Exhibits A-B)(Blumenfeld, Jack)
August 21, 2018 Opinion or Order Filing 382 Letter to The Honorable Mitchell S. Goldberg from Jack B. Blumenfeld regarding joint proposals following status conference - re #377 Order,. (Blumenfeld, Jack)
August 15, 2018 Opinion or Order Filing 381 Letter to Counsel from Judge Goldberg regarding Delaware Case Assignments. (gvw)
August 10, 2018 Opinion or Order Filing 380 [SEALED] OPENING BRIEF in Support re #379 MOTION to Amend/Correct #376 Order,,, filed by Zydus Pharmaceuticals (USA) Inc..Answering Brief/Response due date per Local Rules is 8/24/2018. (Phillips, John)
August 10, 2018 Opinion or Order Filing 379 MOTION to Amend/Correct #376 Order,,, - filed by Zydus Pharmaceuticals (USA) Inc.. (Attachments: #1 Text of Proposed Order)(Phillips, John)
August 9, 2018 Opinion or Order Filing 378 ORDER, Setting Hearings( An In-Person Status Conference is set for 8/23/2018 at 10:00 AM in Courtroom 4B in Wilmington, Delaware before Judge Mitchell S. Goldberg.) It is further ORDERED that the parties shall submit on August 21, 2018 a joint letter setting forth their proposals on how the court should proceed with respect to the invalidity trial and the pending motions. Signed by Judge Mitchell S. Goldberg on 8/8/2018. (nmf)
July 27, 2018 Opinion or Order Filing 377 STATUS CONFERENCE ORDER - IT IS ORDERED that: 1. The parties shall contact chambers to schedule an in-person status conference with the court to be held in Wilmington; and 2. The parties shall submit two days before the status conference a joint letter setting forth their proposals on how the court should proceed with respect to the invalidity trial and the pending motions. Signed by Judge Mitchell S. Goldberg on 7/26/2018. (nmf)
July 27, 2018 Opinion or Order Filing 376 TRIAL ORDER re #375 Opinion. IT IS ORDERED that: 1. Amneal does not infringe any of the claims asserted against it, which are claims 1, 2-4, 6, 8-12, and 14-18 of United States Patent No. 9,375,405 ('the '405 patent"); 2. Piramal does not infringe any of the claims asserted against it, which are claims 1-6 and 8- 20 of the '405 patent; 3. Watson does not infringe any of the claims asserted against it, which are claims 1-6 and 8-20 of the '405 patent; and 4. Zydus does not infringe claims 18 and 20 of the 405 patent; but 5. Zydus does infringe claims 1-4, 6, 8-9, 15-17, and 19 of the 405 patent, to the extent each claim is found valid and enforceable. Signed by Judge Mitchell S. Goldberg on 7/26/2018. (nmf)
July 27, 2018 Opinion or Order Filing 375 OPINION. Signed by Judge Mitchell S. Goldberg on 7/26/2018. (crb)
June 5, 2018 Opinion or Order Filing 374 Letter to The Honorable Mitchell S. Goldberg from Jack B. Blumenfeld regarding request for additional argument. (Blumenfeld, Jack)
June 4, 2018 Opinion or Order Filing 373 REDACTED VERSION of #371 Notice (Other) (Joint Notice of Admitted Trial Exhibits (Filed on Behalf of All Parties)) by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC. (Attachments: #1 Exhibit A)(Moore, David)
May 29, 2018 Opinion or Order Filing 372 REDACTED VERSION of #366 POST Trial Brief by Cadila Healthcare Ltd., Piramal Healthcare Limited, Zydus Pharmaceuticals (USA) Inc.. (Bilson, David)
May 25, 2018 Opinion or Order Filing 371 [SEALED] Joint NOTICE of Admitted Trial Exhibits by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC (filed on behalf of all Parties) (Attachments: #1 Exhibit A)(Moore, David)
May 25, 2018 Opinion or Order Filing 370 REDACTED VERSION of #367 POST Trial Brief by Amgen Inc.. (Blumenfeld, Jack)
May 22, 2018 Opinion or Order Filing 369 Letter to The Honorable Mitchell S. Goldberg from Maryellen Noreika regarding electronic versions of sealed post-trial briefs. (Noreika, Maryellen)
May 22, 2018 Opinion or Order Filing 368 Letter to The Honorable Mitchell S. Goldberg from David E. Moore, Esquire regarding CD containing Defendants' Sealed Responsive Post-Trial E-Brief. (Moore, David)
May 18, 2018 Opinion or Order Filing 367 [SEALED] POST TRIAL BRIEF -- Amgen's Responsive Post-Trial Brief on Infringement by Amgen Inc.. (Blumenfeld, Jack)
May 18, 2018 Opinion or Order Filing 366 [SEALED] POST TRIAL BRIEF Defendants' Post-Trial Responsive Brief (Filed on behalf of all Defendants) by Cadila Healthcare Ltd., Piramal Healthcare Limited, Zydus Pharmaceuticals (USA) Inc.. (Bilson, David)
May 17, 2018 Opinion or Order Filing 365 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amneal Pharmaceuticals LLC for Amneal Pharmaceuticals of New York LLC; Corporate Parent Amneal Pharmaceuticals Inc. for Amneal Pharmaceuticals LLC filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC. (Moore, David)
May 15, 2018 Opinion or Order CORRECTING ENTRY: Per request of filer, the SEALED Post Trial Brief at D.I. #359 has been removed and replaced with a version that has corrected cites to the trial transcripts to conform to the format ordered by Judge Goldberg in D.I. #331 , paragraph 6. (fms)
May 11, 2018 Opinion or Order Filing 364 REDACTED VERSION of #359 POST Trial Brief by Amgen Inc.. (Blumenfeld, Jack)
May 11, 2018 Opinion or Order Filing 363 REDACTED VERSION of #360 POST Trial Brief (filed on behalf of all Defendants) by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC. (O'Byrne, Stephanie)
May 11, 2018 Opinion or Order Filing 362 STIPULATION and Order (regarding trial exhibits and hyperlinked briefs) by Amgen Inc.. (Blumenfeld, Jack)
May 7, 2018 Opinion or Order Filing 361 Letter to The Honorable Mitchell S. Goldberg from David E. Moore, Esquire regarding CD containing Defendants' Sealed Post-Trial E-Brief - re #360 POST Trial Brief. (Moore, David) (Main Document 361 replaced on 5/7/2018) (nmg).
May 4, 2018 Opinion or Order Filing 360 [SEALED] POST TRIAL BRIEF (filed on behalf of all Defendants) by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC. (O'Byrne, Stephanie)
May 4, 2018 Opinion or Order Filing 359 [SEALED] POST TRIAL BRIEF on Infringement by Amgen Inc.. (Blumenfeld, Jack) (Main Document 359 replaced on 5/15/2018) (fms).
April 19, 2018 Opinion or Order Filing 358 ORDER denying #323 MOTION for Reargument re #301 Order and granting #307 MOTION in Limine to Preclude Testimony Contrary to the Court's Claim Construction, and Introduction of New Case Theories. Signed by Judge Mitchell S. Goldberg on 4/19/2018. (crb)
April 19, 2018 Opinion or Order Filing 357 MEMORANDUM OPINION. Signed by Judge Mitchell S. Goldberg on 4/19/2018. (crb)
April 18, 2018 Opinion or Order Filing 356 [SEALED] Transcript of Trial held on 3/9/18 before Judge Mitchell S. Goldberg. (gvw)
April 18, 2018 Opinion or Order Filing 355 [SEALED] Transcript of Trial held on 3/8/18 before Judge Mitchell S. Goldberg. (gvw)
April 18, 2018 Opinion or Order Filing 354 [SEALED] Transcript of Trial held on 3/6/18 before Judge Mitchell S. Goldberg. (gvw)
April 18, 2018 Opinion or Order Filing 353 [SEALED] Transcript of Trial held on 3/5/18 before Judge Mitchell S. Goldberg. (gvw)
April 5, 2018 Opinion or Order Filing 352 REDACTED VERSION of #350 Response to Motion, by Amgen Inc.. (Attachments: #1 Exhibit A - F)(Blumenfeld, Jack)
April 5, 2018 Opinion or Order Filing 351 SCHEDULING ORDER: 1. Amgen's Motion for Extension of Time (D.I. #344 ) is GRANTED; 2. The parties shall file their first post-trial brief in accordance with the instructions and schedule set forth in D.I. #331 and D.I. #340 ; and 3. The parties may file a second post-trial brief, in accordance with the instructions set forth in this Order, simultaneously at 5:00 p.m. ET on May 18, 2018. Signed by Judge Mitchell S. Goldberg on 4/5/2018. (ceg)
March 29, 2018 Opinion or Order Filing 350 [SEALED] Supplemental RESPONSE to Motion re #307 MOTION in Limine to Preclude Testimony Contrary to the Court's Claim Construction, and Introduction of New Case Theories filed by Amgen Inc.. (Attachments: #1 Exhibit A - F)(Blumenfeld, Jack)
March 23, 2018 Opinion or Order Filing 349 RESPONSE to Motion re #344 MOTION for Extension of Time to File Answering Brief in Opposition to The Zydus Defendants' Motion for Judgment [Opposition to Motion] filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.. (Phillips, John)
March 23, 2018 Opinion or Order Filing 348 CONSENT JUDGMENT, Party Aurobindo Pharma USA Inc., Aurobindo Pharma USA,Inc. terminated. Signed by Judge Mitchell S. Goldberg on 3/23/18. (lmm)
March 23, 2018 Opinion or Order Filing 347 REDACTED VERSION of #336 Stipulation by Amgen Inc.. (Blumenfeld, Jack)
March 23, 2018 Opinion or Order Filing 346 REDACTED VERSION of #339 Amended Document, by Zydus Pharmaceuticals (USA) Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4)(Phillips, John)
March 23, 2018 Opinion or Order Filing 345 REDACTED VERSION of #338 Amended Document, by Zydus Pharmaceuticals (USA) Inc.. (Phillips, John)
March 23, 2018 Opinion or Order SO ORDERED, #343 Stipulation of Admissibility (between Plaintiff Amgen and Aurobindo Defendants), filed by Amgen Inc. Ordered by Judge Mitchell S. Goldberg on 3/23/2018. (ceg)
March 22, 2018 Opinion or Order Filing 344 MOTION for Extension of Time to File Answering Brief in Opposition to The Zydus Defendants' Motion for Judgment - filed by Amgen Inc.. (Blumenfeld, Jack)
March 22, 2018 Opinion or Order Filing 343 STIPULATION of Admissibility between Plaintiff and the Aurobindo Defendants by Amgen Inc.. (Blumenfeld, Jack)
March 22, 2018 Opinion or Order Filing 342 PROPOSED CONSENT JUDGMENT between Plaintiff and the Aurobindo Defendants by Amgen Inc.. (Blumenfeld, Jack)
March 22, 2018 Opinion or Order Filing 341 MOTION for Extension of Time to file its Answering Brief in Opposition to the Amneal Defendants' Motion for Judgment (UNOPPOSED) - filed by Amgen Inc.. (Blumenfeld, Jack)
March 22, 2018 Opinion or Order SO ORDERED, #336 Stipulation regarding Infringement filed by Amgen Inc. Ordered by Judge Mitchell S. Goldberg on 3/22/2018. (ceg)
March 22, 2018 Opinion or Order SO ORDERED, #341 Motion for Extension of Time to file Answering Brief in Opposition to the Amneal Defendants' Motion for Judgment (Unopposed), filed by Amgen Inc. (Set Briefing Schedule: Answering Brief due 5/4/2018.). Signed by Judge Mitchell S. Goldberg on 3/22/2018. (ceg)
March 22, 2018 Opinion or Order SO ORDERED, #340 Stipulation regarding Post-Trial Briefing filed by Amgen Inc. Ordered by Judge Mitchell S. Goldberg on 3/22/2018. (ceg)
March 16, 2018 Opinion or Order Filing 340 STIPULATION Regarding Post-Trial Briefing by Amgen Inc.. (Blumenfeld, Jack)
March 16, 2018 Opinion or Order Filing 339 [SEALED] AMENDED DOCUMENT by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.. Amendment to #328 Declaration, Amended to clarify that the motion seeks judgment on partial findings under Fed. R. Civ. P. 52(c). (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4)(Phillips, John)
March 16, 2018 Opinion or Order Filing 338 [SEALED] AMENDED DOCUMENT by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.. Amendment to #327 Opening Brief in Support, Title amended to clarify that motion seeks judgment on partial findings under Fed. R. Civ. P. 52(c). (Phillips, John)
March 16, 2018 Opinion or Order Filing 337 CORRECTED MOTION UNDER FED. R. CIV. P. 52(c) For Judgment on the Pleadings, Correcting #326 to clarify that the motion seeks judgment on partial findings under Fed. R. Civ. P. 52(c) - filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc. (Attachments: #1 Text of Proposed Order)(Phillips, John) Modified on 3/22/2018 (fms). Modified on 3/22/2018 (fms).
March 15, 2018 Opinion or Order Filing 336 [SEALED] STIPULATION and Proposed Order Regarding Infringement by Amgen Inc.. (Blumenfeld, Jack)
March 15, 2018 Opinion or Order Filing 335 REDACTED VERSION of #325 MOTION for Judgment on Partial Findings by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC. (Attachments: #1 Exhibit A-C)(Moore, David)
March 14, 2018 Opinion or Order Filing 334 Letter to The Honorable Mitchell S. Goldberg from Jack B. Blumenfeld regarding why Amgen believes patent validity should be tried before Court issues its decision on infringement. (Blumenfeld, Jack)
March 14, 2018 Opinion or Order Filing 333 REPLY BRIEF re #323 MOTION for Reargument re #301 Order, #300 Memorandum Opinion [Zydus' Supplemental Opposition to Plaintiff's Motion for Reargument of the Court's February 27, 2018 Memorandum and Order] filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.. (Phillips, John)
March 14, 2018 Opinion or Order Filing 332 Letter to The Honorable Mitchell S. Goldberg from David E. Moore regarding case status (filed on behalf of Defendants). (Moore, David)
March 13, 2018 Opinion or Order Filing 331 ORDER - On or before March 16, 2018, the parties shall file a joint stipulation setting forth a post-trial briefing schedule. (See Order for further details). Signed by Judge Mitchell S. Goldberg on 3/13/2018. (crb)
March 12, 2018 Opinion or Order Filing 330 REDACTED VERSION of #308 Opening Brief in Support, by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.. (Phillips, John)
March 12, 2018 Opinion or Order Filing 329 REDACTED VERSION of #307 MOTION in Limine to Preclude Testimony Contrary to the Court's Claim Construction, and Introduction of New Case Theories by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.. (Attachments: #1 Text of Proposed Order)(Phillips, John)
March 9, 2018 Opinion or Order Filing 328 [SEALED] DECLARATION re #326 MOTION for Judgment on the Pleadings [Declaration of John C. Phillips, Jr.] by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4)(Phillips, John)
March 9, 2018 Opinion or Order Filing 327 [SEALED] OPENING BRIEF in Support re #326 MOTION for Judgment on the Pleadings filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc..Answering Brief/Response due date per Local Rules is 3/23/2018. (Phillips, John)
March 9, 2018 Opinion or Order Filing 326 MOTION for Judgment on the Pleadings - filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.. (Attachments: #1 Text of Proposed Order)(Phillips, John)
March 9, 2018 Opinion or Order Minute Entry for proceedings held before Judge Mitchell S. Goldberg - Bench Trial, Day 4, held on 3/9/2018. (Court Reporter Stacy Ingram and Dale Hawkins, Hawkins Reporting.) (jcs)
March 8, 2018 Opinion or Order Filing 325 [SEALED] MOTION for Judgment on Partial Findings - filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC. (Attachments: #1 Exhibit A-C)(Moore, David)
March 8, 2018 Opinion or Order Filing 324 RESPONSE to Motion re #323 MOTION for Reargument re #301 Order, #300 Memorandum Opinion [Filed on Behalf of All Defendants] filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC. (Moore, David)
March 8, 2018 Opinion or Order Minute Entry for proceedings held before Judge Mitchell S. Goldberg - Bench Trial, Day 3, held on 3/8/2018. (Court Reporter Stacy Ingram and Dale Hawkins, Hawkins Reporting.) (ceg)
March 6, 2018 Opinion or Order Filing 323 MOTION for Reargument re #301 Order, #300 Memorandum Opinion - filed by Amgen Inc.. (Blumenfeld, Jack)
March 6, 2018 Opinion or Order Minute Entry for proceedings held before Judge Mitchell S. Goldberg: Bench Trial, day 2, held on 3/6/2018. (Court Reporter Stacy Ingram and Dale Hawkins, Hawkins Reporting.) (jcs)
March 5, 2018 Opinion or Order Filing 322 Official Transcript of Pretrial Conference held on 2/16/2018 before Judge Mitchell S. Goldberg (Contact Connie S. Flores, Transcript Dept.,Telephone number 267-299-7191). Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 3/26/2018. Redacted Transcript Deadline set for 4/5/2018. Release of Transcript Restriction set for 6/4/2018. (crb)
March 5, 2018 Opinion or Order Filing 321 SO ORDERED, #313 Proposed Consent Judgment filed by Amgen Inc. Signed by Judge Mitchell S. Goldberg on 3/5/2018. (ceg)
March 5, 2018 Opinion or Order Filing 320 SO ORDERED, #306 Proposed Consent Judgment filed by Cipla Limited, Cipla USA Inc. Signed by Judge Mitchell S. Goldberg on 3/5/2018. (ceg)
March 5, 2018 Opinion or Order Filing 319 SO ORDERED, #312 Stipulation of Admissibility (between Plaintiff Amgen and Strides Defendants) filed by Amgen Inc. Signed by Judge Mitchell S. Goldberg on 3/5/2018. (ceg)
March 5, 2018 Opinion or Order Filing 318 SO ORDERED, #305 Stipulation of Admissibility (between Plaintiff Amgen Inc. and Defendants Cipla Limited and Cipla USA Inc.) filed by Amgen Inc. Signed by Judge Mitchell S. Goldberg on 3/5/2018. (ceg)
March 5, 2018 Opinion or Order Filing 317 SO ORDERED, #314 Stipulation of Dismissal filed by Amgen Inc., Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd. terminated. Signed by Judge Mitchell S. Goldberg on 3/5/2018. (ceg)
March 5, 2018 Opinion or Order Filing 316 SO ORDERED, #304 Stipulation of Dismissal filed by Amgen Inc., Mylan Inc. and Mylan Pharmaceuticals Inc. terminated. Signed by Judge Mitchell S. Goldberg on 3/5/2018. (ceg) (crb).
March 5, 2018 Opinion or Order Filing 315 SO ORDERED, #311 MOTION for Pro Hac Vice Appearance of Attorney Frederick C. Millett, Rosanna W. Gan, and Kathryn E. Easterling filed by Amgen Inc. Signed by Judge Mitchell S. Goldberg on 3/5/2018. (ceg)
March 5, 2018 Opinion or Order Minute Entry for proceedings held before Judge Mitchell S. Goldberg - Bench Trial, Day 1, held on 3/5/2018. (Court Reporter Stacy Ingram and Dale Hawkins, Hawkins Reporting.) (ceg)
March 4, 2018 Opinion or Order Filing 314 STIPULATION of Dismissal (between Plaintiff and DRL Defendants) by Amgen Inc.. (Blumenfeld, Jack)
March 4, 2018 Opinion or Order Filing 313 PROPOSED CONSENT JUDGMENT (between Plaintiff and Strides Defendants) by Amgen Inc.. (Blumenfeld, Jack)
March 4, 2018 Opinion or Order Filing 312 STIPULATION of Admissibility (between Plaintiff and Strides Defendants) by Amgen Inc.. (Blumenfeld, Jack)
March 3, 2018 Opinion or Order Filing 311 MOTION for Pro Hac Vice Appearance of Attorney Frederick C. Millett, Rosanna W. Gan, and Kathryn E. Easterling - filed by Amgen Inc.. (Blumenfeld, Jack)
March 2, 2018 Opinion or Order Filing 310 RESPONSE to Motion re #307 MOTION in Limine to Preclude Testimony Contrary to the Court's Claim Construction, and Introduction of New Case Theories filed by Amgen Inc.. (Blumenfeld, Jack)
March 2, 2018 Opinion or Order Filing 309 NOTICE of Appearance by Stephanie E. O'Byrne on behalf of Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC (O'Byrne, Stephanie)
March 2, 2018 Opinion or Order Filing 308 [SEALED] OPENING BRIEF in Support re #307 MOTION in Limine to Preclude Testimony Contrary to the Court's Claim Construction, and Introduction of New Case Theories filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc..Answering Brief/Response due date per Local Rules is 3/16/2018. (Phillips, John)
March 2, 2018 Opinion or Order Filing 307 [SEALED] MOTION in Limine to Preclude Testimony Contrary to the Court's Claim Construction, and Introduction of New Case Theories - filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.. (Attachments: #1 Text of Proposed Order)(Phillips, John)
February 28, 2018 Opinion or Order Filing 306 PROPOSED CONSENT JUDGMENT by Cipla Limited, Cipla USA Inc.. (Brauerman, Stephen)
February 28, 2018 Opinion or Order Filing 305 STIPULATION of Admissibility by Cipla Limited, Cipla USA Inc.. (Brauerman, Stephen)
February 28, 2018 Opinion or Order Filing 304 STIPULATION of Dismissal (between Plaintiff and Mylan Defendants) by Amgen Inc.. (Blumenfeld, Jack)
February 28, 2018 Opinion or Order Filing 303 ORDER granting #302 Motion to Appear Pro Hac Vice of Christopher S. Casieri, Esq. Signed by Judge Mitchell S. Goldberg on 2/28/18. (gvw)
February 28, 2018 Opinion or Order Filing 302 MOTION for Pro Hac Vice Appearance of Attorney Christopher S. Casieri - filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.. (Attachments: #1 Certification of Christopher S. Casieri)(Bilson, David)
February 27, 2018 Opinion or Order Filing 301 ORDER re #300 that the disputed claims are conducted as follows: Claim Term - Court's Construction (see order for details) and; 2) Defendant Dr. Reddy's Laboratories shall either produce Movva Snehalatha for a deposition before trial or be prepared to argue at trial why the court should not exclude her as a witness. Signed by Judge Mitchell S. Goldberg on 2/27/18. (gvw)
February 27, 2018 Opinion or Order Filing 300 MEMORANDUM re #294 . Signed by Judge Mitchell S. Goldberg on 2/27/18. (gvw)
February 26, 2018 Opinion or Order Pro Hac Vice Attorney Gregory C. Bays for Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
February 22, 2018 Opinion or Order Filing 299 Letter to The Honorable Mitchell S. Goldberg from Jack B. Blumenfeld regarding response to Defendants' February 21, 2018 e-mail to the Court. (Attachments: #1 Exhibit A)(Blumenfeld, Jack)
February 20, 2018 Opinion or Order Filing 298 Letter to The Honorable Mitchell S. Goldberg from Jack B. Blumenfeld regarding response to Defendants' "critical claim construction" contentions. (Blumenfeld, Jack)
February 16, 2018 Opinion or Order Minute Entry for proceedings held before Judge Mitchell S. Goldberg - Final Pretrial Conference held on 2/16/2018. Appearances: John Murnane, Esq Joshua Rothman, Esq., Alicia Russo, Esq., Jack Blumenfeld, Esq., Lois Kwasigroch, Esq., Wendy Whiteford, Esq., Eric Agovino, Esq., Jake Holdreith, Esq., Oren Langer, Esq. Kelsey Thorkelson, Esq., Alan Silverstein, Esq., Karen Keller, Esq., Chris Essig, Esq., Martin Pavane, Esq., Joseph Bellew, Esq., Marilyn Neiman, Esq., Sara Bussiere, Esq., Stamatios Stamoulis, Esq., David Bilson, Esq., Aaron Barkoff, Esq., Mary Matterer, Esq., Steven Skar, Esq., James Green, Esq. Clerk opens Court. Counsel addresses the Court. Matters related to case discussed. (Court Reporter/Deputy Clerk Stephen Sonnie.) (fms)
February 13, 2018 Opinion or Order Filing 297 NOTICE of Appearance by Alan Richard Silverstein on behalf of Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC (Silverstein, Alan)
February 12, 2018 Opinion or Order Filing 296 ORDER: The Pretrial Conference currently set for Wednesday, February 14, 2018, at 2:00 PM (EST) in Courtroom 4A at the U.S. District Court in Wilmington, Delaware HAS BEEN RESCHEDULED to Friday, February 16, 2018, at 1:30 PM (EST) in Courtroom 10A at the U.S. District Court in Philadelphia, Pennsylvania. Signed by Judge Mitchell S. Goldberg on 2/12/2018. (fms)
February 6, 2018 Opinion or Order Filing 295 ORDER REASSIGNING CASE. Case reassigned to Judge Mitchell S. Goldberg, United States District Judge, United States District Court for the Eastern District of Pennsylvania, for all further proceedings. Judge Gregory M. Sleet no longer assigned to case. Signed by Judge Leonard P. Stark on 2/6/18. Associated Cases: 1:16-cv-00853-GMS et al.(gvw)
February 6, 2018 Opinion or Order CORRECTING ENTRY: The attachment to volume 1 of the Proposed Final Pretrial Order ( #293 ) has been replaced at the request of the filer. (mdb)
February 6, 2018 Opinion or Order CORRECTING ENTRY: The main documents of volumes 1 and 2 of the Proposed Final Pretrial Order ( #293 , #294 ) have been replaced to correct the captions. (mdb)
February 5, 2018 Opinion or Order Filing 294 [SEALED] Proposed Pretrial Order (Volume 2 of 2 - Exhibits 6-8) by Amgen Inc.. (Attachments: #1 Exhibits 6-8)(Noreika, Maryellen) Modified on 2/6/2018 (mdb). (Main Document 294 replaced on 2/6/2018) (mdb).
February 5, 2018 Opinion or Order Filing 293 [SEALED] Proposed Pretrial Order (Volume 1 of 2 - Exhibits 1-5) by Amgen Inc.. (Attachments: #1 Exhibits 1-5)(Noreika, Maryellen) Modified on 2/6/2018 (mdb). (Main Document 293 replaced on 2/6/2018) (mdb). (Attachment 1 replaced on 2/6/2018) (mdb).
February 5, 2018 Opinion or Order Filing 292 NOTICE OF SERVICE of (1) Plaintiff Amgen Inc.'s First Supplemental Objections and Response to Defendant Piramal's First Interrogatory to Plaintiff; (2) Plaintiff Amgen Inc.'s First Supplemental Objections and Responses to Defendants' Joint Interrogatories to Plaintiff Nos. 5 and 7; (3) Plaintiff Amgen Inc.'s First Supplemental Objections and Response to Defendant Mylan Pharmaceuticals Inc. and Mylan Inc.'s Interrogatories to Plaintiff Nos. 1-2; (4) Amgen's First Supplemental Objections and Response to Defendants Dr. Reddy's Laboratories, Ltd.'s and Dr. Reddy's Laboratories, Inc.'s Interrogatory Nos. 1-3; (5) Amgen's First Supplemental Objections and Response to Defendants Watson Laboratories, Inc. and Actavis Pharma, Inc.'s Interrogatory Nos. 1-3; (6) Plaintiff Amgen Inc.'s First Supplemental Objections and Response to Defendants Amneal Pharmaceuticals LLC's and Amneal Pharmaceuticals of New York, LLC's First Set of Interrogatories; (7) Plaintiff Amgen Inc.'s First Supplemental Objections and Response to Defendants Cipla Limited and Cipla USA, Inc.s Interrogatory Nos. 1-2; and (8) Plaintiff Amgen Inc.'s Second Supplemental Objections and Responses to Defendants' Joint Interrogatories Nos. 2-3 filed by Amgen Inc..(Noreika, Maryellen)
February 2, 2018 Opinion or Order Filing 291 Official Transcript of T/C held on 01 22 18 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 2/23/2018. Redacted Transcript Deadline set for 3/5/2018. Release of Transcript Restriction set for 5/3/2018. (kjm)
February 1, 2018 Opinion or Order Filing 290 NOTICE OF SERVICE of Defendants' Notice Pursuant to 35 U.S.C. 282 (Filed on Behalf of All Defendants) filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC.(Moore, David)
January 30, 2018 Opinion or Order Filing 289 NOTICE OF SERVICE of (1) Plaintiff's Amended Infringement Contentions Regarding Aurobindo; (2) Plaintiff's Amended Infringement Contentions Regarding Cipla; (3) Plaintiff's Amended Infringement Contentions Regarding Zydus; (4) Plaintiff's Amended Infringement Contentions Regarding Strides; (5) Plaintiff's Amended Infringement Contentions Regarding Amneal; (6) Plaintiff's Amended Infringement Contentions Regarding Dr. Reddy's; (7) Plaintiff's Amended Infringement Contentions Regarding Watson; (8) Plaintiff's Amended Infringement Contentions Regarding Mylan; and (9) Plaintiff's Amended Infringement Contentions Regarding Piramal filed by Amgen Inc..(Blumenfeld, Jack)
January 30, 2018 Opinion or Order ORAL ORDER - The Pretrial Conference currently set for Thursday, February 15, 2018, at 10:00 AM (EST) in Courtroom 4A HAS BEEN RESCHEDULED to Wednesday, February 14, 2018, at 2:00 PM (EST) in Courtroom 4A, to accommodate the court's calendar. Ordered by Judge Gregory M. Sleet on 1/30/2018. (ctd)
January 24, 2018 Opinion or Order Filing 288 SO ORDERED - re #287 Stipulation to Amend Scheduling Order to Extend Deadline for Proposed Pretrial Order filed by Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Ltd., Piramal Healthcare Limited, Set/Reset Scheduling Order Deadlines: (Proposed Pretrial Order due by 2/5/2018). Signed by Judge Gregory M. Sleet on 1/24/2018. (mdb)
January 23, 2018 Opinion or Order Filing 287 STIPULATION to Amend Scheduling Order to Extend Deadline for Proposed Pretrial Order by Cadila Healthcare Ltd., Piramal Healthcare Limited, Zydus Pharmaceuticals (USA) Inc.. (Phillips, John)
January 22, 2018 Opinion or Order Minute Entry for proceedings held before Judge Gregory M. Sleet - Telephone Conference held on 1/22/2018. Discussion regarding the issue outlined in the joint agenda letter ( #286 ). After discussion, the court will defer the issue pending updates about the expert's health and discussion between counsel. If the parties cannot resolve the issue, the court is available today for a follow-up teleconference. (Court Reporter Kevin Maurer.) (mdb)
January 22, 2018 Opinion or Order ORAL ORDER - A Discovery Telephone Conference (#3) is set for Monday, January 22, 2018, at 11:00 AM (EST). The court is in receipt of the Joint Agenda letter. Plaintiff's counsel shall arrange the call and contact chambers at (302) 573-4559 once all the parties are on the line. Ordered by Judge Gregory M. Sleet on 1/22/2018. (ctd)
January 19, 2018 Opinion or Order Filing 286 Letter to The Honorable Gregory M. Sleet from John C. Phillips, Jr. regarding agenda for discovery dispute teleconference. (Phillips, John)
January 12, 2018 Opinion or Order Filing 285 NOTICE OF SERVICE of Dr. Reddy's Laboratories, Ltd.'s and Dr. Reddy's Laboratories, Inc.'s Document Production DRL0167640 DRL0167657 filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
January 11, 2018 Opinion or Order Filing 284 NOTICE OF SERVICE of Dr. Reddy's Laboratories, Ltd.'s and Dr. Reddy's Laboratories, Inc.'s Document Production DRL0167634 - DRL0167639 [HIGHLY CONFIDENTIAL - ATTORNEYS' EYES ONLY] filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
January 9, 2018 Opinion or Order Filing 283 NOTICE OF SERVICE of Dr. Reddy's Laboratories, Ltd.'s and Dr. Reddy's Laboratories, Inc.'s Document Production DRL0167404 - DRL0167633 filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
January 8, 2018 Opinion or Order Filing 282 NOTICE of Withdrawal of Counsel by Cipla Limited, Cipla USA Inc. (Brauerman, Stephen) Modified on 1/8/2018 (mdb).
January 5, 2018 Opinion or Order Filing 281 NOTICE OF SERVICE of Dr. Reddy's Laboratories, Ltd.'s and Dr. Reddy's Laboratories, Inc.'s Document Production DRL0167391 DRL0167403 [HIGHLY CONFIDENTIAL ATTORNEYS' EYES ONLY], filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
January 3, 2018 Opinion or Order Filing 280 NOTICE OF SERVICE of Second Amended Initial Disclosures Under the Fed. R. Civ. P. and Delaware Default Standard for Discovery filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
January 2, 2018 Opinion or Order Filing 279 NOTICE OF SERVICE of Dr. Reddy's Laboratories, Ltd.'s and Dr. Reddy's Laboratories, Inc.'s Document Production DRL0167382 DRL0167390 [HIGHLY CONFIDENTIAL ATTORNEYS EYES ONLY] filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
December 29, 2017 Opinion or Order Filing 278 NOTICE to Take Deposition of Dr. Martyn C. Davies on January 11, 12, 15, 16 and 17, 2018 beginning at 9:00 a.m. filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
December 29, 2017 Opinion or Order Filing 277 NOTICE OF SERVICE of Dr. Reddy's Laboratories, Ltd.'s and Dr. Reddy's Laboratories, Inc.'s Document Production DRL0167344 - DRL0167381 filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
December 19, 2017 Opinion or Order Filing 276 NOTICE OF SERVICE of the Highly Confidential Reply Expert Report of Dr. Martyn C. Davies Regarding Infringement by Piramal's ANDA Product filed by Amgen Inc..(Noreika, Maryellen)
December 8, 2017 Opinion or Order Filing 275 NOTICE OF SERVICE of Dr. Reddy's Laboratories, Ltd.'s and Dr. Reddy's Laboratories, Inc.'s Document Production DRL0167194 DRL0167343 filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
December 4, 2017 Opinion or Order Filing 274 NOTICE OF SERVICE of Defendants' Supplemental Objections and Responses to Plaintiff's First Set of Interrogatories filed by Cipla Limited, Cipla USA Inc..(Brauerman, Stephen)
December 1, 2017 Opinion or Order SO ORDERED - re #272 MOTION for Pro Hac Vice Appearance of Attorney Jenna Bruce filed by Cipla Limited, Cipla USA Inc.. Ordered by Judge Gregory M. Sleet on 12/1/2017. (mdb)
November 28, 2017 Opinion or Order Filing 273 NOTICE OF SERVICE of Third Supplemental Responses to Plaintiff's First Set of Interrogatories [HIGHLY CONFIDENTIAL] filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
November 28, 2017 Opinion or Order Filing 272 MOTION for Pro Hac Vice Appearance of Attorney Jenna Bruce - filed by Cipla Limited, Cipla USA Inc.. (Attachments: #1 Certification of Jenna Bruce)(Brauerman, Stephen)
November 28, 2017 Opinion or Order Filing 271 NOTICE OF SERVICE of [HIGHLY CONFIDENTIAL] Rebuttal Report of Frank A. Chrzanowski, Ph.D. filed by Piramal Healthcare Limited.(Bilson, David)
November 16, 2017 Opinion or Order Filing 270 NOTICE OF SERVICE of Document Production DRL0166828 - DRL0167193 filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
November 13, 2017 Opinion or Order Filing 269 NOTICE OF SERVICE of Reply Expert Report of Dr. Martyn C. Davies Regarding Infringement by Zydus' ANDA Products filed by Amgen Inc..(Noreika, Maryellen)
November 9, 2017 Opinion or Order Filing 268 SO ORDERED - re (265 in 1:16-cv-00853-GMS, 34 in 1:16-cv-00899-GMS) Proposed Consent Judgment. CONSENT JUDGMENT. Signed by Judge Gregory M. Sleet on 11/9/2017. Associated Cases: 1:16-cv-00899-GMS, 1:16-cv-00853-GMS(mdb)
November 9, 2017 Opinion or Order Filing 267 SO ORDERED - re (264 in 1:16-cv-00853-GMS, 33 in 1:16-cv-00899-GMS) Stipulation of Admissibility (between Plaintiff and Ajanta Pharma Limited and Ajanta Pharma USA Inc.) filed by Amgen Inc.. Signed by Judge Gregory M. Sleet on 11/9/2017. Associated Cases: 1:16-cv-00899-GMS, 1:16-cv-00853-GMS(mdb)
November 9, 2017 Opinion or Order Filing 266 NOTICE OF SERVICE of [HIGHLY CONFIDENTIAL- OUTSIDE COUNSEL'S EYES ONLY] Defendants Zydus Pharmaceuticals (USA) Inc.'s and Cadila Healthcare Limited's Supplemental Objections and Responses to Plaintiff's First Set of Interrogatories (No. 1) filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc..(Bilson, David)
November 8, 2017 Opinion or Order Filing 265 PROPOSED CONSENT JUDGMENT (between Plaintiff and Ajanta Pharma Limited and Ajanta Pharma USA Inc.) by Amgen Inc.. (Noreika, Maryellen) Modified on 11/8/2017 (mdb).
November 8, 2017 Opinion or Order Filing 264 STIPULATION of Admissibility (between Plaintiff and Ajanta Pharma Limited and Ajanta Pharma USA Inc.) by Amgen Inc.. (Noreika, Maryellen)
November 8, 2017 Opinion or Order SO ORDERED - re #259 MOTION for Pro Hac Vice Appearance of Attorney James R. Tyminski filed by Amgen Inc., #258 MOTION for Pro Hac Vice Appearance of Attorney Michael Freno and Harold Storey filed by Cipla Limited, Cipla USA Inc.. Ordered by Judge Gregory M. Sleet on 11/8/2017. (mdb)
November 7, 2017 Opinion or Order Filing 263 NOTICE to Take Deposition of Dr. Martyn C. Davies on December 6, 2017 at 9:00am filed by Cipla Limited, Cipla USA Inc..(Brauerman, Stephen)
November 7, 2017 Opinion or Order Filing 262 NOTICE to Take Deposition of Robert O. Williams III, PH.D. on January 10, 2018 at 9:00am filed by Cipla Limited, Cipla USA Inc..(Brauerman, Stephen)
November 7, 2017 Opinion or Order Filing 261 NOTICE to Take Deposition of William R. Roush, PH.D. on December 15, 2017 at 9:00am filed by Cipla Limited, Cipla USA Inc..(Brauerman, Stephen)
November 7, 2017 Opinion or Order Filing 260 NOTICE to Take Deposition of David W. Feigal, Jr., M.D., M.P.H. on November 10, 2017 at 9:00am filed by Cipla Limited, Cipla USA Inc..(Brauerman, Stephen)
November 6, 2017 Opinion or Order Filing 259 MOTION for Pro Hac Vice Appearance of Attorney James R. Tyminski - filed by Amgen Inc.. (Noreika, Maryellen)
November 6, 2017 Opinion or Order Filing 258 MOTION for Pro Hac Vice Appearance of Attorney Michael Freno and Harold Storey - filed by Cipla Limited, Cipla USA Inc.. (Attachments: #1 (Certification of Michael Freno), #2 (Certification of Harold Storey))(Brauerman, Stephen)
November 6, 2017 Opinion or Order Filing 257 NOTICE OF SERVICE of Opening Expert Report of Dr. Martyn C. Davies Regarding Infringement by Piramal's ANDA Products filed by Amgen Inc..(Noreika, Maryellen)
November 3, 2017 Opinion or Order Filing 256 NOTICE of Adoption by Piramal Healthcare Limited (Phillips, John)
November 3, 2017 Opinion or Order Filing 255 NOTICE OF SERVICE of Objections and Amended and Second Supplemental Responses to Plaintiff's First Set of Interrogatories [HIGHLY CONFIDENTIAL - ATTORNEYS' EYES ONLY] filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
November 3, 2017 Opinion or Order Filing 254 NOTICE to Take Deposition of Dr. Martyn C. Davies on November 13, 2017 filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
November 2, 2017 Opinion or Order Filing 253 SO ORDERED - re #248 Stipulation of Dismissal as to Sun Defendants filed by Amgen Inc., Party Sun Pharmaceutical Industries, Inc., Sun Pharma Global FZE and Sun Pharmaceutical Industries Ltd. terminated.. Signed by Judge Gregory M. Sleet on 11/2/2017. (mdb)
November 2, 2017 Opinion or Order Filing 252 CONSENT JUDGMENT. Party Hetero USA Inc., Hetero Labs Ltd. and Hetero Labs Ltd. Unit V terminated. Signed by Judge Gregory M. Sleet on 11/2/2017. (mdb)
November 2, 2017 Opinion or Order Filing 251 SO ORDERED - re (27 in 1:16-cv-00928-GMS, 246 in 1:16-cv-00853-GMS) Stipulation of Admissibility (between Plaintiff and Hetero USA Inc., Hetero Labs Ltd. and Hetero Labs Ltd. Unit V) filed by Amgen Inc.. Signed by Judge Gregory M. Sleet on 11/2/2017. Associated Cases: 1:16-cv-00853-GMS, 1:16-cv-00928-GMS(mdb)
November 1, 2017 Opinion or Order Filing 250 NOTICE of Change of Address by Stephen B. Brauerman (Brauerman, Stephen)
October 27, 2017 Opinion or Order Filing 249 NOTICE OF SERVICE of Plaintiff Amgen Inc.'s Objections and Response to Defendant Piramal's First Interrogatory to Plaintiff filed by Amgen Inc..(Blumenfeld, Jack)
October 27, 2017 Opinion or Order Filing 248 STIPULATION of Dismissal as to Sun Defendants by Amgen Inc.. (Noreika, Maryellen) Modified on 10/27/2017 (mdb).
October 26, 2017 Opinion or Order Filing 247 PROPOSED CONSENT JUDGMENT (between Plaintiff and Hetero USA Inc., Hetero Labs Ltd., and Hetero Labs Ltd. Unit V) by Amgen Inc.. (Noreika, Maryellen) Modified on 10/27/2017 (mdb).
October 26, 2017 Opinion or Order Filing 246 STIPULATION of Admissibility (between Plaintiff and Hetero USA Inc., Hetero Labs Ltd. and Hetero Labs Ltd. Unit V) by Amgen Inc.. (Noreika, Maryellen) Modified on 10/27/2017 (mdb).
October 26, 2017 Opinion or Order Filing 245 NOTICE requesting Clerk to remove Jaimin Shah as co-counsel. Reason for request: No Longer Affiliated with Schiff Hardin LLP. (Bilson, David)
October 24, 2017 Opinion or Order Filing 244 NOTICE OF SERVICE of [HIGHLY CONFIDENTIAL] Reply Expert Report of Peter H. Rheinstein, M.D., J.D., M.S. filed by Cadila Healthcare Ltd., Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc..(Bilson, David)
October 24, 2017 Opinion or Order Filing 243 NOTICE OF SERVICE of Reply Expert Report of Umesh V. Banakar, Ph.D. [Highly Confidential-Subject to Protective Order] (Also filed on behalf of Defendants Ajanta Pharma Limited, Ajanta Pharma USA, Inc., Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Breckenridge Pharmaceutical, Inc., Cadila Healthcare Ltd. d/b/a Zydus Cadilia, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc., Hetero USA, Inc., Hetero Labs Ltd., Hetero Labs Ltd. Unit V, Micro Labs Limited, Micro Labs USA, Inc., Mylan Pharmaceuticals Inc., Mylan Inc., Strides Pharma Global PTE Limited, Strides Pharma, Inc., Sun Pharmaceutical Industries Ltd., Sun Pharma Global FZE, Sun Pharmaceutical Industries, Inc., Watson Laboratories, Inc., Actavis Pharma, Inc., and Zydus Pharmaceuticals (USA) Inc.) filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC.(Palapura, Bindu)
October 23, 2017 Opinion or Order Filing 242 NOTICE OF SERVICE of (1) Reply Expert Report of Dr. Martyn C. Davies Regarding Infringement by Aurobindo's ANDA Product; (2) Reply Expert Report of Dr. Martyn C. Davies Regarding Infringement by Cipla's ANDA Product; (3) Reply Expert Report of Dr. Martyn C. Davies Regarding Infringement by Strides' ANDA Product; (4) Reply Expert Report of Dr. Martyn C. Davies Regarding Infringement by Amneal's ANDA Product; (5) Reply Expert Report of Dr. Martyn C. Davies Regarding Infringement by DRL's ANDA Product; (6) Reply Expert Report of Dr. Martyn C. Davies Regarding Infringement by Watson's ANDA Product; and (7) Reply Expert Report of Dr. Martyn C. Davies Regarding Infringement by Mylan's ANDA Product filed by Amgen Inc..(Noreika, Maryellen)
October 12, 2017 Opinion or Order SO ORDERED - re (13 in 1:17-cv-00815-GMS) MOTION for Pro Hac Vice Appearance of Attorney Gurpreet Singh Walia filed by Alkem Laboratories Ltd., (241 in 1:16-cv-00853-GMS) MOTION for Pro Hac Vice Appearance of Attorney Gurpreet Singh Walia filed by Hetero USA Inc., Hetero Labs Ltd. Unit V, Hetero Labs Ltd.. Ordered by Judge Gregory M. Sleet on 10/12/2017. Associated Cases: 1:16-cv-00853-GMS, 1:17-cv-00815-GMS(mdb)
October 11, 2017 Opinion or Order Filing 241 MOTION for Pro Hac Vice Appearance of Attorney Gurpreet Singh Walia - filed by Hetero Labs Ltd., Hetero Labs Ltd. Unit V, Hetero USA Inc.. (Dorsney, Kenneth)
October 11, 2017 Opinion or Order Filing 240 NOTICE OF SERVICE of Document Production DRL0166670 - DRL166827 filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
October 10, 2017 Opinion or Order SO ORDERED - re #239 STIPULATION TO EXTEND TIME Regarding Reply Expert Reports to October 20, 2017 filed by Sun Pharmaceutical Industries, Inc., Sun Pharma Global FZE, Zydus Pharmaceuticals (USA) Inc., Sun Pharmaceutical Industries Ltd., Ajanta Pharma Limited, Ajanta Pharma USA Inc., Cadila Healthcare Ltd. Ordered by Judge Gregory M. Sleet on 10/10/2017. (mdb)
October 6, 2017 Opinion or Order Filing 239 STIPULATION TO EXTEND TIME Regarding Reply Expert Reports to October 20, 2017 - filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc., Cadila Healthcare Ltd., Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc., Zydus Pharmaceuticals (USA) Inc.. (Bilson, David)
October 4, 2017 Opinion or Order Filing 238 NOTICE OF SERVICE of (1) Defendant Piramal's [HIGHLY CONFIDENTIAL] Responses to Plaintiff's First and Second Sets of Interrogatories; and (2) Defendant Piramal's Responses to Plaintiff's First, Second and Third Sets of Requests for the Production of Documents and Things filed by Piramal Healthcare Limited.(Bilson, David)
October 3, 2017 Opinion or Order Filing 237 NOTICE OF SERVICE of Objections and Supplemental Responses to Plaintiff's First Set of Interrogatories [HIGHLY CONFIDENTIAL - ATTORNEYS' EYES ONLY] filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
September 27, 2017 Opinion or Order Filing 236 NOTICE OF SERVICE of Defendant Piramal's First Interrogatory to Plaintiff filed by Piramal Healthcare Limited.(Bilson, David)
September 27, 2017 Opinion or Order Filing 235 REDACTED VERSION of (32 in 1:16-cv-00854-GMS, 218 in 1:16-cv-00853-GMS) Stipulation of Dismissal by Amgen Inc.. (Noreika, Maryellen)
September 27, 2017 Opinion or Order Filing 234 REDACTED VERSION of (214 in 1:16-cv-00853-GMS, 30 in 1:16-cv-00926-GMS) Stipulation of Dismissal by Amgen Inc.. (Noreika, Maryellen)
September 26, 2017 Opinion or Order Filing 233 NOTICE OF SERVICE of Rebuttal Expert Report of Dr. Leah Appel, Ph.D. filed by Actavis Pharma, Inc., Watson Laboratories, Inc..(Hoeschen, Nathan)
September 26, 2017 Opinion or Order Filing 232 NOTICE OF SERVICE of Rebuttal Expert Report of Jason McConville, Ph.D. [Highly Confidential Subject to the Protective Order] filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC.(Palapura, Bindu)
September 26, 2017 Opinion or Order Filing 231 NOTICE OF SERVICE of Expert Report of Dr. Bradley A. Clark filed by Strides Pharma Global PTE Limited, Strides Pharma Inc..(Green, James)
September 26, 2017 Opinion or Order Filing 230 NOTICE OF SERVICE of (1) Rebuttal Expert Report of Robert O. Williams III, Ph.D.; (2) Rebuttal Expert Report of William R. Roush, Ph.D. Regarding the Validity of U.S. Patent No. 9,375,405; (3) Rebuttal Expert Report of Dr. Martyn C. Davies in Support of Validity of U.S. Patent No. 9,375,405; and (4) Rebuttal Expert Report of David W. Feigel, Jr., M.D., M.P.H. filed by Amgen Inc..(Noreika, Maryellen)
September 26, 2017 Opinion or Order Filing 229 NOTICE OF SERVICE of Document Production Brittain0000001 Brittain0003478 re #226 Notice of Service, filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
September 26, 2017 Opinion or Order Filing 228 NOTICE OF SERVICE of [HIGHLY CONFIDENTIAL] Responsive Expert Report of Changquan Calvin Sun, Ph.D. Regarding Non-Infringement of U.S. Patent No. 9,375,405 filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc..(Bilson, David)
September 26, 2017 Opinion or Order Filing 227 NOTICE OF SERVICE of [HIGHLY CONFIDENTIAL] Expert Report of Irwin C. Jacobs Regarding Non-Infringement by Ajanta's ANDA Products filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc..(Bilson, David)
September 26, 2017 Opinion or Order Filing 226 NOTICE OF SERVICE of Expert Report of Harry G. Brittain Ph.D. in Opposition to the Opening Expert Report of Dr. Martyn C. Davies and document production DRL0166638 DRL0166649 filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
September 25, 2017 Opinion or Order Filing 225 NOTICE OF SERVICE of Rebuttal Expert Report of Reza Fassihi, Ph. D. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Matterer, Mary)
September 25, 2017 Opinion or Order Filing 224 NOTICE OF SERVICE of Rebuttal Expert Report of Arthur H. Kibbe and Exhibits A-B filed by Cipla Limited, Cipla USA Inc..(Brauerman, Stephen)
September 22, 2017 Opinion or Order Filing 223 NOTICE OF SERVICE of Amgen's Second Supplemental Objections and Response to Defendants Sun Pharmaceutical Industries, Ltd., Sun Pharma Global FZE, and Sun Pharmaceutical Industries, Inc.'s First Interrogatory filed by Amgen Inc..(Noreika, Maryellen)
September 21, 2017 Opinion or Order Filing 222 CONSENT JUDGMENT. Signed by Judge Gregory M. Sleet on 9/21/2017. Associated Cases: 1:16-cv-00853-GMS, 1:16-cv-00927-GMS(mdb)
September 21, 2017 Opinion or Order Filing 221 SO ORDERED - re (27 in 1:16-cv-00927-GMS, 219 in 1:16-cv-00853-GMS) Stipulation of Admissibility (between Plaintiff and Breckenridge Pharmaceutical, Inc.) filed by Amgen Inc.. Signed by Judge Gregory M. Sleet on 9/21/2017. Associated Cases: 1:16-cv-00853-GMS, 1:16-cv-00927-GMS(mdb)
September 20, 2017 Opinion or Order Filing 220 PROPOSED CONSENT JUDGMENT (between Plaintiff and Breckenridge Pharmaceutical, Inc.) by Amgen Inc.. (Noreika, Maryellen) Modified on 9/21/2017 (mdb).
September 20, 2017 Opinion or Order Filing 219 STIPULATION of Admissibility (between Plaintiff and Breckenridge Pharmaceutical, Inc.) by Amgen Inc.. (Noreika, Maryellen) Modified on 9/21/2017 (mdb).
September 20, 2017 Opinion or Order Filing 218 [SEALED] STIPULATION of Dismissal (as to Micro Labs Limited and Micro Labs USA, Inc.) by Amgen Inc.. (Noreika, Maryellen) Modified on 9/20/2017 (mdb).
September 20, 2017 Opinion or Order SO ORDERED - re (32 in 1:16-cv-00854-GMS, 218 in 1:16-cv-00853-GMS) [Sealed] Stipulation of Dismissal filed by Amgen Inc.. Ordered by Judge Gregory M. Sleet on 9/20/2017. Associated Cases: 1:16-cv-00854-GMS, 1:16-cv-00853-GMS(mdb)
September 20, 2017 Opinion or Order CORRECTING ENTRY: The Stipulation of Dismissal (formerly DIs 218 & 32) have been removed from the docket and will be re-filed shortly. Associated Cases: 1:16-cv-00854-GMS, 1:16-cv-00853-GMS(mdb)
September 12, 2017 Opinion or Order SO ORDERED - re #217 MOTION for Pro Hac Vice Appearance of Attorney Eric Agovino filed by Amgen Inc. Ordered by Judge Gregory M. Sleet on 9/12/2017. (mdb)
September 11, 2017 Opinion or Order Filing 217 MOTION for Pro Hac Vice Appearance of Attorney Eric Agovino - filed by Amgen Inc.. (Noreika, Maryellen)
September 11, 2017 Opinion or Order SO ORDERED - re #214 [Sealed] Stipulation of Dismissal filed by Amgen Inc., Party Apotex Corp. and Apotex Inc. terminated. Ordered by Judge Gregory M. Sleet on 9/11/2017. (mdb)
September 11, 2017 Opinion or Order Pro Hac Vice Attorney Elizabeth J. Weiskopf for Cipla Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
September 8, 2017 Opinion or Order SO ORDERED - re #216 MOTION for Pro Hac Vice Appearance of Attorney Peter L. Giunta and Elizabeth J. Weiskopf filed by Cipla Limited, Cipla USA Inc.. Ordered by Judge Gregory M. Sleet on 9/8/2017. (mdb)
September 8, 2017 Opinion or Order SO ORDERED - re #215 Stipulation to Amend Scheduling Order filed by Hetero USA Inc., Hetero Labs Ltd. Unit V, Hetero Labs Ltd., Set/Reset Scheduling Order Deadlines: (Rebuttal Expert Reports due by 9/25/2017., Reply Expert Reports due by 10/13/2017., Expert Discovery due by 11/17/2017). Ordered by Judge Gregory M. Sleet on 9/8/2017. (mdb)
September 7, 2017 Opinion or Order Filing 216 MOTION for Pro Hac Vice Appearance of Attorney Peter L. Giunta and Elizabeth J. Weiskopf - filed by Cipla Limited, Cipla USA Inc.. (Attachments: #1 Certification of Peter L. Giunta, #2 Certification of Elizabeth J. Weiskopf)(Brauerman, Stephen)
September 7, 2017 Opinion or Order Filing 215 STIPULATION to Amend Scheduling Order by Hetero Labs Ltd., Hetero Labs Ltd. Unit V, Hetero USA Inc.. (Dorsney, Kenneth)
September 7, 2017 Opinion or Order CORRECTING ENTRY: The Stipulation of Dismissal filed on September 5, 2017 has been replaced and placed under seal. Associated Cases: 1:16-cv-00853-GMS, 1:16-cv-00926-GMS(mdb)
September 5, 2017 Opinion or Order Filing 214 [SEALED] STIPULATION of Dismissal (as to Apotex Inc. and Apotex Corp.) by Amgen Inc.. (Blumenfeld, Jack) Modified on 9/5/2017 (mdb). (Main Document 30 replaced on 9/7/2017) (mdb). Modified on 9/7/2017 (mdb).
September 1, 2017 Opinion or Order Filing 213 NOTICE OF SERVICE of (1) Plaintiff's First Set of Interrogatories to Piramal (2) Plaintiff's Second Set of Interrogatories to Piramal, (3) Plaintiff's First Set of Requests to Piramal for the Production of Documents and Things, (4) Plaintiff's Second Set of Requests to Piramal for the Production of Documents and Things, (5) Plaintiff's Third Set of Requests to Piramal for the Production of Documents and Things filed by Amgen Inc..(Noreika, Maryellen)
September 1, 2017 Opinion or Order Pro Hac Vice Attorney William D. Hare for Zydus Pharmaceuticals (USA) Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
September 1, 2017 Opinion or Order SO ORDERED - re #212 MOTION for Pro Hac Vice Appearance of Attorney William D. Hare filed by Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Ltd.. Ordered by Judge Gregory M. Sleet on 9/1/2017. (mdb)
August 31, 2017 Opinion or Order Filing 212 MOTION for Pro Hac Vice Appearance of Attorney William D. Hare - filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.. (Attachments: #1 Certification of William D. Hare)(Bilson, David)
August 25, 2017 Opinion or Order Filing 211 NOTICE of Adoption by Piramal Healthcare Limited (Phillips, John)
August 25, 2017 Opinion or Order Filing 210 Official Transcript of T/C held on 08 04 17 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 9/15/2017. Redacted Transcript Deadline set for 9/25/2017. Release of Transcript Restriction set for 11/27/2017. (kjm)
August 25, 2017 Opinion or Order SO ORDERED - re #209 MOTION for Pro Hac Vice Appearance of Attorney Renita S. Rathinam filed by Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Ltd. Ordered by Judge Gregory M. Sleet on 8/25/2017. (mdb)
August 23, 2017 Opinion or Order Filing 209 MOTION for Pro Hac Vice Appearance of Attorney Renita S. Rathinam - filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.. (Attachments: #1 Certification of Renita S. Rathinam)(Bilson, David)
August 22, 2017 Opinion or Order Filing 208 NOTICE of by Cipla Limited, Cipla USA Inc. /Notice of Change of Firm Affiliation (Brauerman, Stephen)
August 21, 2017 Opinion or Order Filing 207 ORAL ORDER: Counsel are to advise by private email to Judge Thynge, with a copy to her judicial administrator, Cathleen Kennedy, by close of business 9/8/17, whether a teleconference in the next 30 days to discuss mediation with plaintiff and defendants or group of defendants would be appropriate. In addition, if the parties feel a teleconference should not be scheduled within the next 30 days, an explanation as to why should be included in the email. Signed by Judge Mary Pat Thynge on 8/21/17. (cak)
August 18, 2017 Opinion or Order Filing 206 NOTICE OF SERVICE of Amended Objections and Responses to Plaintiffs Second Set of Interrogatories and Amended Initial Disclosure Under the Fed. R. Civ. P. and Delaware Default Standard for Discovery filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
August 18, 2017 Opinion or Order Filing 205 NOTICE OF SERVICE of Document Production DRL0166605 DRL0166637 filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
August 18, 2017 Opinion or Order Filing 204 NOTICE OF SERVICE of Document Production COZEN000001 - COZEN002229 filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd., Micro Labs Limited, Micro Labs USA, Inc..(Bellew, Joseph)
August 15, 2017 Opinion or Order Filing 203 NOTICE OF SERVICE of Defendant Piramal Healthcare UK Limited's Disclosures Pursuant to Federal Rule of Civil Procedure 26(A)(1) and Paragraph 3 of the Default Standard for Discovery filed by Piramal Healthcare Limited.(Bilson, David)
August 15, 2017 Opinion or Order Filing 202 NOTICE of Defendant Piramal Healthcare UK Limited's Adoption of Defendants' Joint Initial Invalidity Contentions served on March 3, 2017 by Piramal Healthcare Limited re #30 Notice of Service,,, (Bilson, David)
August 15, 2017 Opinion or Order Filing 201 NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions Regarding Piramal filed by Amgen Inc..(Noreika, Maryellen)
August 15, 2017 Opinion or Order Filing 200 NOTICE OF SERVICE of Opening Expert Report of Umesh V. Banakar, Ph.D. (Also filed on behalf of Defendants Ajanta Pharma Limited, Ajanta Pharma USA, Inc., Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Breckenridge Pharmaceutical, Inc., Cadila Healthcare Ltd. d/b/a Zydus Cadilia, Cipla Limited, Cipla USA, Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc., Hetero USA, Inc., Hetero Labs Ltd., Hetero Labs Ltd. Unit V, Micro Labs Limited, Micro Labs USA, Inc., Mylan Pharmaceuticals Inc., Mylan Inc., Strides Pharma Global PTE Limited, Strides Pharma, Inc., Sun Pharmaceutical Industries Ltd., Sun Pharma Global FZE, Sun Pharmaceutical Industries, Inc., Watson Laboratories, Inc., Actavis Pharma, Inc., and Zydus Pharmaceuticals (USA) Inc.) filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC.(Palapura, Bindu)
August 15, 2017 Opinion or Order Filing 199 NOTICE OF SERVICE of Opening Expert Report of Dr. Martyn C. Davies Regarding Infringement by Defendants' ANDA Products filed by Amgen Inc..(Noreika, Maryellen)
August 15, 2017 Opinion or Order Remark - These cases have been consolidated for ALL PURPOSES. All future filings are to be made ONLY in Lead C.A. No. 16-853 (GMS). Associated Cases: 1:17-cv-00713-GMS, 1:16-cv-00853-GMS(mdb)
August 14, 2017 Opinion or Order Filing 198 NOTICE of Change of Firm Affiliation by Hetero Labs Ltd., Hetero Labs Ltd. Unit V, Hetero USA Inc. (Dorsney, Kenneth)
August 9, 2017 Opinion or Order Pro Hac Vice Attorney Derek S. Neilson for Mylan Inc. and Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg)
August 4, 2017 Opinion or Order Minute Entry for proceedings held before Judge Gregory M. Sleet - Discovery Telephone Conference held on 8/4/2017. Discussion on the disputed items as listed in the Joint Agenda submission. The parties shall follow the court's directives as discussed. (Court Reporter: Kevin Maurer.) (asw)
August 2, 2017 Opinion or Order Filing 197 NOTICE to Take Deposition of Amit Antarkar on August 4, 2017 (Amended Notice of Deposition) filed by Amgen Inc..(Noreika, Maryellen)
August 2, 2017 Opinion or Order Filing 196 Letter to The Honorable Gregory M. Sleet from Maryellen Noreika regarding Agenda for August 4, 2017 Teleconference. (Noreika, Maryellen)
August 1, 2017 Opinion or Order Filing 195 NOTICE to Take Deposition of Dr. Sampathkumar Devarajan (Strides) on August 2, 2017 (AMENDED NOTICE) filed by Amgen Inc..(Noreika, Maryellen)
August 1, 2017 Opinion or Order SO ORDERED - re #194 MOTION for Pro Hac Vice Appearance of Attorney Derek S. Neilson filed by Mylan Inc., Mylan Pharmaceuticals Inc. Ordered by Judge Gregory M. Sleet on 8/1/2017. (mdb)
August 1, 2017 Opinion or Order Set/Reset Hearings: A Discovery Telephone Conference is set for 8/4/2017 at 10:00 AM before Judge Gregory M. Sleet. (asw)
August 1, 2017 Opinion or Order ORAL ORDER SCHEDULING DISCOVERY TELECONFERENCE - A Discovery Telephone Conference (#2) is set for Friday, August 4, 2017, at 10:00 AM (EST). A Joint Agenda letter (Limited to 3 disputed issues) shall be filed no later than noon on Wednesday, August 2, 2017 (sample agenda letter can be located on the court's website). Plaintiff's counsel shall arrange the call and contact chambers at (302) 573-4559 once all participants are on the line. Ordered by Judge Gregory M. Sleet on 8/1/2017. (asw)
July 31, 2017 Opinion or Order Filing 194 MOTION for Pro Hac Vice Appearance of Attorney Derek S. Neilson - filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios)
July 28, 2017 Opinion or Order SO ORDERED - re #188 MOTION for Pro Hac Vice Appearance of Attorney Robert S. Pickens filed by Amgen Inc. Ordered by Judge Gregory M. Sleet on 7/28/2017. (mdb)
July 26, 2017 Opinion or Order Filing 193 NOTICE to Take Deposition of P. Basavaiah Chowdary on July 28, 2017 at 9:30 a.m. (AMENDED NOTICE) filed by Amgen Inc..(Noreika, Maryellen)
July 24, 2017 Opinion or Order Filing 192 NOTICE OF SERVICE of Dr. Reddy's document production numbered DRL0000001 - DRL0164517 filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
July 24, 2017 Opinion or Order Filing 191 NOTICE OF SERVICE of Micro Lab's document production numbered MICROLABS0000001 - MICROLABS0141369 filed by Micro Labs Limited, Micro Labs USA, Inc..(Bellew, Joseph)
July 24, 2017 Opinion or Order Filing 190 NOTICE to Take Deposition of Manohar Lalge on July 27, 2017 at 9:30 a.m. (AMENDED NOTICE) filed by Amgen Inc..(Noreika, Maryellen)
July 24, 2017 Opinion or Order Filing 189 NOTICE OF SERVICE of Plaintiff Amgen Inc.'s Responses to Defendants' First Notice of Rule 30(b)(6) Deposition of Plaintiff Amgen Inc. filed by Amgen Inc..(Blumenfeld, Jack)
July 21, 2017 Opinion or Order Filing 188 MOTION for Pro Hac Vice Appearance of Attorney Robert S. Pickens - filed by Amgen Inc.. (Noreika, Maryellen)
July 20, 2017 Opinion or Order Filing 187 NOTICE to Take Deposition of Hung-Ren H. Lin on July 27, 2017 at 9:00a.m. filed by Cipla Limited, Cipla USA Inc..(Brauerman, Stephen)
July 19, 2017 Opinion or Order Filing 186 ORDER Construing the Terms of U.S. Patent No. 9,375,405. Signed by Judge Gregory M. Sleet on 7/19/2017. (mdb)
July 18, 2017 Opinion or Order Filing 185 NOTICE to Take Deposition of Glen Gary Lawrence on July 21, 2017 at 9:00 a.m. filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd., Micro Labs Limited, Micro Labs USA, Inc..(Bellew, Joseph)
July 18, 2017 Opinion or Order Filing 184 NOTICE OF SERVICE of Defendants Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals of New York, LLC's Privilege Log filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC.(Palapura, Bindu)
July 18, 2017 Opinion or Order Filing 183 NOTICE OF SERVICE of Defendant Strides Pharma Global Pte Limited and Stride Pharma, Inc.s Privilege Document Log filed by Strides Pharma Global PTE Limited, Strides Pharma Inc..(Green, Jared) Modified on 7/18/2017 (mdb).
July 17, 2017 Opinion or Order Filing 182 NOTICE OF SERVICE of various discovery responses (see notice for details) filed by Amgen Inc..(Blumenfeld, Jack)
July 14, 2017 Opinion or Order Filing 181 NOTICE OF SERVICE of Privilege Log of Cipla Ltd. and Cipla USA, Inc. filed by Cipla Limited, Cipla USA Inc..(Brauerman, Stephen)
July 14, 2017 Opinion or Order Filing 180 NOTICE OF SERVICE of Amended Privilege Log filed by Micro Labs Limited, Micro Labs USA, Inc..(Bellew, Joseph)
July 14, 2017 Opinion or Order Filing 179 NOTICE OF SERVICE of Privilege Log filed by Micro Labs Limited, Micro Labs USA, Inc..(Bellew, Joseph)
July 14, 2017 Opinion or Order Filing 178 NOTICE OF SERVICE of Privilege Log filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
July 14, 2017 Opinion or Order Filing 177 NOTICE OF SERVICE of Privilege Log and Document Productions filed by Mylan Inc., Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios)
July 13, 2017 Opinion or Order Filing 176 NOTICE OF SERVICE of Amgen's Objections and Response to Defendants Ajanta Pharma Limited and Ajanta Pharma USA Inc.'s First Set of Interrogatories to Plaintiff (Nos. 1-2) filed by Amgen Inc..(Noreika, Maryellen)
July 12, 2017 Opinion or Order Filing 175 NOTICE OF SERVICE of Amgen's Notice of Rule 30(b)(6) Deposition of Defendant Breckenridge Pharmaceutical, Inc. filed by Amgen Inc..(Blumenfeld, Jack)
July 12, 2017 Opinion or Order Filing 174 NOTICE OF SERVICE of Amgen's Objections and Response to Defendants Watson Laboratories, Inc. and Actavis Pharma, Inc.'s First Set of Interrogatories to Plaintiff filed by Amgen Inc..(Blumenfeld, Jack)
July 11, 2017 Opinion or Order Filing 173 NOTICE to Take Deposition of Francisco J. Alvarez [AMENDED NOTICE] on July 19, 2017 filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Bilson, David)
July 10, 2017 Opinion or Order Filing 172 NOTICE OF SERVICE of (1) Plaintiff Amgen Inc.'s First Supplemental Objections and Responses to Defendants' First Set of Joint Interrogatories (Nos. 1-3); (2) Amgen's First Supplemental Objections and Response to Defendants Sun Pharmaceutical Industries, Ltd., Sun Pharma Global FZE, and Sun Pharmaceutical Industries, Inc.'s First Interrogatory; and (3) Plaintiff Amgen Inc.'s First Supplemental Objections and Response to Defendant Sun Pharmaceutical Industries, Ltd., Sun Pharma Global FZE, and Sun Pharmaceutical Industries, Inc.'s Second Interrogatory filed by Amgen Inc..(Blumenfeld, Jack)
June 30, 2017 Opinion or Order Filing 171 NOTICE of Subpoena by Amgen Inc. (Noreika, Maryellen)
June 29, 2017 Opinion or Order Filing 170 NOTICE to Take Deposition of Plaintiff Amgen Inc. on a date, time, and location to be agreed upon by Counsel filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc..(Bilson, David)
June 29, 2017 Opinion or Order Filing 169 NOTICE to Take Deposition of Dr. Shailesh Singh (Ajanta) on a date, time, and location to be agreed up on by counsel filed by Amgen Inc..(Noreika, Maryellen)
June 29, 2017 Opinion or Order Filing 168 NOTICE to Take Deposition of Deepika Bhat (Ajanta) on a date, time, and location to be agreed up on by counsel filed by Amgen Inc..(Noreika, Maryellen)
June 28, 2017 Opinion or Order Filing 167 NOTICE OF SERVICE of Amgen's First Supplemental Objections and Responses to Defendants Hetero USA Inc., Hetero Labs Ltd., and Hetero Labs Ltd. Unit V's First Interrogatory filed by Amgen Inc..(Blumenfeld, Jack)
June 27, 2017 Opinion or Order Filing 166 NOTICE to Take Deposition of Mr. Sunil Tiwari (Hetero) on a date, time, and location to be agreed up on by counsel filed by Amgen Inc..(Noreika, Maryellen)
June 27, 2017 Opinion or Order Filing 165 NOTICE to Take Deposition of Dr. Sampathkumar Devarajan (Strides) on a date, time, and location to be agreed up on by counsel filed by Amgen Inc..(Noreika, Maryellen)
June 26, 2017 Opinion or Order SO ORDERED - re (164 in 1:16-cv-00853-GMS) MOTION for Pro Hac Vice Appearance of Attorney Erica L. Norey of FITZPATRICK, CELLA, HARPER & SCINTO filed by Amgen Inc., (7 in 1:17-cv-00713-GMS) MOTION for Pro Hac Vice Appearance of Attorney Erica L. Norey of Fitzpatrick, Cella, Harper & Scinto filed by Amgen Inc. Ordered by Judge Gregory M. Sleet on 6/26/2017. Associated Cases: 1:16-cv-00853-GMS, 1:17-cv-00713-GMS(mdb)
June 23, 2017 Opinion or Order Filing 164 MOTION for Pro Hac Vice Appearance of Attorney Erica L. Norey of FITZPATRICK, CELLA, HARPER & SCINTO - filed by Amgen Inc.. (Blumenfeld, Jack)
June 22, 2017 Opinion or Order Filing 163 NOTICE to Take Deposition of Hung-Ren H. Lin on a date, time, and location to be agreed upon by Counsel filed by Cipla Limited, Cipla USA Inc..(Brauerman, Stephen)
June 21, 2017 Opinion or Order Filing 162 NOTICE OF SERVICE of (1) Plaintiff Amgen, Inc.'s Objections and Responses to Defendants Sun Pharmaceutical Industries, Ltd., Sun Pharma Global FZE, and Sun Pharmaceutical Industries, Inc.'s Third Interrogatory to Plaintiff and (2) Plaintiff Amgen Inc.'s Responses to Defendants Sun Pharmaceutical Industries, Ltd., Sun Pharma Global FZE, and Sun Pharmaceutical Industries, Inc.'s First Requests for the Production of Documents and Things filed by Amgen Inc..(Blumenfeld, Jack)
June 20, 2017 Opinion or Order Filing 161 NOTICE to Take Deposition of Manohar Lalge on a date, time, and location to be agreed up on by counsel filed by Amgen Inc..(Blumenfeld, Jack)
June 20, 2017 Opinion or Order Filing 160 NOTICE to Take Deposition of P. Basavaiah Chowdary on a date, time, and location to be agreed up on by counsel filed by Amgen Inc..(Blumenfeld, Jack)
June 20, 2017 Opinion or Order Filing 159 NOTICE to Take Deposition of Amit Antakar on a date, time, and location to be agreed up on by counsel filed by Amgen Inc..(Blumenfeld, Jack)
June 16, 2017 Opinion or Order Filing 158 NOTICE to Take Deposition of Tzuchi R. Ju filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Matterer, Mary)
June 15, 2017 Opinion or Order Filing 157 NOTICE OF SERVICE of Plaintiff Amgen Inc.'s Objections and Response to Defendants' Second Set of Joint Interrogatories to Plaintiff (No. 4) filed by Amgen Inc..(Noreika, Maryellen)
June 15, 2017 Opinion or Order Filing 156 NOTICE OF SERVICE of 1) Plaintiff Amgen Inc.'s Objections and Response to Defendants Sun Pharmaceutical Industries, Ltd., Sun Pharma Global FZE, and Sun Pharmaceutical Industries Inc's Second Interrogatory to Plaintiff; and 2) Plaintiff's Third Set of Requests to Zydus for the Production of Documents and Things (Confidential) filed by Amgen Inc..(Blumenfeld, Jack)
June 15, 2017 Opinion or Order Filing 155 NOTICE to Take Deposition of Glen Gary Lawrence filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit V, Hetero USA Inc., Micro Labs Limited, Micro Labs USA, Inc..(Bellew, Joseph)
June 15, 2017 Opinion or Order Filing 154 NOTICE OF SERVICE of Defendants' Third Set of Joint Interrogatories to Plaintiff (Nos. 5-10) (Filed on Behalf of all Defendants) filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC.(Palapura, Bindu)
June 15, 2017 Opinion or Order Filing 153 NOTICE OF SERVICE of Amneal's First Set of Interrogatories filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC.(Palapura, Bindu)
June 15, 2017 Opinion or Order Filing 152 NOTICE OF SERVICE of Second Set of Interrogatories to Plaintiff Amgen, Inc. filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
June 15, 2017 Opinion or Order Filing 151 NOTICE OF SERVICE of Second Set of Interrogatories to Plaintiff Amgen, Inc. filed by Micro Labs Limited, Micro Labs USA, Inc..(Bellew, Joseph)
June 14, 2017 Opinion or Order Filing 150 NOTICE OF SERVICE of Defendants Mylan Pharmaceuticals Inc. and Mylan, Inc.s First Set of Interrogatories to Plaintiffs (Nos. 1-3) filed by Mylan Inc., Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios)
June 14, 2017 Opinion or Order Filing 149 NOTICE OF SERVICE of Defendants' Second Requests for the Production of Documents and Things (Nos. 46-53) filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc., Breckenridge Pharmaceutical Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Bilson, David)
June 14, 2017 Opinion or Order Filing 148 NOTICE OF SERVICE of Defendant Breckenridge Pharmaceutical, Inc.'s First Set of Interrogatories to Plaintiff (Nos. 1-2) filed by Breckenridge Pharmaceutical Inc..(Bilson, David)
June 14, 2017 Opinion or Order Filing 147 NOTICE OF SERVICE of Defendants Cipla Limited and Cipla Usa, Inc.'s First Set of Interrogatories to Plaintiff (1-3) filed by Cipla Limited, Cipla USA Inc..(Brauerman, Stephen) Modified on 6/14/2017 (mdb).
June 14, 2017 Opinion or Order Filing 146 NOTICE OF SERVICE of Sun Pharmaceutical Industries, Ltd., Sun Pharma Global FZE and Sun Pharmaceutical Industries, Inc's Fourth Set of Interrogatories to Plaintiff filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Bilson, David)
June 13, 2017 Opinion or Order Filing 145 NOTICE to Take Deposition of Francisco J. Alvarez filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Bilson, David)
June 13, 2017 Opinion or Order Filing 144 NOTICE OF SERVICE of Defendants Ajanta Pharma Limited and Ajanta Pharma USA Inc.'s First Set of Interrogatories to Plaintiff (Nos. 1-2) filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc..(Bilson, David)
June 13, 2017 Opinion or Order Pro Hac Vice Attorney Elizabeth E. Grden for Actavis Pharma, Inc.,Elizabeth E. Grden for Watson Laboratories, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb)
June 12, 2017 Opinion or Order Filing 143 Amended Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios)
June 12, 2017 Opinion or Order Filing 142 NOTICE OF SERVICE of Watson's First Set of Interrogatories to Plaintiff filed by Watson Laboratories, Inc..(Russell, Andrew)
June 8, 2017 Opinion or Order Filing 141 NOTICE OF SERVICE of Plaintiff Amgen Inc.'s Objections and Responses to Defendants' Second Set of Joint Interrogatories to Plaintiff (No. 4) filed by Amgen Inc..(Noreika, Maryellen)
June 6, 2017 Opinion or Order Filing 140 MOTION for Pro Hac Vice Appearance of Attorney Elizabeth E. Grden - filed by Actavis Pharma, Inc., Watson Laboratories, Inc.. (Keller, Karen)
June 6, 2017 Opinion or Order SO ORDERED - re #140 MOTION for Pro Hac Vice Appearance of Attorney Elizabeth E. Grden filed by Actavis Pharma, Inc., Watson Laboratories, Inc. Ordered by Judge Gregory M. Sleet on 6/6/2017. (mdb)
June 2, 2017 Opinion or Order Filing 139 NOTICE of Adoption of Defendants' Joint Initial Invalidity Contentions served on March 3, 2017 by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc. (Phillips, John)
June 2, 2017 Opinion or Order Filing 138 NOTICE OF SERVICE of Sun Pharmaceutical Industries, Ltd., Sun Pharma Global FZE and Sun Pharmaceutical Industries, Inc.'s [HIGHLY CONFIDENTIAL] Objections and Supplemental Responses to Plaintiff's First Set of Interrogatories to Defendants (No. 1) filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Bilson, David)
June 1, 2017 Opinion or Order Filing 137 NOTICE OF SERVICE of (1) Amgen's Objections and Response to Defendants Dr. Reddy's Laboratories, Ltd.'s and Dr. Reddy's Laboratories, Inc.'s First Set of Interrogatories to Plaintiff Amgen, Inc.; and (2) Amgen's Objections and Response to Defendants Micro Labs Limited's and Micro Labs USA, Inc.'s First Set of Interrogatories to Plaintiff Amgen, Inc. filed by Amgen Inc..(Noreika, Maryellen)
May 31, 2017 Opinion or Order Filing 136 NOTICE OF SERVICE of Plaintiff Amgen Inc.'s Objections and Responses to Defendants Sun Pharmaceutical Industries, Ltd., Sun Pharma Global FZE, and Sun Pharmaceutical Industries, Inc.'s First Interrogatory to Plaintiff filed by Amgen Inc..(Blumenfeld, Jack)
May 30, 2017 Opinion or Order Filing 135 NOTICE OF SERVICE of Defendants Apotex Inc. and Apotex Corp.'s Responses to Plaintiff's Third Set of Requests for the Production of Documents and Things [designated HIGHLY CONFIDENTIAL] filed by Apotex Corp., Apotex Inc..(Gattuso, Dominick)
May 30, 2017 Opinion or Order Filing 134 Official Transcript of Markman Hrg. held on 05 22 17 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 6/20/2017. Redacted Transcript Deadline set for 6/30/2017. Release of Transcript Restriction set for 8/28/2017. (kjm)
May 25, 2017 Opinion or Order Filing 133 NOTICE OF SERVICE of (1) Defendants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's Objections and Responses to Plaintiff's First Set of Interrogatories (No. 1); (2) Defendants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's Objections and Responses to Plaintiff's Second Set of Interrogatories (Nos. 2-6); (3) Defendants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's Objections and Responses to Plaintiff's First Set of Requests for the Production of Documents and Things; and (4) Defendants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's Objections and Responses to Plaintiffs Second Set of Requests for the Production of Documents and Things filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc..(Bilson, David)
May 24, 2017 Opinion or Order Filing 132 NOTICE OF SERVICE of Plaintiff Amgen Inc.'s Responses to Defendants Mylan Pharmaceutials Inc. and Mylan, Inc.'s First Set of Requests for the Production of Documents and Things to Plaintiff (Nos. 1-35) filed by Amgen Inc..(Noreika, Maryellen)
May 24, 2017 Opinion or Order Filing 131 NOTICE of Appearance by Arun John Mohan on behalf of Ajanta Pharma Limited, Ajanta Pharma USA Inc. (Mohan, Arun)
May 23, 2017 Opinion or Order Filing 130 NOTICE OF SERVICE of Amgen's Objections and Response to Defendants Apotex Inc. and Apotex Corp.'s First Set of Interrogatories filed by Amgen Inc..(Blumenfeld, Jack)
May 22, 2017 Opinion or Order Filing 129 NOTICE OF SERVICE of Mylan Pharmaceuticals Inc. and Mylan, Inc.s Response to Plaintiffs Third Set of Requests for Production of Documents Nos. 75-78 filed by Mylan Inc., Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) Modified on 5/23/2017 (mdb).
May 22, 2017 Opinion or Order Filing 128 NOTICE OF SERVICE of Defendant Breckenridge Pharmaceutical, Inc.'s Responses and Objections to Plaintiff's Third Set of Requests for the Production of Documents and Things filed by Breckenridge Pharmaceutical Inc..(Bilson, David)
May 22, 2017 Opinion or Order Filing 127 NOTICE OF SERVICE of Ajanta Pharma Limited and Ajanta Pharma USA Inc.'s [CONFIDENTIAL] Objections and Responses to Plaintiff's Third Set of Requests for Production of Documents and Things filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc..(Bilson, David)
May 22, 2017 Opinion or Order Filing 126 NOTICE OF SERVICE of Responses to Third Set of Requests for Production filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Matterer, Mary)
May 22, 2017 Opinion or Order Filing 125 NOTICE OF SERVICE of Sun Pharmaceutical Industries, Ltd, Sun Pharma Global FZE and Sun Pharmaceutical Industries, Inc.'s (i) Third Interrogatory to Plaintiff; (ii) First Requests for the Production of Documents and Things; and (iii) Objections and Responses to Plaintiff's Third Set of Requests for Production to Defendants (Nos. 75-80) filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Bilson, David)
May 22, 2017 Opinion or Order Filing 124 NOTICE OF SERVICE of Defendants' Responses to Plaintiff's Third Set of Requests for the Production of Documents and Things [Highly Confidential Under Protective Order] filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC.(Palapura, Bindu)
May 22, 2017 Opinion or Order Filing 123 NOTICE OF SERVICE of Watson's Responses to Plaintiff's Third Set of Requests for the Production of Documents and Things filed by Actavis Pharma, Inc., Watson Laboratories, Inc..(Keller, Karen)
May 22, 2017 Opinion or Order Filing 122 NOTICE OF SERVICE of Defendants' Responses and Objections to Plaintiff's Third Set of Requests for Production of Documents and Things filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
May 22, 2017 Opinion or Order Filing 121 NOTICE OF SERVICE of Defendants' Responses and Objections to Plaintiff's Third Set of Requests for Production of Documents and Things filed by Micro Labs Limited, Micro Labs USA, Inc..(Bellew, Joseph)
May 22, 2017 Opinion or Order Filing 120 NOTICE OF SERVICE of Defendant Strides' Responses to Plaintiff's Third Set of Requests for Production of Documents and Things filed by Strides Pharma Global PTE Limited, Strides Pharma Inc..(Green, James)
May 22, 2017 Opinion or Order Filing 119 NOTICE OF SERVICE of Defendants Cipla Limited and Cipla Usa, Inc.'s Responses to Plaintiff's Third Set of Requests for the Production of Documents and Things filed by Cipla Limited, Cipla USA Inc..(Bussiere, Sara) Modified on 5/22/2017 (mdb).
May 22, 2017 Opinion or Order Filing 118 NOTICE OF SERVICE of Hetero's responses to Amgen's Third Set of Requests for Production filed by Hetero Labs Ltd., Hetero Labs Ltd. Unit V, Hetero USA Inc..(Dorsney, Kenneth)
May 22, 2017 Opinion or Order Minute Entry for proceedings held before Judge Gregory M. Sleet - Markman Hearing held on 5/22/2017. Claim construction presentations; the Court will take the matter under advisement and issue a ruling in due course. (Court Reporter Kevin Maurer.) (mdb)
May 19, 2017 Opinion or Order Filing 117 ANSWER to #99 Answer to Complaint, Counterclaim by Amgen Inc..(Blumenfeld, Jack)
May 17, 2017 Opinion or Order Filing 116 NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's Disclosures under Paragraph 3 of the District of Delaware Default Standard filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc..(Bilson, David)
May 17, 2017 Opinion or Order Filing 115 NOTICE OF SERVICE of (1) Plaintiff's Disclosures Pursuant to District of Delaware Default Standard Paragraph 3 to Zydus and (2) Plaintiff's Initial Infringement Contentions Regarding Zydus filed by Amgen Inc..(Noreika, Maryellen)
May 16, 2017 Opinion or Order Filing 114 NOTICE OF SERVICE of Sun Pharmaceutical Industries, Ltd, Sun Pharma Global FZE and Sun Pharmaceutical Industries, Inc.'s Second Interrogatory to Plaintiff filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Bilson, David)
May 11, 2017 Opinion or Order Filing 113 NOTICE of Adoption of Defendants' First Requests for the Production of Documents and Things served on January 5, 2017; and Defendants' First Set of Joint Interrogatories to Plaintiff (Nos. 1-3) served on March 14, 2017. by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc. (Phillips, John)
May 11, 2017 Opinion or Order Filing 112 NOTICE OF SERVICE of Defendants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc..(Bilson, David)
May 10, 2017 Opinion or Order Filing 111 NOTICE OF SERVICE of (1) Plaintiff's Rule 26(a)(1) Initial Disclosures to Zydus and (2) Plaintiff's Default Standard Paragraph 4(a) Disclosures to Zydus filed by Amgen Inc..(Noreika, Maryellen)
May 10, 2017 Opinion or Order Filing 110 NOTICE of Appearance by David A. Bilson on behalf of Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc. (Bilson, David)
May 8, 2017 Opinion or Order Filing 109 NOTICE OF SUBSTITUTION OF COUNSEL re Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.: Entry of appearance of attorney John C. Phillips, Jr. Attorney J. Clayton Athey terminated. (Phillips, John)
May 8, 2017 Opinion or Order SO ORDERED - re #108 Proposed Stipulated Protective Order filed by Amgen Inc.. Ordered by Judge Gregory M. Sleet on 5/8/2017. (mdb)
May 4, 2017 Opinion or Order Filing 108 PROPOSED ORDER -- Stipulated Protective Order -- by Amgen Inc.. (Blumenfeld, Jack)
May 4, 2017 Opinion or Order Filing 107 NOTICE OF SERVICE of Amgen's Objections and Response to Defendants Hetero USA Inc., Hetero Labs Ltd., and Hetero Labs Ltd. Unit V's First Interrogatory filed by Amgen Inc..(Blumenfeld, Jack)
May 4, 2017 Opinion or Order Filing 106 Official Transcript of T/C held on 05 01 17 before Judge Sleet. Court Reporter/Transcriber Kevin Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 5/25/2017. Redacted Transcript Deadline set for 6/5/2017. Release of Transcript Restriction set for 8/2/2017. (kjm)
May 3, 2017 Opinion or Order Filing 105 NOTICE OF SERVICE of Defendants' First Set of Interrogatories to Plaintiff filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
May 3, 2017 Opinion or Order Filing 104 NOTICE OF SERVICE of Defendants' First Set of Interrogatories to Plaintiff filed by Micro Labs Limited, Micro Labs USA, Inc..(Bellew, Joseph)
May 2, 2017 Opinion or Order Filing 103 NOTICE OF SERVICE of Defendants Second Set Of Joint Interrogatories To Plaintiff (No. 4) filed by Mylan Inc., Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Main Document 103 replaced on 5/2/2017) (mdb).
May 2, 2017 Opinion or Order CORRECTING ENTRY: The Notice of Service ( #103 ) has been replaced with the correct document per counsel's request. (mdb)
May 2, 2017 Opinion or Order Pro Hac Vice Attorney Gene A. Lang for Micro Labs USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
May 1, 2017 Opinion or Order Filing 102 NOTICE OF SERVICE of Sun Pharmaceutical Industries, Ltd, Sun Pharma Global FZE and Sun Pharmaceutical Industries, Inc.'s First Interrogatory to Plaintiff filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Bilson, David)
May 1, 2017 Opinion or Order SO ORDERED - re #95 MOTION for Pro Hac Vice Appearance of Attorney Gene A. Lang filed by Dr. Reddys Laboratories, Inc., Micro Labs USA, Inc., Micro Labs Limited, Dr. Reddys Laboratories, Ltd., #97 MOTION for Pro Hac Vice Appearance of Attorney Jonathan D. Carpenter filed by Sun Pharmaceutical Industries, Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd. Ordered by Judge Gregory M. Sleet on 5/1/2017. (mdb)
May 1, 2017 Opinion or Order Minute Entry for proceedings held before Judge Gregory M. Sleet - Telephone Conference held on 5/1/2017. Discussion on the disputed item regarding the Protective Order as listed in the Joint Agenda Letter submission. The parties shall follow the court's directives in favor of the Plaintiff as discussed. (Court Reporter: Kevin Maurer.) (asw)
April 28, 2017 Opinion or Order Filing 101 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Cadila Healthcare Ltd.. (Athey, J.)
April 28, 2017 Opinion or Order Filing 100 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Zydus International Pvt. Ltd. Ireland (owned by Cadila Healthcare Limited) for Zydus Pharmaceuticals (USA) Inc., Zydus Pharmaceuticals (USA) Inc. filed by Zydus Pharmaceuticals (USA) Inc.. (Athey, J.)
April 28, 2017 Opinion or Order Filing 99 ANSWER to #1 Complaint, Affirmative Defenses and, COUNTERCLAIM against Amgen Inc. by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc..(Athey, J.) Modified on 4/28/2017 (mdb).
April 28, 2017 Opinion or Order Filing 98 NOTICE of Appearance by J. Clayton Athey on behalf of Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc. (Athey, J.)
April 27, 2017 Opinion or Order Filing 97 MOTION for Pro Hac Vice Appearance of Attorney Jonathan D. Carpenter - filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.. (Attachments: #1 Certification of Jonathan D. Carpenter)(Bilson, David)
April 27, 2017 Opinion or Order Filing 96 Letter to The Honorable Gregory M. Sleet from Dominick T. Gattuso regarding hearing on May 1 concerning protective order dispute. (Gattuso, Dominick)
April 26, 2017 Opinion or Order Filing 95 MOTION for Pro Hac Vice Appearance of Attorney Gene A. Lang - filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd., Micro Labs Limited, Micro Labs USA, Inc.. (Bellew, Joseph)
April 26, 2017 Opinion or Order Filing 94 NOTICE OF SERVICE of Defendants Cipla Ltd. and Cipla Usa, Inc.s Objections and Responses to Plaintiffs Second Set of Interrogatories filed by Cipla Limited, Cipla USA Inc..(Brauerman, Stephen) Modified on 4/26/2017 (mdb).
April 26, 2017 Opinion or Order Filing 93 NOTICE OF SERVICE of Responses and Objections to Second Set of Requests for Production filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Matterer, Mary)
April 25, 2017 Opinion or Order Filing 92 NOTICE OF SERVICE of (1) Plaintiff's First Set of Requests to Zydus for the Production of Documents and Things; (2) Plaintiff's First Set of Interrogatories to Zydus; (3) Plaintiff's Second Set of Requests to Zydus for the Production of Documents and Things; and (4) Plaintiff's Second Set of Interrogatories to Zydus filed by Amgen Inc..(Blumenfeld, Jack)
April 25, 2017 Opinion or Order Filing 91 NOTICE OF SERVICE of Strides' Objections and Responses to Plaintiff's Second Set of Interrogatories filed by Strides Pharma Global PTE Limited, Strides Pharma Inc..(Green, James)
April 25, 2017 Opinion or Order Filing 90 NOTICE OF SERVICE of Objections and Responses to Plaintiff's Second Set of Interrogatories [HIGHLY CONFIDENTIAL - ATTORNEYS' EYES ONLY] filed by Micro Labs Limited, Micro Labs USA, Inc..(Bellew, Joseph)
April 25, 2017 Opinion or Order Filing 89 NOTICE OF SERVICE of Objections and Responses to Plaintiff's Second Set of Interrogatories [HIGHLY CONFIDENTIAL - ATTORNEYS' EYES ONLY] filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
April 25, 2017 Opinion or Order ORAL ORDER - A Discovery Telephone Conference (#1) is set for Monday, May 1, 2017, at 2:00 PM (EST). A Joint Agenda letter shall be filed no later than noon on Thursday, April 27, 2017 (sample agenda letter can be located on the court's website). The court directs counsel for plaintiff to arrange the call and contact chambers at (302) 573-4559 once all the participants are on the line. Ordered by Judge Gregory M. Sleet on 4/25/2017. (mdb)
April 24, 2017 Opinion or Order Filing 88 NOTICE OF SERVICE of (1) Watson's Responses to Plaintiff's Second Set of Interrogatories filed by Actavis Pharma, Inc., Watson Laboratories, Inc..(Keller, Karen)
April 24, 2017 Opinion or Order Filing 87 NOTICE OF SERVICE of Mylan Pharmaceuticals Inc. and Mylan, Inc.s Response to Plaintiffs 2nd Set of Interrogatories and Defendants Mylan Pharmaceuticals Inc. and Mylan, Inc.s 1st Set of Requests for the Production of Documents and Things to Plaintiffs (Nos. 1-35) filed by Mylan Inc., Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios)
April 24, 2017 Opinion or Order Filing 86 NOTICE OF SERVICE of (1) Breckenridge Pharmaceuticals, Inc.'s [HIGHLY CONFIDENTIAL - OUTSIDE COUNSEL'S EYES ONLY] Objections and Responses to Plaintiff's Second Set of Interrogatories to Breckenridge; (2) Defendants Ajanta Pharma Limited and Ajanta Pharma USA Inc.'s Objections and Responses to Plaintiff's Second Set of Interrogatories; and (3) Sun Pharmaceutical Industries, Ltd., Sun Pharma Global FZE and Sun Pharmaceuticals Industries, Inc.'s Objections and Responses to Plaintiff's Second Set of Interrogatories to Defendants (No. 2-6) filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc., Breckenridge Pharmaceutical Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Bilson, David)
April 24, 2017 Opinion or Order Filing 85 NOTICE OF SERVICE of Hetero's responses to Amgen's Second Set of Interrogatories filed by Hetero Labs Ltd., Hetero Labs Ltd. Unit V, Hetero USA Inc..(Dorsney, Kenneth)
April 24, 2017 Opinion or Order Filing 84 NOTICE OF SERVICE of Defendants Apotex Inc. and Apotex Corp.'s Responses to Plaintiff's Second Set of Interrogatories filed by Apotex Corp., Apotex Inc..(Gattuso, Dominick)
April 24, 2017 Opinion or Order Filing 83 REDACTED VERSION of #79 Claim Construction Answering Brief by Amgen Inc.. (Blumenfeld, Jack)
April 24, 2017 Opinion or Order Filing 82 NOTICE OF SERVICE of Defendants Amneal Pharmaceuticals LLC's and Amneal Pharmaceuticals of New York, LLC's Responses to Plaintiff's Second Set of Interrogatories (Confidential Pursuant to D. Del. LR 26.2) filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC.(Moore, David)
April 24, 2017 Opinion or Order CORRECTING ENTRY: The Notice of Service ( #78 ) has been replaced at the request of the filer. (mdb)
April 21, 2017 Opinion or Order Filing 81 Joint APPENDIX in Support of Claim Construction Briefing by Amgen Inc.. (Blumenfeld, Jack) Modified on 4/24/2017 (mdb).
April 21, 2017 Opinion or Order Filing 80 CLAIM CONSTRUCTION ANSWERING BRIEF (filed on behalf of all defendants) filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC. (Palapura, Bindu) Modified on 4/24/2017 (mdb).
April 21, 2017 Opinion or Order Filing 79 [SEALED] CLAIM CONSTRUCTION ANSWERING BRIEF re #60 Claim Construction Opening Brief filed by Amgen Inc.. (Blumenfeld, Jack)
April 21, 2017 Opinion or Order Filing 78 NOTICE OF SERVICE of (1) Plaintiff's Third Set of Requests to Strides for the Production of Documents and Things; (2) Plaintiff's Third Set of Requests to Sun for the Production of Documents and Things; (3) Plaintiff's Third Set of Requests to Ajanta for the Production of Documents and Things; (4) Plaintiff's Third Set of Requests to Apotex for the Production of Documents and Things; (5) Plaintiff's Third Set of Requests to Breckenridge for the Production of Documents and Things; (6) Plaintiff's Third Set of Requests to Dr. Reddys for the Production of Documents and Things; (7) Plaintiff's Third Set of Requests to Hetero for the Production of Documents and Things; (8) Plaintiff's Third Set of Requests to Watson for the Production of Documents and Things; (9) Plaintiff's Third Set of Requests to Amneal for the Production of Documents and Things; (10) Plaintiff's Third Set of Requests to Aurobindo for the Production of Documents and Things; (11) Plaintiff's Third Set of Requests to Cipla for the Production of Documents and Things; (12) Plaintiff's Third Set of Requests to Micro Labs for the Production of Documents and Things; and (13) Plaintiff's Third Set of Requests to Mylan for the Production of Documents and Things filed by Amgen Inc..(Blumenfeld, Jack) (Main Document 78 replaced on 4/24/2017) (mdb).
April 21, 2017 Opinion or Order Filing 77 NOTICE OF SERVICE of Defendants' Apotex Inc. and Apotex Corp.'s First Set of Interrogatories to Plaintiff filed by Apotex Corp., Apotex Inc..(Gattuso, Dominick)
April 19, 2017 Opinion or Order SO ORDERED - re #76 STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to April 20, 2017 filed by Apotex Inc., Apotex Corp. Ordered by Judge Gregory M. Sleet on 4/19/2017. (mdb)
April 18, 2017 Opinion or Order Filing 76 STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to April 20, 2017 - filed by Apotex Corp., Apotex Inc.. (Gattuso, Dominick)
April 14, 2017 Opinion or Order Filing 75 NOTICE OF SERVICE of Mylan's Invalidity Contentions Regarding U.S. Patent No. 9,375,405 filed by Mylan Inc., Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios)
April 13, 2017 Opinion or Order Filing 74 NOTICE OF SERVICE of Amgen's Objections and Responses to Defendants' First Set of Joint Interrogatories (Nos. 1-3) filed by Amgen Inc..(Blumenfeld, Jack)
April 6, 2017 Opinion or Order Remark - This case has been consolidated with Lead C.A. No. 16-853 (GMS). All future filings are to be made ONLY in the Lead Case. Associated Cases: 1:17-cv-00183-GMS, 1:16-cv-00853-GMS(mdb)
April 4, 2017 Opinion or Order Filing 73 ORDER: A teleconference regarding mediation was held on Tuesday, April 4, 2017 in this consolidated matter. As a result, IT IS ORDERED as follows: On or before Friday, May 5, 2017, each party or each party group shall email to Chief Magistrate Judge Thynge, with a copy to her Judicial Administrator, Cathleen Kennedy, the requested information contained in the Order. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 4/4/17. (cak)
April 4, 2017 Opinion or Order Filing 72 NOTICE of Change of Address by David Ellis Moore (Moore, David)
April 4, 2017 Opinion or Order Filing 71 NOTICE OF SERVICE of Hetero's First Set of Interrogatories to Plaintiff (No. 1) filed by Hetero Labs Ltd., Hetero Labs Ltd. Unit V, Hetero USA Inc..(Dorsney, Kenneth)
April 4, 2017 Opinion or Order Filing 70 NOTICE OF SERVICE of Objections and Responses to Plaintiff's First Set of Interrogatories [HIGHLY CONFIDENTIAL - ATTORNEYS' EYES ONLY] filed by Micro Labs Limited, Micro Labs USA, Inc..(Bellew, Joseph)
April 4, 2017 Opinion or Order Filing 69 NOTICE OF SERVICE of Objections and Responses to Plaintiff's First Set of Interrogatories [HIGHLY CONFIDENTIAL - ATTORNEYS' EYES ONLY] filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd..(Bellew, Joseph)
April 4, 2017 Opinion or Order Filing 68 NOTICE OF SERVICE of Objections and Responses to Plaintiff's First Set of Interrogatories filed by Strides Pharma Global PTE Limited, Strides Pharma Inc..(Green, James)
April 3, 2017 Opinion or Order Filing 67 NOTICE OF SERVICE of Mylan's Responses to Amgen's Written Discovery Requests filed by Mylan Inc., Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios)
April 3, 2017 Opinion or Order Filing 66 NOTICE OF SERVICE of (1) Breckenridge Pharmaceuticals, Inc.s [HIGHLY CONFIDENTIAL OUTSIDE COUNSELS EYES ONLY] Objections and Responses to Plaintiffs First Set of Interrogatories to Breckenridge; (2) Defendants Ajanta Pharma Limited and Ajanta Pharma USA Inc.s [HIGHLY CONFIDENTIAL OUTSIDE COUNSELS EYES ONLY] Objections and Response to Plaintiffs First Set of Interrogatories; and (3) Sun Pharmaceutical Industries, Ltd., Sun Pharma Global FZE and Sun Pharmaceuticals Industries, Inc.s Objections and Responses to Plaintiffs First Set of Interrogatories to Defendants (No. 1) filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc., Breckenridge Pharmaceutical Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Bilson, David)
April 3, 2017 Opinion or Order Filing 65 NOTICE OF SERVICE of Responses to Plaintiff's First Set of Interrogatories filed by Apotex Corp., Apotex Inc..(Gattuso, Dominick)
April 3, 2017 Opinion or Order Filing 64 NOTICE OF SERVICE of Responses to First Set of Interrogatories filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Matterer, Mary)
April 3, 2017 Opinion or Order Filing 63 NOTICE OF SERVICE of Defendants Cipla Limited and Cipla Usa, Inc.'s Objections and Responses to Plaintiff's First Set of Interrogatories filed by Cipla Limited, Cipla USA Inc..(Bussiere, Sara) Modified on 4/3/2017 (mdb).
April 3, 2017 Opinion or Order Filing 62 NOTICE OF SERVICE of Defendants Amneal Pharmaceuticals LLC's and Amneal Pharmaceuticals of New York, LLC's Responses to Plaintiff's First Set of Interrogatories filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC.(Moore, David)
April 3, 2017 Opinion or Order Filing 61 NOTICE OF SERVICE of Watson's Responses to Plaintiff's First Set of Interrogatories filed by Actavis Pharma, Inc., Watson Laboratories, Inc..(Keller, Karen)
April 3, 2017 Opinion or Order SO ORDERED - re #57 MOTION for Pro Hac Vice Appearance of Attorney Steven H. Sklar and Attorney Gregory C. Bays filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc. Ordered by Judge Gregory M. Sleet on 4/3/2017. (mdb)
March 31, 2017 Opinion or Order Filing 60 CLAIM CONSTRUCTION OPENING BRIEF filed by Cipla Limited, Cipla USA Inc.. (Attachments: #1 Exhibit A)(Brauerman, Stephen) Modified on 4/3/2017 (mdb).
March 31, 2017 Opinion or Order Filing 59 CLAIM CONSTRUCTION OPENING BRIEF filed by Amgen Inc.. (Noreika, Maryellen)
March 30, 2017 Opinion or Order Filing 58 NOTICE OF SERVICE of Hetero's responses to Plaintiff's First Set of Interrogatories filed by Hetero Labs Ltd., Hetero Labs Ltd. Unit V, Hetero USA Inc..(Dorsney, Kenneth)
March 30, 2017 Opinion or Order Filing 57 MOTION for Pro Hac Vice Appearance of Attorney Steven H. Sklar and Attorney Gregory C. Bays - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc.. (Matterer, Mary)
March 27, 2017 Opinion or Order SO ORDERED - re #54 STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to April 14, 2017 filed by Amgen Inc. Ordered by Judge Gregory M. Sleet on 3/27/2017. (mdb)
March 24, 2017 Opinion or Order Filing 56 CLAIM Construction Chart by Amgen Inc.. (Noreika, Maryellen)
March 24, 2017 Opinion or Order Filing 55 NOTICE OF SERVICE of (1) Plaintiff's Second Set of Interrogatories to Aurobindo; (2) Plaintiff's Second Set of Interrogatories to Cipla; (3) Plaintiff's Second Set of Interrogatories to Ajanta; (4) Plaintiff's Second Set of Interrogatories to Breckenridge; (5) Plaintiff's Second Set of Interrogatories to Sun; (6) Plaintiff's Second Set of Interrogatories to Strides; (7) Plaintiff's Second Set of Interrogatories to Amneal; (8) Plaintiff's Second Set of Interrogatories to Apotex; (9) Plaintiff's Second Set of Interrogatories to Hetero; (10) Plaintiff's Second Set of Interrogatories to Micro Labs; (11) Plaintiff's Second Set of Interrogatories to Dr. Reddy's; (12) Plaintiff's Second Set of Interrogatories to Watson; (13) Plaintiff's Second Set of Interrogatories to Mylan; and (14) Plaintiff's Initial Infringement Contentions Regarding Mylan filed by Amgen Inc..(Noreika, Maryellen)
March 24, 2017 Opinion or Order Filing 54 STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to April 14, 2017 - filed by Amgen Inc.. (Noreika, Maryellen)
March 21, 2017 Opinion or Order Pro Hac Vice Attorney John K. Hsu for Ajanta Pharma Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
March 20, 2017 Opinion or Order Filing 53 NOTICE OF SERVICE of (i) Defendants Apotex Inc. and Apotex Corp.'s Responses to Plaintiff's First Set of Requests for the Production of Documents and Things; and (ii) Defendants Apotex Inc. and Apotex Corp.'s Responses to Plaintiff's Second Set of Requests for the Production of Documents and Things filed by Apotex Corp., Apotex Inc..(Gattuso, Dominick)
March 20, 2017 Opinion or Order Filing 52 MOTION for Pro Hac Vice Appearance of Attorney John K. Hsu - filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc.. (Attachments: #1 Certification of John K. Hsu)(Bilson, David)
March 20, 2017 Opinion or Order SO ORDERED - re #52 MOTION for Pro Hac Vice Appearance of Attorney John K. Hsu filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc. Ordered by Judge Gregory M. Sleet on 3/20/2017. (mdb)
March 17, 2017 Opinion or Order Filing 51 NOTICE OF SERVICE of Plaintiff's Proposed Constructions of Disputed Claim Terms filed by Amgen Inc..(Blumenfeld, Jack)
March 16, 2017 Opinion or Order Pro Hac Vice Attorney Christopher B. Essig,Zachary L. Sorman,George C. Lombardi for Watson Laboratories, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
March 15, 2017 Opinion or Order Filing 50 NOTICE OF SERVICE of Mylan's Paragraph 3 Initial Disclosures filed by Mylan Inc., Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios)
March 15, 2017 Opinion or Order Filing 49 NOTICE OF SERVICE of Defendants' First Set of Joint Interrogatories to Plaintiff (Nos. 1-3) filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc., Breckenridge Pharmaceutical Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Bilson, David)
March 13, 2017 Opinion or Order Filing 48 NOTICE OF SERVICE of 1. Watson's Responses to Plaintiff's First Set of Requests for the Production of Documents and Things and 2. Watson's Responses to Plaintiff's Second Set of Requests for the Production of Documents and Things filed by Watson Laboratories, Inc..(Keller, Karen)
March 13, 2017 Opinion or Order Filing 47 NOTICE requesting Clerk to remove John W. Bateman, C. Kyle Musgrove, and Elizabeth M. Crompton as co-counsel.. (Keller, Karen)
March 10, 2017 Opinion or Order Filing 46 NOTICE OF SERVICE of (1) Responses to First Set of Requests for Production and (2) Responses to Second Set of Requests for Production filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Matterer, Mary)
March 10, 2017 Opinion or Order Filing 45 NOTICE OF SERVICE of Initial Disclosures and Document Production filed by Mylan Inc., Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios)
March 10, 2017 Opinion or Order SO ORDERED, re #42 MOTION for Pro Hac Vice Appearance of Attorney (1) George C. Lombardi (2) Christopher B. Essig and (3) Zachary L. Sorman filed by Actavis Pharma, Inc., Watson Laboratories, Inc. Ordered by Judge Gregory M. Sleet on 3/10/2017. (asw)
March 10, 2017 Opinion or Order Pro Hac Vice Attorney Iams J. Travis for Mylan Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
March 9, 2017 Opinion or Order Filing 44 Official Transcript of Conference held on 2 23 17 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 3/30/2017. Redacted Transcript Deadline set for 4/10/2017. Release of Transcript Restriction set for 6/7/2017. (kjm)
March 8, 2017 Opinion or Order Filing 43 ORDER Setting Teleconference: Plaintiff's counsel to initiate the call. A Telephone Conference is set for 4/3/2017 at 12:00 Noon Eastern Time before Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 3/8/17. (cak)
March 8, 2017 Opinion or Order SO ORDERED - re #33 Proposed Order filed by Amgen Inc., SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR; the parties SHALL WAIT to be contacted by the assigned Magistrate Judge. (Joinder of Parties due by 6/30/2017., Amended Pleadings due by 6/30/2017., Fact Discovery completed by 7/14/2017., Claim Construction Opening Briefs due by 3/31/2017., Claim Construction Answering Briefs due by 4/21/2017., A Markman Hearing (1/2 day) is set for 5/22/2017 at 9:30 AM in Courtroom 4A., Opening Expert Reports due by 8/11/2017., Rebuttal Expert Reports due by 9/8/2017., Reply Expert Reports due by 9/29/2017., Expert Discovery due by 11/3/2017., Proposed Pretrial Order due by 1/29/2018., A Final Pretrial Conference is set for 2/15/2018 at 10:00 AM in Courtroom 4A., A 7-day Bench Trial is set for 3/5/2018 at 9:00 AM in Courtroom 4A). Ordered by Judge Gregory M. Sleet on 3/8/2017. (mdb)
March 8, 2017 Opinion or Order CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at # http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (cak)
March 7, 2017 Opinion or Order Filing 42 MOTION for Pro Hac Vice Appearance of Attorney (1) George C. Lombardi (2) Christopher B. Essig and (3) Zachary L. Sorman - filed by Actavis Pharma, Inc., Watson Laboratories, Inc.. (Keller, Karen)
March 7, 2017 Opinion or Order Filing 41 NOTICE OF SERVICE of 1) Defendants' Responses and Objections to Plaintiff's First Set of Requests to Dr. Reddy's for the Production of Documents and Things; and 2) Defendants' Responses and Objections to Plaintiff's Second Set of Requests to Dr. Reddy's for the Production of Documents and Things filed by Dr. Reddys Laboratories, Inc..(Bellew, Joseph)
March 7, 2017 Opinion or Order Filing 40 NOTICE OF SERVICE of 1) Defendants' Responses and Objections to Plaintiff's First Set of Requests to Micro Labs for the Production of Documents and Things; and 2) Defendants' Responses and Objections to Plaintiff's Second Set of Requests to Micro Labs for the Production of Documents and Things filed by Micro Labs Limited.(Bellew, Joseph)
March 7, 2017 Opinion or Order Filing 39 NOTICE OF SERVICE of (1) Hetero's responses to Plaintiff's First Set of Requests for Production; and (2) Hetero's responses to Amgen's Second Set of Requests for Production filed by Hetero Labs Ltd., Hetero Labs Ltd. Unit V, Hetero USA Inc..(Dorsney, Kenneth)
March 7, 2017 Opinion or Order Filing 38 NOTICE OF SERVICE of Defendants' Responses to Plaintiff's First and Second Set of Requests for the Production of Documents and Things filed by Strides Pharma Inc..(Green, James)
March 7, 2017 Opinion or Order Filing 37 NOTICE OF SERVICE of (1) Defendant Breckenridge Pharmaceutical, Inc.'s Responses and Objections to Plaintiffs First Set of Requests for the Production of Documents and Things; and (2) Defendant Breckenridge Pharmaceutical, Inc.s Responses and Objections to Plaintiffs Second Set of Requests for the Production of Documents and Things filed by Breckenridge Pharmaceutical Inc..(Phillips, John)
March 7, 2017 Opinion or Order CORRECTING ENTRY: The Proposed Scheduling Order ( #33 ) has been replaced to correct a date listed in the order. (mdb)
March 7, 2017 Opinion or Order SO ORDERED - re #31 MOTION for Pro Hac Vice Appearance of Attorney Travis J. Iams filed by Mylan Inc., Mylan Pharmaceuticals Inc. Ordered by Judge Gregory M. Sleet on 3/7/2017. (mdb)
March 6, 2017 Opinion or Order Filing 36 NOTICE OF SERVICE of Defendants Cipla Limited and Cipla Usa, Inc.S Responses to Plaintiffs First Set of Requests for the Production of Documents and Things; and (2) Defendants Cipla Limited and Cipla Usa, Inc.s Responses to Plaintiffs Second Set of Requests for the Production of Documents and Things filed by Cipla Limited, Cipla USA Inc..(Bussiere, Sara) Modified on 3/7/2017 (mdb).
March 6, 2017 Opinion or Order Filing 35 NOTICE OF SERVICE of (1) Ajanta Pharma Limited and Ajanta Pharma USA Inc.s Objections and Responses to Plaintiffs First Set of Requests for the Production of Documents and Things (Nos. 1-62); and (2) Ajanta Pharma Limited and Ajanta Pharma USA Inc.s Objections and Responses to Plaintiffs Second Set of Requests for the Production of Documents and Things (Nos. 63-74) filed by Ajanta Pharma Limited, Ajanta Pharma USA Inc..(Bilson, David)
March 6, 2017 Opinion or Order Filing 34 NOTICE OF SERVICE of (1) Sun Pharmaceutical Industries, Ltd., Sun Pharma Global FZE and Sun Pharmaceutical Industries, Inc.s Objections and Responses to Plaintiffs First Set of Requests for Production to Defendants (Nos. 1-62); and (2) Sun Pharmaceutical Industries, Ltd., Sun Pharma Global FZE and Sun Pharmaceutical Industries, Inc.s Objections and Responses to Plaintiffs Second Set of Requests for Production to Defendants (Nos. 63-74) filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Bilson, David)
March 6, 2017 Opinion or Order Filing 33 PROPOSED ORDER -- Scheduling Order -- by Amgen Inc.. (Attachments: #1 Letter to The Honorable Gregory M. Sleet enclosing order)(Noreika, Maryellen) (Main Document 33 replaced on 3/7/2017) (mdb).
March 6, 2017 Opinion or Order Filing 32 NOTICE OF SERVICE of Defendants' Responses to Plaintiff's Second Set of Requests for the Production of Documents and Things and Defendants' Responses to Plaintiff's First Set of Requests for the Production of Documents and Things filed by Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC.(Palapura, Bindu)
March 6, 2017 Opinion or Order Filing 31 MOTION for Pro Hac Vice Appearance of Attorney Travis J. Iams - filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios)
March 3, 2017 Opinion or Order Filing 30 NOTICE OF SERVICE of (1) Defendants' Joint Initial Invalidity Contentions and (2) this Notice of Service filed by Actavis Pharma, Inc., Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York LLC, Apotex Corp., Apotex Inc., Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Breckenridge Pharmaceutical Inc., Cipla Limited, Cipla USA Inc., Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit V, Hetero USA Inc., Micro Labs Limited, Micro Labs USA, Inc., Mylan Inc., Mylan Pharmaceuticals Inc., Strides Pharma Global PTE Limited, Strides Pharma Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc., Watson Laboratories, Inc..(Brauerman, Stephen)
March 3, 2017 Opinion or Order Filing 29 NOTICE OF SERVICE of (1) Plaintiff's Rule 26(a) Initial Disclosures to Mylan, (2) Plaintiff's Disclosures Pursuant to District of Delaware Default Standard Paragraph 3 to Mylan, and (3) Plaintiff's Default Standard Para 4(a) Disclosures to Mylan filed by Amgen Inc..(Noreika, Maryellen)
March 2, 2017 Opinion or Order Filing 28 NOTICE OF SERVICE of (1) Plaintiff's First Set of Requests to Mylan for the Production of Documents and Things; (2) Plaintiff's Second Set of Requests to Mylan for the Production of Documents and Things; (3) Plaintiff's First Set of Interrogatories to Ajanta; (4) Plaintiff's First Set of Interrogatories to Amneal; (5) Plaintiff's First Set of Interrogatories to Apotex; (6) Plaintiff's First Set of Interrogatories to Aurobindo; (7)Plaintiff's First Set of Interrogatories to Breckenridge; (8) Plaintiff's First Set of Interrogatories to Cipla; (9) Plaintiff's First Set of Interrogatories to Dr. Reddy's; (10) Plaintiff's First Set of Interrogatories to Hetero; (11) Plaintiff's First Set of Interrogatories to Micro Labs; (12) Plaintiff's First Set of Interrogatories to Mylan; (13) Plaintiff's First Set of Interrogatories to Strides; (14) Plaintiff's First Set of Interrogatories to Sun; (15) Plaintiff's First Set of Interrogatories to Watson filed by Amgen Inc..(Noreika, Maryellen)
February 28, 2017 Opinion or Order Pro Hac Vice Attorney Joseph M. Janusz, Deepro R. Mukerjee, Stephanie M. Roberts, and Lance A Soderstrom for Mylan Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg)
February 27, 2017 Opinion or Order SO ORDERED - re #26 MOTION for Pro Hac Vice Appearance of Attorney Deepro R. Mukerjee, Lance Soderstrom, Stephanie Roberts and Joseph M. Janusz filed by Mylan Inc., Mylan Pharmaceuticals Inc. Ordered by Judge Gregory M. Sleet on 2/27/2017. (mdb)
February 24, 2017 Opinion or Order Filing 27 NOTICE OF SERVICE of Plaintiff's Proposed Claim Terms for Construction filed by Amgen Inc..(Noreika, Maryellen)
February 24, 2017 Opinion or Order Filing 26 MOTION for Pro Hac Vice Appearance of Attorney Deepro R. Mukerjee, Lance Soderstrom, Stephanie Roberts and Joseph M. Janusz - filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios)
February 23, 2017 Opinion or Order Minute Entry for proceedings held before Judge Gregory M. Sleet - Scheduling Conference held on 2/23/2017. Discussion regarding the schedule and issues outlined in the joint status report. The court orders that these cases are consolidated for all purposes, including trial, without prejudice. All future filings are to be made ONLY in Lead C.A. No. 16-853 (GMS). There will be no summary judgment deadlines in the schedule. The Markman Hearing (1/2 day) is set for 5/22/2017 at 9:30 AM in Courtroom 4A; the Proposed Final Pretrial Order is due by the close of business on 1/29/2018; the Final Pretrial Conference is set for 2/15/2018 at 10:00 AM in Courtroom 4A; and a 7-day Bench Trial is set for 3/5/2018 at 9:00 AM in Courtroom 4A. The parties are given leave to amend the remaining deadlines in light of the assignment of these dates, and these cases are referred to the Magistrate Judge for exploring ADR. The plaintiff shall file the amended scheduling order by 3/6/2017, in the Lead Case only. (Court Reporter Kevin Maurer.) Associated Cases: 1:16-cv-00853-GMS et al.(mdb)
February 23, 2017 Opinion or Order Remark - These cases have been consolidated for all purposes. All future filings shall be made ONLY in Lead C.A. No. 16-853 (GMS) (mdb)
February 10, 2017 Opinion or Order Filing 25 NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions Regarding Aurobindo filed by Amgen Inc..(Blumenfeld, Jack)
February 6, 2017 Opinion or Order Filing 24 NOTICE OF SERVICE of Planitiff Amgen Inc.'s Responses and Objections to Defendants' First Requests for the Production of Documents and Things filed by Amgen Inc..(Blumenfeld, Jack)
February 3, 2017 Opinion or Order Filing 23 NOTICE OF SERVICE of (1) Plaintiff's First Set of Requests to Aurobindo for the Production of Documents and Things and (2) Plaintiff's Second Set of Requests to Aurobindo for the Production of Documents and Things filed by Amgen Inc..(Noreika, Maryellen)
January 26, 2017 Opinion or Order ORAL ORDER - A Scheduling Conference is set for Thursday, February 23, 2017 at 10:00 AM (EST) in Courtroom 4A to discuss the contents of the Joint Status Report and Proposed Schedule. Ordered by Judge Gregory M. Sleet on 1/26/2017. Associated Cases: 1:16-cv-00853-GMS et al.(mdb)
January 13, 2017 Opinion or Order Filing 22 NOTICE OF SERVICE of Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) and Paragraph 3 Disclosures Pursuant to Default Standard for Discovery filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Matterer, Mary)
January 13, 2017 Opinion or Order Filing 21 NOTICE OF SERVICE of (1) Plaintiff's Disclosures Pursuant to District of Delaware Default Standard Paragraph 3 and (2) Plaintiff's Rule 26(a)(1) Initial Disclosures filed by Amgen Inc..(Blumenfeld, Jack)
January 9, 2017 Opinion or Order SO ORDERED - re (24 in 1:16-cv-00854-GMS, 20 in 1:16-cv-00927-GMS, 22 in 1:16-cv-00900-GMS, 26 in 1:16-cv-00882-GMS, 19 in 1:16-cv-00853-GMS, 23 in 1:16-cv-00881-GMS, 22 in 1:16-cv-00855-GMS, 24 in 1:16-cv-00899-GMS, 20 in 1:16-cv-00928-GMS, 23 in 1:16-cv-00880-GMS, 21 in 1:16-cv-00926-GMS, 21 in 1:16-cv-00925-GMS) STIPULATION TO EXTEND TIME to serve Initial Disclosures Puruant to Fed. R. Civ. P. 26(a) and Pursuant to Paragrah 3 of Default Standard for Discovery to January 13, 2017 filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc. Ordered by Judge Gregory M. Sleet on 1/9/2017. Associated Cases: 1:16-cv-00882-GMS et al.(mdb)
January 6, 2017 Opinion or Order Filing 20 NOTICE OF SERVICE of Plaintiff's Default Standard 4(a) Disclosures filed by Amgen Inc..(Blumenfeld, Jack)
January 6, 2017 Opinion or Order Filing 19 STIPULATION TO EXTEND TIME to serve Initial Disclosures Puruant to Fed. R. Civ. P. 26(a) and Pursuant to Paragrah 3 of Default Standard for Discovery to January 13, 2017 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc.. (Matterer, Mary)
January 6, 2017 Opinion or Order Filing 18 Amended ANSWER to #10 Answer to Complaint, Counterclaim by Amgen Inc. (Blumenfeld, Jack) Modified on 1/9/2017 (mdb).
January 5, 2017 Opinion or Order Filing 17 NOTICE OF SERVICE of Defendants First Set of Requests for Production filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Matterer, Mary)
December 23, 2016 Opinion or Order Filing 16 AMENDED ANSWER to #10 Answer to Complaint, Counterclaim by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc.. (Matterer, Mary)
December 22, 2016 Opinion or Order SO ORDERED - re #15 STIPULATION TO EXTEND TIME for Plaintiff to respond to Defendants' counterclaims to December 23, 2016 filed by Amgen Inc. Ordered by Judge Gregory M. Sleet on 12/22/2016. (mdb)
December 20, 2016 Opinion or Order Filing 15 STIPULATION TO EXTEND TIME for Plaintiff to respond to Defendants' counterclaims to December 23, 2016 - filed by Amgen Inc.. (Noreika, Maryellen)
December 15, 2016 Opinion or Order Filing 14 Joint STATUS REPORT by Amgen Inc.. (Noreika, Maryellen)
December 12, 2016 Opinion or Order SO ORDERED - re (15 in 1:16-cv-00928-GMS, 17 in 1:16-cv-00855-GMS, 16 in 1:16-cv-00899-GMS, 16 in 1:16-cv-00925-GMS, 13 in 1:16-cv-00853-GMS, 19 in 1:16-cv-00881-GMS, 19 in 1:16-cv-00854-GMS, 17 in 1:16-cv-00900-GMS, 20 in 1:16-cv-00882-GMS, 19 in 1:16-cv-00880-GMS, 16 in 1:16-cv-00926-GMS, 15 in 1:16-cv-00927-GMS) STIPULATION TO EXTEND TIME for the parties to submit the joint status report and proposed scheduling order to December 15, 2016 filed by Amgen Inc. Ordered by Judge Gregory M. Sleet on 12/12/2016. Associated Cases: 1:16-cv-00854-GMS et al.(mdb)
December 8, 2016 Opinion or Order Filing 13 STIPULATION TO EXTEND TIME for the parties to submit the joint status report and proposed scheduling order to December 15, 2016 - filed by Amgen Inc.. (Blumenfeld, Jack)
November 30, 2016 Opinion or Order Filing 12 ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 11/30/2016. (asw)
November 28, 2016 Opinion or Order Filing 11 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Ltd. for Aurobindo Pharma USA Inc. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc.. (Matterer, Mary)
November 28, 2016 Opinion or Order Filing 10 ANSWER to #1 Complaint, , COUNTERCLAIM against Amgen Inc. by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Matterer, Mary)
November 15, 2016 Opinion or Order SO ORDERED - re (13 in 1:16-cv-00882-GMS, 12 in 1:16-cv-00926-GMS, 11 in 1:16-cv-00928-GMS, 9 in 1:16-cv-00927-GMS, 15 in 1:16-cv-00880-GMS, 16 in 1:16-cv-00854-GMS, 11 in 1:16-cv-00855-GMS, 14 in 1:16-cv-00900-GMS, 11 in 1:16-cv-00925-GMS, 12 in 1:16-cv-00881-GMS, 9 in 1:16-cv-00853-GMS) MOTION for Pro Hac Vice Appearance of Attorney Lois M. Kwasigroch and Wendy A. Whiteford filed by Amgen Inc. Ordered by Judge Gregory M. Sleet on 11/15/2016. Associated Cases: 1:16-cv-00853-GMS et al.(mdb)
November 9, 2016 Opinion or Order Filing 9 MOTION for Pro Hac Vice Appearance of Attorney Lois M. Kwasigroch and Wendy A. Whiteford - filed by Amgen Inc.. (Noreika, Maryellen)
November 9, 2016 Opinion or Order SO ORDERED - re (10 in 1:16-cv-00855-GMS, 10 in 1:16-cv-00928-GMS, 8 in 1:16-cv-00853-GMS, 11 in 1:16-cv-00881-GMS, 9 in 1:16-cv-00899-GMS, 10 in 1:16-cv-00925-GMS, 15 in 1:16-cv-00854-GMS, 13 in 1:16-cv-00900-GMS, 14 in 1:16-cv-00880-GMS, 11 in 1:16-cv-00926-GMS, 8 in 1:16-cv-00927-GMS, 12 in 1:16-cv-00882-GMS) MOTION for Pro Hac Vice Appearance of Attorney John D. Murnane, Joshua I. Rothman and Alicia A. Russo of FITZPATRICK, CELLA, HARPER & SCINTO filed by Amgen Inc. Ordered by Judge Gregory M. Sleet on 11/9/2016. Associated Cases: 1:16-cv-00854-GMS et al.(mdb)
November 7, 2016 Opinion or Order Filing 8 MOTION for Pro Hac Vice Appearance of Attorney John D. Murnane, Joshua I. Rothman and Alicia A. Russo of FITZPATRICK, CELLA, HARPER & SCINTO - filed by Amgen Inc.. (Noreika, Maryellen)
October 17, 2016 Opinion or Order Filing 7 WAIVER OF SERVICE returned executed by Amgen Inc.: For Aurobindo Pharma USA Inc. waiver sent on 9/26/2016, answer due 11/25/2016. (Blumenfeld, Jack)
October 17, 2016 Opinion or Order Filing 6 WAIVER OF SERVICE returned executed by Amgen Inc.: For Aurobindo Pharma Ltd. waiver sent on 9/26/2016, answer due 11/25/2016. (Blumenfeld, Jack)
September 28, 2016 Opinion or Order Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. Associated Cases: 1:16-cv-00853-GMS, 1:16-cv-00854-GMS, 1:16-cv-00855-GMS (rjb)
September 23, 2016 Opinion or Order Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc.. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (aah)
September 22, 2016 Opinion or Order Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Amgen Inc.. (aah)
September 22, 2016 Opinion or Order Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,375,405 B2; (aah)
September 22, 2016 Opinion or Order Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/8/2016. Date of Expiration of Patent: 9/22/2026.(aah)
September 22, 2016 Opinion or Order Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (aah)
September 22, 2016 Opinion or Order Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2000837.) - filed by Amgen Inc. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(aah)

Access additional case information on PACER

Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Amgen Inc. v. Amneal Pharmaceuticals et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Aurobindo Pharma Ltd
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Cadila Healthcare Ltd. doing business as Zydus Cadila
Represented By: David A. Bilson
Represented By: John C. Phillips, Jr.
Represented By: J. Clayton Athey
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Hetero USA Inc.
Represented By: Kenneth Laurence Dorsney
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Mylan Pharmaceuticals Inc.
Represented By: Stamatios Stamoulis
Represented By: Derek S. Neilson
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Cipla Limited
Represented By: Sara E. Bussiere
Represented By: Stephen B. Brauerman
Represented By: Anil H. Patel
Represented By: Elizabeth J. Weiskopf
Represented By: Joshua H. Lee
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Cipla USA Inc.
Represented By: Sara E. Bussiere
Represented By: Stephen B. Brauerman
Represented By: Anil H. Patel
Represented By: Joshua H. Lee
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Strides Pharma Inc.
Represented By: Joseph M. Bennett-Paris
Represented By: James S. Green
Represented By: Philip Y. Kouyoumdjian
Represented By: Jared Thomas Green
Represented By: Ian Scott
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Zydus Pharmaceuticals (USA) Inc.
Represented By: David A. Bilson
Represented By: John C. Phillips, Jr.
Represented By: William D. Hare
Represented By: J. Clayton Athey
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Sun Pharmaceutical Industries Ltd.
Represented By: Caroline L. Marsili
Represented By: David A. Bilson
Represented By: John C. Phillips, Jr.
Represented By: Mark S. Schuman
Represented By: Samuel T. Lockner
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Amneal Pharmaceuticals LLC
Represented By: Oren D. Langer
Represented By: Alan Richard Silverstein
Represented By: David Ellis Moore
Represented By: Bindu Ann George Palapura
Represented By: Kelsey J. McElveen
Represented By: Stephanie E. O'Byrne
Represented By: Jake M. Holdreith
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Micro Labs USA, Inc.
Represented By: Martin B. Pavane
Represented By: Marilyn Neiman
Represented By: Gene A. Lang
Represented By: Joseph J. Bellew
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Aurobindo Pharma USA Inc.
Represented By: Mary Matterer
Represented By: Gregory C. Bays
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Hetero Labs Ltd.
Represented By: Kenneth Laurence Dorsney
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Dr. Reddys Laboratories, Inc.
Represented By: Joseph J. Bellew
Represented By: Martin B. Pavane
Represented By: Marilyn Neiman
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Ajanta Pharma USA Inc.
Represented By: Arun John Mohan
Represented By: Tara L. Feld
Represented By: David A. Bilson
Represented By: John C. Phillips, Jr.
Represented By: Jaimin H. Shah
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Aurobindo Pharma Ltd.
Represented By: Mary Matterer
Represented By: Gregory C. Bays
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Micro Labs Limited
Represented By: Martin B. Pavane
Represented By: Marilyn Neiman
Represented By: Joseph J. Bellew
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Slate Run Pharmaceuticals, LLC
Represented By: John C. Phillips, Jr.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Actavis Pharma, Inc.
Represented By: Elizabeth M. Crompton
Represented By: Karen Elizabeth Keller
Represented By: John W. Bateman
Represented By: C. Kyle Musgrove
Represented By: John W. Shaw
Represented By: David M. Fry
Represented By: Elizabeth E. Grden
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Watson Laboratories, Inc.
Represented By: Elizabeth M. Crompton
Represented By: Karen Elizabeth Keller
Represented By: Christopher B. Essig
Represented By: John W. Bateman
Represented By: George C. Lombardi
Represented By: C. Kyle Musgrove
Represented By: John W. Shaw
Represented By: David M. Fry
Represented By: Zachary L. Sorman
Represented By: Elizabeth E. Grden
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Amneal Pharmaceuticals of New York LLC
Represented By: Oren D. Langer
Represented By: Alan Richard Silverstein
Represented By: David Ellis Moore
Represented By: Bindu Ann George Palapura
Represented By: Kelsey J. McElveen
Represented By: Stephanie E. O'Byrne
Represented By: Jake M. Holdreith
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Hetero Labs Ltd. Unit V
Represented By: Kenneth Laurence Dorsney
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Apotex Inc.
Represented By: Steven A. Maddox
Represented By: Dominick T. Gattuso
Represented By: Kaveh V. Saba
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Apotex Corp.
Represented By: Steven A. Maddox
Represented By: Dominick T. Gattuso
Represented By: Kaveh V. Saba
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Mylan Inc.
Represented By: Lance A. Soderstrom
Represented By: Stephanie M. Roberts
Represented By: Iams J. Travis
Represented By: Deepro R. Mukerjee
Represented By: Stamatios Stamoulis
Represented By: Derek S. Neilson
Represented By: Joseph M. Janusz
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Cipla Ltd.
Represented By: Michael J. Farnan
Represented By: Brian E. Farnan
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Breckenridge Pharmaceutical Inc.
Represented By: David A. Bilson
Represented By: John C. Phillips, Jr.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Sun Pharmaceutical Industries, Inc.
Represented By: Kasey E. Koballa
Represented By: Courtney S. Dabbiere
Represented By: Caroline L. Marsili
Represented By: David A. Bilson
Represented By: John C. Phillips, Jr.
Represented By: Mark S. Schuman
Represented By: Mitchell G. Stockwell
Represented By: Samuel T. Lockner
Represented By: Dominick T. Gattuso
Represented By: David Clay Holloway
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Ajanta Pharma Limited
Represented By: Arun John Mohan
Represented By: Tara L. Feld
Represented By: David A. Bilson
Represented By: John C. Phillips, Jr.
Represented By: John K. Hsu
Represented By: Jaimin H. Shah
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Strides Pharma Global PTE Limited
Represented By: Joseph M. Bennett-Paris
Represented By: James S. Green
Represented By: Philip Y. Kouyoumdjian
Represented By: Jared Thomas Green
Represented By: Ian Scott
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Piramal Healthcare Limited
Represented By: Rajendra A. Chiplunkar
Represented By: David A. Bilson
Represented By: Alejandro Menchaca
Represented By: John C. Phillips, Jr.
Represented By: Aaron F. Barkoff
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Dr. Reddys Laboratories, Ltd.
Represented By: Martin B. Pavane
Represented By: Marilyn Neiman
Represented By: Joseph J. Bellew
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Sun Pharma Global FZE
Represented By: Kasey E. Koballa
Represented By: Courtney S. Dabbiere
Represented By: Caroline L. Marsili
Represented By: David A. Bilson
Represented By: John C. Phillips, Jr.
Represented By: Mark S. Schuman
Represented By: Mitchell G. Stockwell
Represented By: Samuel T. Lockner
Represented By: Dominick T. Gattuso
Represented By: David Clay Holloway
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Cipla USA, Inc.
Represented By: Michael J. Farnan
Represented By: Brian E. Farnan
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Sun Pharmaceutical Industries Ltd.,
Represented By: Kasey E. Koballa
Represented By: Courtney S. Dabbiere
Represented By: Mitchell G. Stockwell
Represented By: Dominick T. Gattuso
Represented By: David Clay Holloway
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Amgen Inc.
Represented By: Maryellen Noreika
Represented By: Jack B. Blumenfeld
Represented By: Wendy A. Whiteford
Represented By: Derek James Fahnestock
Represented By: J. Drew Diamond
Represented By: Lois M. Kwasigroch
Represented By: Brian Kao
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
3rd party defendant: Alkem Laboratories Ltd.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
3rd party defendant: Ascend Laboratories, LLC
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Counter claimant: Cadila Healthcare Ltd.
Represented By: David A. Bilson
Represented By: J. Clayton Athey
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?